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Abstract 
Objective: There is evidence that in patients with epilepsy interictal discharges can 
be accompanied by transitory cognitive impairment (TCI). However, it is not kno\vn 
whether interictal discharges and TCI impair day to day psychosocial functioning, 
and if so whether drug treatment to suppress discharges is effective in the absence of 
clinical seizures. 
Aims of study: (1) Effect of lamotrigine on interictal discharges, behaviour and 
cognition in children with epilepsy. (2) Effect of interictal discharges on behaviour 
and cognition in children with epilepsy. (3) Effect of suppression of discharges 
behaviour in children with epilepsy. 
Method: In a randomised, double-blind, placebo-controlled, cross-over study with 
lamotrigine ambulatory EEG, cognitive test battery and behavioural scores were 
measured in 61 patients at baseline, placebo and lamotrigine phase. 
Results: 
Interictal discharges are common in children with epilepsy even if seizures are well 
controlled. Lamotrigine reduced the duration of discharges per hour, but not the total 
number per hour in this group of patients. Lamotrigine had no significant negative or 
positive effect on cognitive performance in children with epilepsy. Tel was found in 
over 500/0 of patients with sufficient discharges for analysis. There was a significant 
correlation of side of discharges to the type of test (spatial or verbal), when 
correcting for dominant hemisphere. Interictal discharges were associated with 
impaired cognitive performance (working memory). During treatment with 
lamotrigine global rating of behaviour significantly improved in patients with a 
reduction in discharges rate, but not in patients with without a change in discharge 
rate. This was independent of randomization or presence of seizures. 
Conclusion: lnterictal discharges are common even in children Vvith well-controlled 
epilepsy and associated \vith cognitive impairment particularly affecting \\orking 
memory. Our data suggest that suppressing interictal discharges can improve 
behaviour in children with behavioural problems and epilepsy. 
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Chapter 1: Introduction 
1.1. Seizures and epilepsies 
1.1.1. Classification of epileptic seizures and syndromes 
Epilepsy is generally defined as a condition characterised by the occurrence of 
recurrent epileptic seizures of cerebral origin. Epileptic seizures consist of a 
paroxysmal dysfunction of cerebral neurophysiological function and, in general, have 
a correlate on the electroencephalogram (EEG). 
Epilepsy can be classified in several ways - by clinical events, aetiology, EEG 
changes, pathophysiology, anatomy, or age. In 1969 the International League against 
Epilepsy (ILAE) introduced a classification of seizure type, revised in 1981 
(Commission on Classification and Terminology of the International League against 
Epilepsy, 1981), in which the EEG data are taken into account whereas aetiology, 
age, and anatomical side were ignored. In this scheme seizures are divided into three 
groups: generalised, partial and unclassifiable. Generalised seizures are further 
divided into absence (typical and atypical), myoclonic, clonic, tonic, tonic-clonic and 
atonic. Partial seizures, i.e. seizures beginning focally or locally, are divided into 
simple partial without impairment of consciousness and complex partial with 
alteration of consciousness. If seizures begin as partial seizures and then spread to 
become generalised, they are termed secondarily generalised. 
An epilepsy syndrome may be defined as a disorder characterised by a cluster of 
signs and symptoms occurring together. The ILAE proposed a new scheme in 1989 
which takes into account seizure type, EEG, prognostic, pathophysiological and 
aetiological data, the classification of the epilepsies and epilepsy syndromes and 
related seizure disorders (Commission on Classification and Terminology of the 
International League against Epilepsy, 1989). The main subdivision is into focal or 
localisation-related epilepsies and epilepsy syndromes on the one hand and 
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generalised epilepsies and epilepsy syndromes on the other. The two major 
dichotomies are into epilepsies characterised by seizures which are partial at onset 
and those which are primary generalised. The second dichotomy is between seizures 
that are idiopathic and those which are symptomatic. This usually devolves into those 
which have a genetic predisposition and those which are determined by a structural or 
lesional aetiology. Two new categories are added in this classification: cryptogenic 
(symptomatic aetiology is suspected but the aetiology is not known), and special 
syndromes. In contrast to adults it is usually easier and more practicable to classify 
seizure disorders in children according to syndromes rather than seizures. More 
recently the Task Force on Classification and Terminology of the ILAE has published 
a new proposal for a diagnostic scheme (Engel, 2001). 
Conditions investigated in this thesis are idiopathic and symptomatic epilepsy 
syndromes of childhood. A population based epidemiologic study of epilepsy in 
school age children carried out in Italy found a prevalence of epileptics aged 5 to 14 
years varied between 0.40/0 and 0.50/0. The primary generalized epilepsies represent 
30%, the epilepsies with rolandic spike foci 24%, the other types of partial epilepsy 
42%, and the Lennox-Gastaut syndrome 3% (Cavazzuti 1980). 
1.1.2. Pathophysiology of seizure activity 
Seizures result from excessive synchronous electrical discharge (depolarisation) of 
the neurones in the brain due to an intercellular influx of sodium and calcium. 
Seizure activity begins when a number ofneurones depolarise simultaneously. As 
initial depolarisation is caused by influx of calcium- and sodium-ions, blockade of 
ion channels stabilises the neuronal membrane and prevents depolarisation. A 
clinically apparent seizure occurs when the abnormal impulse spreads from its point 
of origin to adjacent and/or distant areas of the brain. y-Aminobutyric acid (GABA), 
the major inhibitory neurotransmitter in the human brain, suppresses distribution of 
the impulse by opening neuronal chloride and potassium channels, thereby inducing 
membrane hyperpolarisation. A defect in the activity of GABA may therefore result 
in enhanced propagation of the epileptiform discharge. 
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Increased activity of excitatory neurotransmitters, such as glutamate and possibly 
aspartate, may also contribute to the spread of epileptic activity. Glutamate appears to 
be the main excitatory neurotransmitter involved in this process. Glutamate is active 
at several postsynaptic receptor sites, namely the N-methyl-d-aspartate (NMDA) 
receptor, the d-amino-hydroxy-5-methyl-4-isoxazolepropionate (AMP A) receptor, 
the kinate receptor and the quisqualate receptor. After binding to the NMDA 
receptor, glutamate induces intermittent bursts of neuronal firing similar to those 
seen in an epileptic discharges. Antagonists of the NMDA receptor have been shown 
to be effective antiepileptics in animal models (Rogawski, 1992). Thus, it is at this 
receptor that glutamate is thought to exert its convulsive effects. Glutamate release 
depends on presynaptic membrane depolarisation produced by fast, transient, 
voltage-activated, inward sodium currents. These are followed by a brief period of 
fast inactivation. Slow inactivation gradually develops during sustained rapid firing 
that tends to terminate the discharge. 
Infants and children are more prone to have seizures than adults. The immature brain 
appears to suffer from excessive depolarisation for a number of reasons. Factors 
which disturb energy production will cause failure of the adenosine triphosphate 
dependant Na-K pump (which maintains the cells equilibrium potential) and hence 
excessive depolarisation (Moshe, 1993). Hypoxemia, ischaemia and hypoglycaemia 
are common neonatal conditions which decrease energy production. 
1.2. Cognitive and Psychosocial Function in Children with Epilepsy 
Cognition can be defined as an individual's ability to acquire, retain, process and act 
upon information about and from the environment in an adaptive manner. This skill 
involves a wide range of mental processes including perception, memory, learning. 
attention, vigilance, understanding and interpretation. Behaviour, in the broadest 
sense encompasses all activities concerning autonomic responses and integrated 
reactions to dynamic situations. the experiencing and expressing of emotions and the 
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forming and maintaining of interpersonal relationships. Cognition and behaviour, 
therefore are the ways in which an individual interacts with the world and it's 
inhabitants. Cognition depends on many factors in the person's overall physical and 
mental state (e.g. pain, arousal, sensation and emotion). 
The idea that epilepsy might be associated with loss of intellectual ability and 
emotional stability is not a new one. William Gowers (1885) said: 
"The mental state of epileptics, as is well known, frequently presents deterioration ... 
In its slighter forms there is merely defective memory, especially for recent 
acquisition. In more severe degree there is greater imperfection of intellectual power, 
weakened capacity for attention and often defective moral control. Mischievous 
restlessness and irritability in childhood may develop to vicious and even criminal 
tendencies in adult life. Every grade of intellectual defect may be met with, down to 
actual imbecility." 
More recently studies of quality of life have examined the difference between that in 
children with epilepsy and in other chronically ill children (Hoare, 1984; Austin et 
al., 1994, 1996, 1998). Austin et al. (1994) compared children with epilepsy and 
those with asthma, another chronic disease with unpredictable episodes, requiring 
medication and regular visits to a physician. Children with epilepsy showed a more 
compromised quality of life in psychological, social and educational domains, even 
though they developed their condition at a later age and were having fewer episodes. 
In contrast, children with asthma had a more compromised quality of life in the 
physical domain. This suggests that, in addition to dealing with a chronic disorder, 
other aspects of epilepsy are related to a poorer quality of life in psychosocial and 
cognitive domains. 
It is an ongoing controversy as to whether the epilepsy causes cognitive and 
behavioural problems or whether epilepsy is to be viewed as a concomitant to the 
deterioration of cognitive function and behaviour. These explanations are not 
mutually exclusive. In this context, the definition of cognitive function will be the 
ability to dealtneaningfully with information from the surrounding world, and the 
definition of behaviour will be the ability to interact \vith others. 
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1.2.1. Cognitive Impairment 
1.2.1.1. Intellectual Ability 
It is generally believed that people with epilepsy show scores in IQ tests between 5 to 
10 points lower than healthy subjects. This, however, may reflect social factors and 
education rather than biological factors. The careful and often quoted 
epidemiological Isle of Wight study (Rutter et aI., 1970) included 2193 10- and 11-
year old children whose home was on the Island and was based on interviews and 
standardised rating scales completed by parents and teachers. Rutter and co-workers 
found an impairment of intelligence in those children whose seizures were associated 
with cerebral palsy or other brain disorders. Variability in distribution of IQ sub-tests 
was much greater and performance was worse on verbal tests than in normal 
children. A significantly higher proportion of children with epilepsy showed learning 
difficulties than would be expected in such a population. 
In a large longitudinal study it was found that the mean IQ score of children with 
non-febrile seizures tested at 7 years was not significantly different from the mean 
score of their seizure-free siblings. Mental retardation was more common among 
children with seizures but the excess was accounted for by children who had 
neurological abnormalities before the first seizure (Ellenberg et aI., 1986). Others 
found significantly lower mean IQ scores in a group of 50 children with idiopathic 
epilepsy and 25 of their non-epileptic siblings compared to 30 healthy controls 
(Singhi et aI., 1992). The IQ scores of the children with epilepsy were also 
significantly lower than those of their siblings, suggesting that both the cause(s) of 
the epilepsy and the epilepsy itself have an effect. 
1.2.1.2. Scholastic Performance 
The m~jority of children with epilepsy are educated in mainstream schools. However, 
several surveys have consistently shown that problems of learning and behaviour are 
over-represented in such children (Ross et al., 1980). Harrison and Taylor (1976) 
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found that 90-95% of children with epilepsy were attending ordinary schools, 
whereas Verity and Ross (1985) in the National Child Development Study found that 
only 670/0 of 64 children with epilepsy attended ordinary schools at the age of 11 
years, with only 580/0 attending at the age of 15 years. Attending mainstream schooL 
however, does not imply that there are no scholastic problems. Holdsworth and 
Whitmore (1974) examined 117 children with epilepsy from mainstream schools, and 
found that 690/0 were considered by their teachers to be below average or falling 
seriously behind in their work. Twenty one percent had serious behavioural problems 
and 420/0 were markedly inattentive in class. Mellor et al. (1973) examined a large 
population of epileptic children attending mainstream schools in Scotland and 
compared their findings with those in healthy matched controls. Significantly more 
children with epilepsy performed poorly on a reasoning quotient, and 270/0 had 
behavioural problems, as rated by a questionnaire in comparison with 150/0 of 
controls (p<0.05). 
More recently, using a questionnaire designed to look at educational problems and to 
be completed by teachers, Bennet-Levy and Stores (1984) showed that teachers 
perceive children with epilepsy as having poor concentration and mental processing, 
and as being less alert than their non-epileptic peers. Overall, they rate children with 
epilepsy as poor achievers, especially in mathematics. 
Examining the academic achievements of 122 children with epilepsy, Seidenberg et 
al. (1986) noted that they achieved less than expected for their age and IQ. The 
greatest differences were in arithmetic, spelling, reading, comprehension and word 
recognition. 
1.2.2. Behavioural Problems 
Children with epilepsy are at a higher risk of developing behavioural problems and 
psychiatric disorders than their healthy peers. Early reports described multiple 
behavioural problems in children with epilepsy. Bradley reported mood fluctuations, 
hyperactivity, and irritability along with decreased attention span and selecti\'e 
difficulty with mathematics (1951). Ounsted described distractibility. inattention, 
aggression, and mood labiality in children with epilepsy (1955). Pond noted 
neuroticism, aggression, and hyperactivity, and thought that neuroticism was 
relatively more associated with absence seizures and aggression with complex partial 
seizures of temporal lobe origin (1970). 
Rutter's Isle of White study (1970) showed that psychiatric disorders occurred in 8% 
of the general population, in 16% of children with chronic medical disorders, 290/0 of 
children suffering from idiopathic epilepsy, and in 58% of epilepsy cases associated 
with structural cerebral abnormalities (Rutter et aI., 1970). For recent reviews on 
psychiatric disorders in children with epilepsy see Gaitatzis et al. (2004) and Besag 
(2002). 
Some children with epilepsy have specific attention problems (Holdsworth and 
Whitmore, 1974; Stores, 1973). Epileptic boys were significantly more inattentive 
than non-epileptic boys according to teachers and parents. In addition, they 
performed less well on tests of sustained attention and perceptual accuracy (Stores, 
1978). Interestingly, no such differences were seen between two groups of girls with 
and without epilepsy. Others could not confirm such gender difference (Hoare and 
Kerley, 1991), but Austin et al. reported more problems in girls (1992). 
Seizures in children have been associated with specific behavioural problems, with 
disruptive behaviours and mood disorder being found most commonly. There seems 
to be an association between epilepsy and autism, with seizures occurring in up to 
one-third of children with autism. Tuchman and Rapin (1997) have suggested that 
epilepsy and interictal discharges may be implicated in the pathophysiology of a 
minority of children with autism. 
Weglage et al. (1997) assessed the behavioural status of 40 children with centro-
temporal spikes with and without obvious seizures and compared them with 20 
matched controls. The global score of children with discharges was significantly 
worse than controls, due to more problems in the subscales social problems, 
delinquent and compulsive behaviour. 
Of the disruptive disorders, the association between attention-deficitlhyperactivity 
disorder (ADHD) and epilepsy has the best support from research data. Carlton-Ford 
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et al. reported impulsivity in 39% of children with a history of epilepsy versus 11 % 
of controls (1995). Semrud-Clikeman and Wical (1999), using both structured 
interviews and a computerized continuous performance test, found that 33% of 
children with partial complex seizures had ADHD as defined by DSM-III-R criteria. 
Using either the Child or Adolescent Symptom Inventory, Dunn et ai. (2003) noted 
symptoms of ADHD, combined type, in 11 % and ADHD, predominantly inattentive 
type, in 24% of a sample of 175 children with chronic seizures. 
As found in adults with epilepsy, there appears to be an association between 
depression and epilepsy in children and adolescents (Gaitatzis et aI., 2004). Ettinger 
et ai. (1998) reported elevated scores on the Child Depression Inventory in 26% of a 
sample of children 7-18 years of age with epilepsy. Dunn et al. (1999) found that 
230/0 of a sample of adolescents with epilepsy had symptoms of depression. Oguz et 
al. (2002) noted more symptoms of depression in adolescents 12-18 years of age 
with epilepsy when compared with children 9-11 years of age with seizures or 
healthy controls. Children with complex partial seizures had elevated scores on the 
internalizing section of the CBCL, suggesting a risk for depression or anxiety 
(Schoenfeld et aI., 1999). 
Though the increased prevalence of behavioural problems has often been 
documented in children with chronic seizures, several studies have also shown an 
increased prevalence of behavioural problems in children with new-onset or recent-
onset seizures. Aman et al. (1992) examined behaviour in a group of 112 children 
aged 6 to 12 years, with well-controlled seizures and normal IQ. They found 
significantly worse scores on all six subscales of the Child Behavior Checklist 
compared to a healthy control group. Subjects with partial seizures were rated as 
slightly more aggressive and antisocial than those with generalized seizures. 
Comparing behaviour in children with epilepsy and children with diabetes, Hoare 
(1984) found impairment in 48% of children with chronic seizures, 45% of children 
with recent-onset seizures, 170/0 of children with chronic diabetes, and 170/0 of 
children with recent-onset diabetes. Dunn et al. (1997) found that a fourth of the 
children with new-onset seizures had elevated scores on the Child Behavior 
Checklist suggesting a risk for behavioural problems. Austin et aI. (2001) found that 
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320/0 of the children with new-onset seizures had baseline behavioural scores in the 
clinical or at-risk range. 
Medication side effects, such as the association between phenobarbital and increased 
hyperactivity (Vining et al., 1987), and psychosocial issues, such as the stigma of 
epilepsy, have been suggested as contributors to behavioural difficulties in children 
with epilepsy. However, a recent study documented behaviour problems prior to the 
time of first recognized seizures, suggesting that for some children epilepsy is a 
pervasive condition that includes both seizures and behaviour difficulties (Austin et 
al.,2001). 
1.2.3. Factors affecting Cognition and Behaviour 
These data confirm that children with epilepsy, even from non-selected groups, are 
more likely to fail academically and to show increased behavioural problems when 
compared not only with normal healthy children, but also with children having a 
different chronic disorder. Reasons for this are multifactorial and include underlying 
brain lesion, age of onset, seizure type and frequency, adverse social attitudes, 
antiepileptic drugs and EEG abnormalities (Kwan and Brodie, 2001). They need to 
be considered, both singly and in combination, in each individual child (Stores, 
1990). 
1.2.3.1.E1etiology 
Several large studies have shown that patients with epilepsy and a history of 
structural lesions are more likely to develop intellectual impairment compared to 
patients with epilepsy but without such a history (Lennox 1942; Chevrie and AicardL 
1972). However, these studies did not control for years of education. Bourgeois et al. 
(1983) found the mean IQ of children with idiopathic epilepsy to be 102.5 ± 16.1 and 
of children with symptomatic epilepsy to be 89.1 ± 29.6. Finally the Collaborative 
Perinatal Project (Ellenberg et aL 1986) found pre-existing neurological 
abnormalities, including developmental delay, to be a significant predictor for poorer 
intellectual functioning in follow-up. There is no study comparing cognitive function 
in different idiopathic or cryptogenic epilepsy syndromes. 
The type and anatomic location of the brain pathology have crucial impact on the 
type of cognitive deficit. Verbal memory deficit is more commonly associated v,:ith 
left-sided TLE and nonverbal or visual memory is typically affected in right temporal 
seizures (Kwan and Brodie, 2001; Meador, 2002). However, the extent of the 
neurocognitive dysfunction in focal epilepsies is usually more widespread. 
Benign childhood epilepsy with centro-temporal spikes (also called Rolandic 
epilepsy) is regarded as an idiopathic epilepsy and was therefore believed not to be 
accompanied by any neurological or neuropsychological deficits. Several recent 
studies, however, have reported impaired visual-motor co-ordination (Heijbel and 
Bohman, 1975) and attention problems, particularly in children with right-sided 
discharges (Piccirilli et aI., 1994). The only study including a matched control group 
found deficits in performance IQ, visual perception, motor skills and short term 
memory in children with rolandic epilepsy (Weglage et aI., 1997). No significant 
differences could be found for simple finger-motor speed test or a linguistic test. 
Deficits in IQ were significantly correlated with frequency of EEG discharges, but 
not with seizure frequency, lateralisation of discharges or time since the Rolandic 
focus was diagnosed. 
A number of rare epilepsy syndromes are linked with cognitive impairment, 
including Rasmussen' encephalitis and progressive myoclonus epilepsies such as 
Lafora body disease or MELAS. In these cases cognitive impairment clearly arises 
from impairment of brain function caused by the underlying disease, for example 
chronic encephalitis in a Rassmussen's patient. 
1.2.3.2. Age of onset 
Keith et ai. (1955) found that the incidence of mental retardation (defined by various 
IQ n1easures) in children with seizures that began before the age of 6 months was 
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650/0, from 6 months to 2 years 49%, from 2 to 4 years 34%, from 4 to 7 years 22% 
and from 7 to 15 years 12%. It is however, likely that the number of patients \\-ith 
severe epilepsies and consequent learning difficulties is over represented if the 
population is drawn from academic centres. Other studies have confirmed that the 
later in life patients experience their first seizure, the better their subsequent mental 
functioning (Rodin et aI., 1968; Dikmen et aI., 1975). Bourgeois et al. (1983) re-
tested intelligence in children with epilepsy at yearly intervals and found that of 
children whose mean IQ decreased with time, seizures had begun at a significantly 
earlier age than those whose IQ did not decrease. Seizures may interfere with brain 
development and therefore may explain the poor prognosis for cognitive 
development in patients in whom the epilepsy starts early. Alternatively a severe 
underlying cerebral disturbance may cause both, an early onset and more obvious 
learning difficulties. Both processes may operate independently. 
1.2.3.3. Seizure Variables 
Evaluation of the effects of seizure frequency independent from effects of duration or 
severity of epilepsy may not be feasible. However, there is convincing evidence 
showing that higher frequency and duration of temporal lobe epilepsy are associated 
with more severe hippocampal atrophy and cognitive deficiency, possibly through 
secondary neuronal metabolic and structural deterioration (Dodrill, 1986). Seizure 
frequency has been found to influence information processing, alertness, short-term 
memory, and abstraction (Dodrill, 1986 and 2004). Generalized cognitive 
impairment with global decline in attention, memory, and general intelligence is 
more likely to be seen with increasing seizure frequency and epilepsy duration 
(Theodore et aL 1999). Seizure frequency has also been reported as among the most 
relevant determinants of poor quality of life scores in chronic epilepsy (Berto et al.. 
2002). 
Development of hippocampal sclerosis and atrophy in patients with chronic ten1poral 
lobe epilepsy has been correlated \vith age at seizure onset, epilepsy duration. and a 
history of atypical and prolonged febrile seizures. Theodore ct al. (1999) c:\amined 
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MRIs of 35 patients with refractory temporal lobe epilepsy and found a significant 
correlation between the duration of temporal lobe epilepsy, history of febrile seizures, 
and severity of hippocampal sclerosis. However, the age at onset was not predictive 
of hippocampal sclerosis. Comparing patients with unilateral temporal lobe epilepsy 
of>30 years duration to those with 15-30 years duration, 10keit and Ebner (1999) 
showed that psychometric intelligence of patients with longer duration of refractory 
temporal lobe epilepsy were more severely impaired. 
Status epilepticus and prolonged or repetitive seizures may induce permanent 
neuronal injury and result in neuro-cognitive damage. However, this issue requires 
further evaluation as some authors have correlated the development of mental 
deterioration with repeated "convulsive" seizures or status epilepticus only (DodrilL 
1986; Duncan, 2002). 
Pre- and post-ictal effects have also to be considered, but may be more difficult to 
detect and therefore for the family to accept. Nocturnal seizures are thought to have 
detrimental effects on language function and memory (Renier, 1987). 
Patients experiencing more than one hundred generalised tonic-clonic seizures in 
their lifetime are more likely to suffer diminished intelligence than those 
experiencing occasional seizures. Since an early onset of epilepsy relates to a greater 
total number of seizures in a life time, this may be a confounding factor. 
Experiencing more than one type of seizure may impair mental functioning more 
than having only one seizure type (Dodrill 1992). It is believed that generalised tonic-
clonic seizures and complex partial seizures have most effect on cognitive 
functioning (Dodrill, 1978; Seidenberg et al., 1981; Dodrill and Batzel, 1986). 
However, it can similarly be argued that a severe underlying cerebral disturbance 
may cause both more seizures and more obvious learning difficulties. 
In children with idiopathic epilepsies, lower IQ scores are associated with a history of 
status epilepticus, the duration of the seizure disorder and the total number of 
seizures suffered (Singhi et al., 1992). 
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1.2.3.4. Social Factors 
Adverse social attitudes playa major part, particularly the belief that a child with 
epilepsy is fundamentally incapable of the same levels of attainment as other 
children. As a consequence, expectations are set too low and the child is denied the 
usual encouragement to succeed. Equally to be avoided is setting too high 
expectations causeing low self-esteem. Such psychological factors have been 
relatively neglected in research on cognitive function in children with epilepsy, in 
favour of studies into biological influences (Whitman and Hermann, 1989). 
Furthermore, the restrictions imposed by parents and doctors to avoid seizure related 
injuries can impair the quality of life, although restrictions were often not adequately 
adapted to seizure-related risks and were therefore unnecessary (Carpay et a1., 1997). 
1.2.3.5. Antiepileptic Drugs 
When focusing specifically on the cognitive aspects of antiepileptic drugs (AED) 
treatment it is important to realise that it can be difficult to isolate this issue from 
other aspects. AEDs can act on all of the processes if cognition (see section 1.2) and 
thereby indirectly affect the cognitive process. Even in objective neuropsychological 
tests, these other aspects will influence the measures. The use of neuropsychological 
testing, however, has been the major method of objectively measuring cognitive 
function related to the use of AEDs and approximately 100 studies on this issue have 
been published during the last 30 years. For recent reviews see Brunbech and Sabers 
(2002), Loring and Meador (2004) and Besag (2004). Despite this voluminous work, 
much uncertainty still exists with regard to the degree of cognitive effects of AEDs 
and whether there are significant differences in cognitive effects between the major 
AEDs. The reason for this uncertainty is a result of a number of methodological 
problems, which are dealt with in several reviews (Devinsky, 1995; K \van and 
Brodie, 2001; Brunbech and Sabers, 2002; Loring and Meador, 2004). 
These include: (a) no prospective data collection, (b) wider spontaneous cognitive 
fluctuations in patients w'ith epilepsy, (c) no or inadequate control group, (d) testing 
patients during postictal phase, ( e) sample size too small or trying to analyse more 
29 
factors than is warranted by the sample size, (f) testing two or more drugs 
simultaneously, (g) extrapolating data from normal volunteers to patients with 
epilepsy, (h) attributing observations to the AED by default, (i) comparing two drugs 
at doses that are not comparable, and (j) emphasising statistical significance over 
clinical relevance. 
Bennet-Levy and Stores (1984) assessed the profile of cognitive function in 42 
children with epilepsy attending mainstream schools comparing them with a group of 
matched controls. There were no significant differences in concentration, processing 
of information, alertness, confidence, and total attainment scores for reading, maths 
and spelling. However, patients receiving any AED showed lower scores for 
concentration, mental processing, alertness and total attainment scores than patients 
without medication. Various study designs have been used for the purpose of 
identifying and separating a possible drug effect and some of the studies in children 
will be discussed in the following. 
Studies in healthy volunteers 
The cognitive effects of gabapentin 2400 mg/day were compared with carbamazepine 
(mean dosage 731 mg/day) in a double-blind, randomised crossover study on 35 
healthy volunteers (Meador et aI., 1999). A neuropsychological test battery was 
administered at baseline and after a 5-week treatment period. Neuropsychological 
variables were attention/vigilance, dual task, cognitive/motor speed, memory, and 
executive functions. After a I-month non-drug washout period the participants were 
retested. The procedure was duplicated after the second treatment and washout 
period. Gabapentin showed superiority compared with carbamazepine on eight out of 
31 neuropsychological measures; however, compared to the non-drug period, 
gabapentin was favoured in one measure (verbal memory) but was inferior in four 
measures of speed and attention. 
In a study on cognitive function in healthy volunteers, topiramate was compared to 
gabapentin and lamotrigine (Martin et aI., 1999). Seventeen participants were 
divided into three groups and received on average topiramate 2.8 mg/kg, gabapentin 
17 Ing/kg or lamotriginc 3 .5mg/kg per day. Cognitive tests and Profile of Mood 
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States (POMS) were administered at baseline, acutely (3 hours after medication), and 
after 2 and 4 weeks of receiving the drug. The cognitive tests used measured verbal 
fluency, verballeaming and retention, sustained attention, and psychomotor speed. 
Gabapentin and lamotrigine did not alter cognitive function significantly. Only the 
group treated with topiramate showed significant cognitive decline acutely and after 
2 and 4 weeks. The study has been criticised for the small sample size, dosage size 
and administration, and the rather short test interval (Lhatoo et aI., 2000). 
However, data from healthy volunteers have to be treated with caution. In general the 
power of such studies is limited by small sample sizes and the drug-exposure period 
is limited. Thus, rare effects and effects due to longer term treatment can not be 
observed. Nevertheless, volunteer studies may provide information on the short term 
effects of an AED. 
Comparisons between AEDs 
Vining et al. (1987) compared cognitive and behavioural effects of PB and VP A in 
21 children in a double-blind crossover fashion. While on sodium valproate, the 
patients scored significantly higher on full scale IQ, performance IQ, block design 
and Berkeley Paired Association Learning Test. While on phenobarbital, patients 
were rated significantly lower by their parents on three items for behaviour, and were 
also more hyperactive. 
A potential pitfall when comparing neuropsychological effects of two AEDs is 
illustrated by the studies of Dodrill and Troupin. In their original crossover study of 
phenytoin and carbamazepine (Dodrill and Troupin, 1977), the performance of adult 
patients were significantly better for five variables while they were on 
carbamazepine. However, different blood levels were not taken into account. The 
study was reanalysed (Dodrill, 2004) and when patients with a baseline phenytoin 
level of ~ 30 mg/L were eliminated, there were no significant differences. This 
reanalysis does demonstrate the shortcomings of the initial study, but is not in itself a 
valid demonstration of a lack of differences between the two drugs, since a high 
percentage of patients had to be excluded from the phenytoin arm and rendering the 
original randomisation invalid. 
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A multi centre study compared tiagabine with carbamazepine and phenytoin add-on to 
either carbamazepine or phenytoin monotherapy (Dodrill et al., 2000). The cognitive 
test battery measured verbal fluency, verbal learning and retention, visualleaming. 
sustained attention, psychomotor speed and executive functions. 153 patients 
receiving carbamazepine monotherapy were randomised to add-on phenytoin (up to 
maximum 600 or 1000 mg/day) or tiagabine (up to maximum 80 mg/day), and 124 
patients on phenytoin monotherapy were randomised to add-on carbamazepine (up to 
maximum 2000 mg/day) or tiagabine (up to maximum 80 mg/day). After a 16-week 
double-blind treatment period, no significant differences were seen with tiagabine 
compared with add-on carbamazepine or add-on phenytoin. 
Studies in newly diagnosed patients 
Studies in newly diagnosed patients have the advantage of being prospective, but the 
possible effect of seizure activity cannot be eliminated. In a placebo-controlled 
prospective study, 217 children with at least one febrile convulsion were randomised 
to either phenobarbital or placebo (Farwell et al., 1990). Compared with the placebo 
group, the mean IQ score of children randomised to phenobarbital was 8.4 points 
lower after 2 years of treatment, and 5.2 points lower after the medication had been 
discontinued. Stores et al. (1992) tested 63 schoolchildren with newly diagnosed 
epilepsy and 47 matched controls. Patents were randomly assigned to sodium 
valproate or carbamazepine and underwent testing before and 1,3,6, and 12 months 
after onset of treatment. Pre-treatment testing showed lower scores for visoumotor 
co-ordination and aspects of attention, as well as modest behavioural abnormalities 
among the children with epilepsy. During the early phases of treatment, mild 
cognitive and behavioural impairments were detected. Twelve months into treatment 
both drugs were effective in most cases at modest dosage without causing notable 
psychological effects. The authors concluded that the mild and temporary adverse 
cognitive effects seen earlier in treatment could have been the result of uncontrolled 
seizure discharge rather then drug related. 
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Comparison of high versus low doses or levels 
Aman et al. (1990) tested 50 children on carbamazepine who had been seizure free 
for at least two months, once when the drug concentration was expected to be low 
and again at peak levels. During the peak concentration testing session, children 
showed lower scores for matching familiar figures and for auditory-visual 
integration, but higher scores for memory tasks, motor performance and in a 
continuous performance task. However, the concentration of carbamazepine levels in 
saliva did not correlate with any of variables measured. 
Comparison of an AED versus placebo as add-on drug 
This design is usually used for new AEDs in patients with drug resistant epilepsy. 
This design has several disadvantages: (1) patients are on two or three AEDs already 
and accumulative effects of the different drugs can not be differentiated; (2) effect of 
on-going seizure activity cannot be eliminated; (3) patients often have pre-existing 
learning difficulties and behavioural problems. However, for ethical reasons this 
design has to be used for II and early phase III studies and occasionally cognitive 
testing has been included in such studies. The addition of tiagabine could not be 
shown to cause clinically important changes in terms of cognition or quality of life 
effects in studies in adults (Kalviainen et al., 1996; Dodrill et a1., 1997). For studies 








Impairment of cognitive functioning 
None 
No significant change 
No clear effect 
Impairment of memory in normal volunteers 
Impairment of short term memory 
Lower I Q scores compared to VP A 
persisting lower IQ in children with FC 
Reading skills impaired 
Impairment at high serum levels 
Disturbance of vi suo-motor performance & IQ 
Impairment of memory in normal volunteers 
Disturbance of vi suo-motor performance, attention 
No clear effect 
Behavioural disturbances 
No clear effect 
Hyperactivity 
Attentiveness 
No clear effect 
Associated with behavioural disturbances 
Table 1.1 a: The effects of old antiepileptic drugs on cognitive function and behaviour 
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Author 
Gallassi et aI., 1986 
Arnan et aI., 1990 
Stores et aI., 1992 
Meador et aI., 2001 
Ingram, 1986 
MacLeod et aI., 1978 
Vining et aI., 1987 
Farwell et aI., 1990 
Stores, 1978 
Nolte et aI., 1980 
Gallassi et aI., 1987 
Meador et aI., 1993 
Gallassi et aI., 1990 
Stores et aL 1992 
Browne, 1976 
Drug Impairment of cognitive functioning 




No significant difference compared to PHT, PB, VPA, CPZ 
worsening on 1 variable (short term memory) 
deterioration in attention, vigilance and word naming 
no significant difference compared to PHT or CBZ 
significantly better performance compared to CBZ 
No change in psychomotor and memory tests 
Levetiracetam Small improvements in tapping rate, selective reaction time, and memory, but no control group 
Vigabatrin improved on memory, and flexibility of mental processing compared to CBZ 
Impaired Digit Cancellation Test with increasing dose 
Author 
Aikiti et al., 1 992 
Sabers et aL 1995 
Aldenkamp et aL 2000 
Meador et al., 1 997 
Dodrill et aL 2000 
Meador et al., 1999 
Leach et al., 1997 
Neyens et aI., 1995 
Kalvitiinen et aL 1995 
Dodrill et aL 1995 
---- --------------------------------------------------------------------------------------------------
Tahlc 1.1 b: The effects of new antiepileptic drugs on cognitive function and behaviour (for lamotrigine, see Chapter 1.4). CBZ: carbamazepine, PB: 
phenobarbital, PHT: phenytoin, VPA: sodium valproate, CNZ: clonazepam. 
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Withdrawal studies 
Assessing cognitive and behavioural effects of AEDs by testing seizure-free subjects 
before and after discontinuation eliminates many confounding factors, in particular 
the effect of on-going seizure activity. A possible shortcoming of such a design is 
that it may not unmask potential chronic cumulative cognitive effects that are not or 
only slowly reversible. Also, control groups are essential to assess a possible learning 
effect. Gallassi et ai. (1986, 1987, 1990) used a withdrawal design to study the effects 
of phenobarbital, carbamazepine, phenytoin and sodium valproate. A group of 16 
adolescents and young adults, seizure-free on either phenobarbital or carbamazepine 
monotherapy were tested before and after discontinuation of the medication (Gallassi 
et aI., 1986). Before discontinuation, patients on carbamazepine performed better 
than those on phenobarbital on one measure only (spatial span). One year after 
discontinuation, patients withdrawn from phenobarbital had improved on this same 
measure, patients withdrawn from carbamazepine had a shorter simple reaction time, 
and there were no differences between the groups. In a similar study of 10 adults 
discontinued from phenytoin monotherapy, patents performed worse than controls on 
three measures before the drug was stopped. No differences between patients and 
controls were detected 1 year after discontinuation, suggesting a reversible drug 
effect (Gallassi et aI., 1987). Similarly, 20 seizure-free adults performed worse than 
controls on three measures before discontinuation of sodium valproate monotherapy 
(Gallassi et aI., 1990), and these deficits were completely reversible within 1 year. In 
the so called Holmfried study 83 children with epilepsy who had been seizure free for 
at least one year, and 83 matched controls were tested before and after drug 
withdrawal (monotherapy with either carbamazepine, phenytoin or sodium 
valproate). Significant improvement was found in only one of the 12 cognitive tests, 
namely, psychomotor speed, suggesting that the impact of AED treatment on higher-
order cognitive function is rather limited (Aldencamp et aL 1993; Tonnby et aL 
1994). Another explanation would be that impairment of cognition and behaviour 
during a time of learning and information acquisition has long lasting impact, \vhich 
my or may not diminish with time. 
There is no\y considerable evidence that in adults polytherapy has a severe impact on 
cognitive function and can cause multiple types of cognitive impairment and 
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behavioural and psychiatric disturbances (Thompson and Trimble, 1982). Two drugs 
that individually have relatively mild cognitive effects may induce serious cognitiye 
impairment when used together, possibly because of potentiation of tolerability 
problems (Trimble 1987). Duncan et al. (1990) studied the effect of discontinuation 
of sodium valproate, phenytoin or carbamazepine in 58 patients with active epilepsy 
treated with multiple AEDs and 25 controls. Simple motor skills became faster on 
discontinuation of phenytoin, carbamazepine, and sodium valproate. Attention and 
concentration improved on discontinuation of phenytoin. However, the position in 
children on polytherapy remains unclear. 
Table 1 summarises the findings from some studies that examined the effects of 
certain antiepileptic drugs on cognition and behaviour. 
1.2.3.6. EEG Abnormalities 
The occurrence of subclinical epileptiform discharges in some patients with epilepsy 
has been correlated with poor cognitive functioning. Dodrill and Wilkus (1976) 
looked at cognitive functioning in adults with epilepsy. They compared those whose 
EEG showed subclinical epileptiform discharges with patients in whom discharges 
were absent, and found that lower intelligence scores were significantly associated 
with the presence of discharges, especially in patients in whom discharges were 
generalised rather than focal and occurred at an average rate of more than one per 
minute. 
Continuous epileptic activity without motor components lasting for hours, days. or 
even weeks is often referred to as "non-convulsive status epilepticus". It may have a 
rather dramatic presentation as "pseudo-dementia" but often the changes are more 
subtle (Stores, 1986). Unfortunately, there has been little systematic research of the 
effects of such prolonged discharges on mental function. Stores et al. (1978) 
demonstrated significantly more behavioural disturbances in boys \vith left temporal 
discharges than in boys with epilepsy but without inter-ictal discharges. Ho\yever, the 
difference between right and left sided discharges has not been confirmed by others. 
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Electrical status epilepticus during slow wave sleep (ESES) is an EEG phenomenon, 
describing the occurrence of epileptiform discharges during no less than 85% of non-
rapid eye movement (non-REM) sleep of continuous, bilateral diffuse slow spike and 
wave activity, which abates during REM periods. It occurs in the following four 
epileptic syndromes: Epilepsy with continuous spike and wave during slow wave 
sleep (CSWS), Landau Kleffner syndrome (LKS), anterior opercula syndrome and 
some cases of benign partial epilepsy with centro-temporal spikes. CSWS is 
characterised by intellectual disturbance and behavioural problems in a previous 
normal child with age of onset between 3-9 years (Patry et aI., 1971; Tassinari et aI., 
1985). LKS is characterized by language regression in the form of a verbal auditory 
agnosia in a previous normal child usually 3-9 years old. In both syndromes seizures 
occur in around two-thirds of children only and usually cease during adolescence. 
They may be of various types, often including generalised tonic-clonic seizures, 
absences and simple motor seizures. The neuropsychological importance of ESES 
lies in its association with concurrent global intellectual deterioration, which persists 
in some after ESES has abated (Robinson et aI., 2001). It has been postulated that the 
long lasting persistence of spike wave during sleep is responsible for mental 
impairment and psychiatric disturbances. The aetiology of LKS is still unclear but it 
is likely that it has more than one. It has been suggested that at least in some patients 
the pathophysiology of the nocturnal discharges is the same as in benign partial 
epilepsy (see later) and that benign childhood epilepsy with centro-temporal spikes, 
ESES and LKS are not specific entities but in fact represent part of a spectrum 
disorder (Deonna, 1991; Jayakar and Seshia, 1991; Galanopoulou et aI., 2000; Doose 
et aI., 2000). 
In addition to the possibility that seizures during sleep may themselves harm 
cognitive function, the quality of sleep may also be relevant. Evidence is 
accumulating that sleep fragmentation, i.e. repeated brief interruptions in the 
continuity of sleep, so-called micro-arousals, may be caused by epileptiform 
discharges and associated with impaired performance and other behavioural changes 
during the day (Levine et aI., 1987). 
Sonle studies ha\'e found no relationship between an abnormal EEG and beha\'ioural 
disturbances (Hartlage et al., 1972: Mellor et aI., 197-1-). Howc\,er. in other 
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investigations, a temporal lobe focus has been found to be associated with disturbed 
behaviour (Stores 1978; Hoare 1984; Whitman et aI., 1982) and with aggressive 
behaviour (Bagley, 1973) and dependency (Stores and Piran 1978). 
There is an ongoing discussion as to whether the discharges may cause the cognitive 
dysfunction or whether both discharges and cognitive dysfunction are caused by the 
underlying pathology. These mechanisms are not mutually exclusive. 
1.3. Electroencephalography 
1.3.1. History 
The discovery of the electroencephalogram was hailed by the following sentence in a 
short report published in the British Medical Journal on the electric currents of the 
brain by Richard Caton, an electrophysiologist in Liverpool, in August 1875. 'Feeble 
currents of varying direction pass through the multiplier when the electrodes are 
placed on two points of the external surface, or one on the surface of the skull'. 
Fifteen years later, Beck working in Krakow, Poland, explored the electrical activity 
of the brain in much greater detail and made great contributions to the techniques of 
localisation of sensory functions in the brain as well as to knowledge of the 
electroencephalogram. Many other scientists were also experimenting on the 
electrical activity of the brain at the same time but unknown to each other, most 
notably Danilevsky who described electrographic potentials in his doctoral thesis in 
1876. Cybulski who was Beck's teacher and friend also contributed greatly to the 
investigation of the early electroencephalogram. In 1914 he published recordings of 
the spontaneous electrical activity of the cortex of the dog and monkey and 
demonstrated also the induction of an epileptic seizure in the dog. Meanwhile in 
Russia the subject of spontaneous oscillations in the brain were being explored by 
Kaufmann in St Petersburg and he was the first to demonstrate that an epileptic 
attack was accompanied by abnormal discharges. Another Russian scientist, 
Neminsky became interested in the electrical acti\'ity of the brain and in 1912 
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published the first photographs of the electroencephalogram - also unknown to 
Cybulski who published his photographs in 1914. Neminsky was the first to publish 
observations on the frequency of the activity in the EEG. He reported the oscillations 
from dogs to be 12-14 per second and those from the surface of the brain and dura as 
12-20 per second but up to approximately 35 per second. He also found that in 
asphyxia these oscillations slowed to 4-7 per second. 
Hans Berger, a German psychiatrist, using a string-galvanometer was the first to 
record the electroencephalogram in man in 1924. Only after developing a machine 
with a higher sensitivity, the coil-galvanometer in 1926 constructed by Siemens, 
could he convince himself that what he was measuring was actual brain electrical 
activity (Figure 1.1). 
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Figure 1.1: Early EEG-registration by Berger, 1928, one year before his first 
publication. Arrow annotates 'Augen geschlossen, Lid bewegungen ~ 
(eyes closed, lid movement) and correlates with the onset of a rhythm. 
Five years after his discovery and following further experiments he published his 
findings in the German journal "Archiv fur Psychatrie" (Berger, 1929). Later he 
described alpha and beta activity in the physiological and pathological state and even 
recorded absence attacks with regular rhythmic high-voltage slow waves at a 
frequency of 3 per second. However he failed to demonstrate the associated spike and 
felt that what he had recorded was an artefact. The validity of his pioneering \\"ork 
and its value in diagnosing and treating epilepsy was shortly afterwards confirmed in 
Great Britain hy Adrian and Matthews (1934) and in the United States by Gibbs, 
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Davis and Lennox (1935). The EEG rapidly gained value in other neurological 
conditions also, e.g. Gray Walter in 1936 described focal slow waves over brain 
tumours and until relatively recently, when CT and MRI became widely accessible, 
the EEG was the only non-invasive method for diagnosing intracranial mass lesions. 
1.3.2. Origin of the EEG 
The electroencephalogram (EEG) records potential differences of the order of 
microvolts (/-1 V) between pairs of electrodes, measured continuously over time and 
displayed as a function of amplitude and frequency. EEG activity recorded from the 
scalp is of cortical origin, being derived from the post-synaptic potentials of the 
cortical pyramidal neurones. The depolarisation of cortical neurones may originate 
from elsewhere, e.g. the thalamus. It is a measure of the extracellular current flow 
associated with the summed activity of many (hundreds of thousands) individual 
neurones and postsynaptic potentials. 
An excitatory post synaptic potential (EPSP) is a transient partial reduction in the 
negative membrane potential which is usually due to an increased local permeability 
to sodium and other cations. It is caused by presynaptic release of the excitatory 
neurotransmitter glutamate. An inhibitory post synaptic potential (IPSP) is a transient 
increase in the negative membrane potential usually the result of a local increase of 
permeability to potassium or chloride ions caused by presynaptic release of the 
inhibitory neurotransmitter GABA. Tonic activity in afferent fibres results in a long 
lasting EPSP with small fluctuations during which the EEG shows only a reduction 
in amplitude. 
The dendrites of the pyramidal neurones guide the flow of currents generated by 
post-synaptic potentials at either the cell body in the deep layers of the cortex, or at 
the dendrites in the more superficial layers, through the entire thickness of the cortex. 
These neurones are closely packed and orientated parallel to one another, facilitating 
spatial summation of the currents generated by each neurone. 
The factors that determine whether a cortical potential is recorded over the scalp 
include its voltage, the extent to which the generator cells are discharging 
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synchronously, the area of cortex involved and the orientation of neurones in respect 
to the surface. In bipolar recording, the net potential is proportional to the algebraic 
difference between the solid angles subtended by the generator surface at each 
individual electrode position. Radial dipoles from the gyri appear in the EEG, 
whereas tangential dipoles from the sulci do not, but may be recorded by 
magnetoncephalography. 
The cortical activity has a regular rhythmicity that seems to depend on the functional 
integrity of subcortical mechanisms. The thalamus is believed to serve as a 
pacemaker of certain cortical rhythms that are recorded in the EEG such as sleep 
spindles. Postsynaptic inhibitory potentials synchronise the activity of the thalamic 
cells, thereby leading to the generation of a series of excitatory waves and governing 
the interval between successive waves (Andersen and Andersson 1975). 
1.3.3. Technology of EEG recording 
The EEG activity is measured with metal electrodes that are fixed to the scalp using 
an adhesive conductive paste and connected to a recording apparatus. Modern EEG 
recording machines are digital and the analog EEG signal recorded by electrodes is 
digitised by analog to digital converters and then displayed on screen. As different 
regions of the head generate different types of activity, electrodes have to be applied 
in a systematic fashion so that each area of the brain is studied. The need for a 
general electrode placement format led the International Federation of Societies for 
Electroencephalography and Clinical Neurophysiology to recommend a specific 
system of electrode placement for use in all laboratories under standard conditions. 
This is referred to as the 10-20 system of electrode placement (Fig. 1.2). Specific 
measurements from bony landlnarks (nasion, inion and left and right pre-auricular 
points) are used to determine the placement of electrodes. The term 10-20 is used 
because electrodes are placed at points 10 % and 200/0 along lines between these bony 
landmarks. The standard numbering system places even-numbered electrodes on the 
right, and odd-numbered electrodes on the left with a letter designating the 
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anatomical area. Midline electrodes are designated with the letter' z·. However this 
system has been criticised because of inadequate temporal lobe coverage. 
® ® @ 
@ @ @ 
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Figure 1.2: 10-20 Electrode Placement System. 
Another system exists called the Modified Maudsley system of electrode placement, 
which provides more information on temporal lobe activity (Fig. 1.3) and which 
adapts itself better to abnormalities in cranial morphology (Binnie et aI., 1982). 
Figure 1.3: Modified Maudsley system of electrode placement 
EEG activity can be displayed is dependent using different montages. A montage is a 
pattern of the electrode arrangements used for EEG display. They are generally 
selected so that recordings are made from rows of equidistant electrodes running 
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from the front to the back of the head or transversely across it. Examples of montages 
are illustrated on Figure 1.4. Recording arrangements can be varied so that the 
potential difference is measured between pairs of scalp electrodes (bipolar) or 
between individual electrodes and a common reference point. In the latter 
arrangement the reference site can be either a relatively inactive site (such as linked 
ears) or a point connected to all the electrodes in use so that it reflects the average of 
the potentials at these electrodes. Most modern digital EEG machines use the 
common reference method for EEG signal acquisition, but have the ability to 
redisplay the EEG in any montage required. 
2 
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Figure 1.4: Examples of bipolar montages: a) Neonatal montage. b) 'Double 
Banana' montage often used in children and adults. In this study this 
montage without Cz was used. 
1.3.4. Normal activity recorded in the EEG 
The EEG is a gently fluctuating waveform with a fairly wide frequency spectrum. 
Different parts of the brain produce different waveform characteristics. The ongoing 
continuous pattern in the EEG is referred to as the background activity. This pattern 
is described in terms of its amplitude, frequency, symmetry and synchrony between 
both cerebral hemispheres. The frequencies in the EEG are split into frequency 
bands, which have individual characteristics. Berger in 1929 described the alpha (8-
13Hz) and beta rhythms (> 13Hz) or \\"aves. Grey Walter introduced the term 'delta 
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rhythm' to describe all frequencies below alpha rhythm and decided that those 
frequencies in the 4-7Hz range needed a special designation called theta. 
Alpha activity (a) 
Alpha activity is a frequency of activity 
from 8-13 Hz (Fig. 1.5). Alpha rhythm 
is the classical EEG correlate of 
relaxed wakefulness and specifically 
refers to the normal rhythmic activity 
of this frequency seen over posterior 
regions of the head on eye closure. It 
appears from the age of 3 years. 
o· 






Figure 1.5: Alpha rhythm 
The frequency reaches a mean of 10Hz at the age of 10 years and may decline with 
advancing age. It is found most typically over the posterior regions of the head but 
may also be present in central and temporal regions. The rhythm is attenuated or 
abolished by visual attenuation and transiently by other sensory stimuli. 
Beta activity (13) 
Any activity in the EEG that has a 
frequency greater than 13 Hz is called 
beta activity (Fig. 1.6). It usually has 
an amplitude of less than 30l-l v. 
Activity with a frequency of 18-25 Hz 
is usually more conspicuous during 
drowsiness, light sleep, and rapid 
movement sleep (REM) than during 
wakefulness. Beta activity may be 








Figure 1.6: Beta activity oyer frontal 
drugs, particularly barbiturates and benzodiazepines. Excessive beta acti,·ity has 
recently been described in the EEGs of children with lissencephaly. 
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Theta activity (¢) 
Activity with a frequency range of 4-7 
Hz is termed theta activity (Fig. 1.7). 
The normal waking adult EEG contains 
very little theta activity; it only 
becomes evident during drowsiness and 
sleep. There is however considerable 
theta activity in the EEGs of children 
and infants. In very young children a 







Figure 1.7: Theta activity 
present which gradually matures to alpha rhythm. 
Delta activity (t5) 
This is activity below 4 Hz. (Fig. 1.8). 
It is present during sleep in the normal 
adult and is the predominant EEG 
activity of the infant. Posterior slow 
waves of youth develop as slow 
transients after the first year of life, are 
maximal in the female at 5 years and in 
the male at 9 year, than decrease in the 
middle teens and are usually gone in 
the early twenties. Polymorphic delta 







Figure 1.8: Posterior delta activity in a 
2 year old boy. 
activity that varies considerably in duration and amplitude with time, persists 
during sleep, and shows little variation with change in the physiological state of the 
patient. This activity can be found postictally in patients with epilepsy. It is 
commonly seen, with a localised distribution over destructive cerebral lesions 
involving subcortical white matter. It is also seen in patients with white matter 
encephalopathies. Delta actiyity may also be intermittent and rhythmic. 
1.3.5. Other types of EEG activity 
Mu Rhythm (f.1) 
This is a type of activity that is 
sometimes seen over central regions, 
has a frequency usually in the alpha 
range and is arch shaped (Fig. 1.9). It 
is strongly related in a negative sense 
to motor movement, being blocked by 
movement, or the thought of 
movement. Its presence is not thought 
to have any diagnostic significance. 
Lambda waves (1) 
These are well-defined electropositive 
sharp waves that can occur in the 
occipital region in normal subjects 
during visual exploration (Fig. 1.10). 
They are usually associated with very 
clear responses to varying rates of 
photic stimulation including single 
flashes. Lambda waves are most 















Figure 1.10: Lambda waves. Note eye 
movement artefacts 
1.3.6. Maturation of the EEG 
The development of the EEG from the newborn to the adult is not linear. The most 
abrupt changes occur between early prematurity and the first three months after term. 
The EEG of the premature baby depends less on the gestational age than the 
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corrected gestational age. After the first three months neonatal patterns are replaced 
by patterns which show different rhythms in different areas. From around six months 
of age mu-like rhythms are often prominent. This differentiation and the frequency of 
the rhythms increase fairly rapidly during the first year of life. Figure 1.11 
summarises the development of the posterior rhythm during childhood. During 
childhood and adolescence the EEG develops rather steadily towards that of the adult 
with the exception of a few patterns which appear transiently during this time. The 
predominant background activity is between 5-8 Hz during wakefulness in children 
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Figure 1.11: Normal maturation of posterior dominant rhythm (after Misulis and 
Head, 2003). 
1.3.7. The Abnormal EEG in Epilepsy 
The EEG is an indispensable investigation for the early assessment of epilepsy in 
infants and children. Abnormalities in the EEG may consist of epileptiform 
discharges, paroxysmal slow waves. background activity inappropriate to age or 
seizure discharges. Epileptiform discharges are sharp waves or spikes with or without 
associated slow waves. They are clearly distinguishable from the background activity 
and are usually surface negative. A spike is of shorter duration « 70 msec) than a 
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sharp wave (70 - 200 msec) and may occur as polyspikes i.e. a group of spikes 
together. Slow waves may also be paroxysmal i.e. are clearly distinguished from the 
background activity and have an abrupt onset and termination. 
Patterns seen on the EEG that are abnormal in adults may be normal in younger 
people. Synchrony, distribution and relation to sleep stages must be taken into 
consideration when deciding whether a wave form is normal or abnormal. 
EEG is important for seizure classification, in particular to differentiate between 
symptomatic epilepsy in patients with structural brain lesions, cryptogenic epilepsies 
due to presumed but unproven pathology and idiopathic epilepsies arising in a 
structurally normal brain. 
1.3.7.1. Ictal discharges 
During an epileptic seizure, the EEG typically shows continuous rhythmic activity, 
often associated with spiky transients. The routine 20-30 min EEG rarely 
demonstrates clinical seizures. However, a notable exception is the hyperventilation 
induced absence seizure (Figure 1.12). 
Figure 1.12: Absence seizure with typical 3 per sec spike and wave activity in a 7 
year old girl occurring during hyperventilation. She stops counting, 
stares upwards and is unresponsive . 
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When a seizure is captured on EEG, seizure classification is much more accurate and 
in the case of symptomatic epilepsies, localisation of the seizure focus is often 
possible. Figure 1.13 shows a seizure in a 17 year old girl, who previously had 
demonstrated generalised interictal discharges without clear lateralisation. Howeyer. 
as can be clearly seen in Figure 1.13, during a complex partial seizure occurring 








Figure 1.13a: Complex partial seizure in a 17 year old adolescent. Beginning of the 
seizure with rhythmical activity building up over the right fronto-







Figure 1.13b: After 18 seconds the patient lifts her left hand and scratches her neck. 
The EEG shows more widely spread discharges oyer the right side and 
generalised movement and muscle artefacts. 
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1.3.7.2. Interictal changes 
Epileptiform discharges may also occur in the interictal state, between overt seizures 
and are more likely to be isolated or brief. They can be either generalised (Fig. 1.14) 
or focal (Fig. 1.lS). These are usually referred to as subclinical epileptiform or 
interictal discharges. Interictal changes may also show non-epileptiform changes 
consisting of generalised or focal background abnormalities such as slow waves. 
Aarts et aI. (1984) classified a 
discharge as subclinical where 'the 
available methods of clinical 
observation, applied under particular 
circumstances, fail to show any 
changes in the patient'. This definition 
has been adopted by others and will be 
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Figure 1.14: Generalised spike and 
wave without clinical 
correlate 
Interictal discharges occur in up to 900/0 of patients with epilepsy, although they are 
not necessarily observed in every EEG recording (Ajmone Marsan and Zivin, 1970; 
Salinsky et aI., 1987, Sundaram et aI., 1990). Seizure type and aetiology do not seem 
to influence occurrence of ID (Salinsky et aI., 1987, Sundaram et aI., 1990) which 
can be present even when a patient has been seizure free for many years. Interictal 
spiking does not change before seizures but increase markedly after them, 
particularly after secondary generalised seizures (Gotman and Marciani, 1985). 
The effect of anticonvulsant is still unclear. Ludwig and Ajmone-Marsan (197S) 
described activation of discharges after withdrawal of medication, whereas other 
studies showed no relationship between interictal discharges and anticonvulsants as 
carbmnazepine, phenytoin (Rodin et aI., 197-+; Wilkus et aI., 1978; Gotman and 
MarcianL 1985; Salinsky et aI., 1987). An acute intravenous injection of phenytoin 
is, however. followed by decreased interictal discharges (Milligan et al.. 1983). 
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Ludwig and Ajmone Marsan (1975) described activation of discharges after 
withdrawal of medication, whereas other studies showed no relationship between 
interictal discharges and AEDs (Duncan, 1987). 
In fact, some drugs, for example carbamazepine, are known to cause no improvement 
or even deterioration in the EEG whilst improving seizure control (Wilkus et al.. 
1978). Rectal or intravenous diazepam (Milligan et aI., 1982) as well as intravenous 
injection of phenytoin (Milligan et aI., 1983) reduces interictal discharges. There is 
some evidence that phenobarbital (Frost, Jr. et aI., 1986), sodium valproate (Adams 
et aI., 1978) and lamotrigine (Binnie et aI., 1986; Jawad et aI., 1986; Besag, 1994) 
can reduce the number of interictal discharges. Ethosuximide reduces discharges in 
respect to diurnal 3 Hz spike wave activity only (Sato et aI., 1982). 
In benign epilepsy of childhood with 
centro-temporal spikes (BECT), the 
most common idiopathic epilepsy 
syndrome of childhood, interictal 
sharp waves (Fig. 1.15) occur in up to 
700/0 of children with BECT during 
wakefulness and in almost all during 
drowsiness and sleep (Degen et aI., 







Figure 1.15: Rolandic sharp wave 
Since many epilepsy syndromes have a genetic component it is not surprising that 
interictal discharges are also found in members of the families of children with 
epilepsy (Gerken and Doose, 1973). Possibly for the same reason Eeg-Olafson et al. 
(1971) found interictal discharges in 1 - 3.5% of children with no history of clinical 
seizures. Although such children were said to be neurologically normat 50% of them 
showed some evidence of behavioural disturbances and up to 20% had severe 
learning difficulties. 
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1.4. Transitory Cognitive Impairment (TCI) 
1.4.1. History and Definition 
Shortly after the invention of electroencephalography, Berger (1933) showed that 
absence seizures were accompanied by high amplitude rhythmic spike and wave on 
the EEG. Gibbs et al. demonstrated as early as 1935 that these characteristic wave 
forms could occur without obvious clinical symptoms and named them 'larval 
discharges' . 
Schwab (1939) developed new methods of studying the precise effects of these EEG 
phenomena on individuals. He tested the ability of patients who suffered from 
absence seizures to respond to auditory and visual stimuli during spike and wave 
discharges. Stimulus presentation and motor response were recorded simultaneously 
on a four-channel electroencephalograph so that the temporal relationship between 
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Figure 1.16: Schwab (1939): First Tel testing by means of a simple reaction time 
task: the patients had to press the rubber bulb as soon as the light \yas switched on. 
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Stimulus presentation was triggered manually by the examiner as soon as he saw a 
discharge on the EEG. In addition the patient was given a number of stimuli when no 
EEG abnormalities were apparent, so that reaction times with and without discharges 
could be compared. Thus each patient acted as his or her own control, nullifying 
critical confounding factors such as age, education, concomitant learning difficulties, 
seizure frequency and medication. It was found that if there was any response at all to 
a stimulus given during a discharge the reaction time was longer than to stimuli 
presented at other times. Duration of reaction times varied roughly in proportion to 
the length of the bursts seen in the EEG, and often no response at all was associated 
with the longer bursts. Schwab concluded that he had demonstrated six levels of 
impairment of consciousness as reflected in various degrees of prolonged reaction 
times. 
In 1984 Aarts and colleagues used a computerised version of the CORSI Blocks test 
(Corsi, 1972). The patient was presented with an array of coloured blocks on the 
screen which flashed in a random sequence; he or she was then required to replicate 
the whole sequence using a light pen. In the verbal version a sequence of words 
appeared followed by a list of words from which to choose the correct words in 
sequence. In a newer version a touch screen instead of the light pen is used. As in 
Schwab's experiment, performance in trials with subclinical discharges was 
compared with that during trials without discharges in the same patient. A significant 
impairment of performance was found during trials with discharges in half the 
patients tested. Aarts et al. termed this brief and transient cognitive deficit during 
subclinical epileptiform discharges 'transitory cognitive impairment' (TCI). 
1.4.2. Frequency of Tel in Persons with Epilepsy 
It is important to note that many of the early studies following Schwab's disco\'ery 
did not differentiate between pure subclinical EEG activity and minor seizures 
without motor concomitants such as absences (Shimazono et al.. 1953; Kooi and 
Hovey, 1957; Tizzard and Margerison, 1963a; Mirsky and Van Buren, 1965; Ishihara 
and Yoshii, 1967; Goode et aI., 1970). Some authors \\"ere merely interested in 
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responsiveness during generalised spike and wave discharges (Porter et aI, 1973; 
Brown et al. 1974) and never actually claimed to investigate subclinical discharges, 
an assertion claimed subsequently by others on their behalf. Indeed, Kooi and Hovey 
(1957), Ishihara and Yoshii (1967) and Goode et al. (1970) described automatism 
during generalised spike wave activity in some of their patients: "Only one patient 
demonstrated extended three-per-seconds generalised spike and wave bursts. These 
were associated with staring, rhythmical twitching of the eyelids and loss of neck 
tone. This patient did not respond to any question asked during a burst until after the 
paroxysmal activity subsided" (Kooi and Hovey, 1957). 
Thus, in some reports cognitive functioning during absences, rather then that during 
subclinical epileptiform discharges was measured. Yeager and Guerrant (1957) were 
probably the first to describe behaviour during EEG abnormalities with an attempt to 
distinguish between clinical and subclinical effects. As the probability of recognising 
an absence seizure and of detecting a cognitive deficit both increase with the duration 
of discharge, it is imperative to observe patients carefully, either with the help of 
video monitoring (Aarts et al., 1984) or on a one-to-one basis. Since this issue has 
been taken into account the number of patients with typical 3 Hz spike and wave 
activity reported in Tel studies has dropped dramatically. It has been suggested that 
interictal discharges probably do not occur in typical childhood absence epilepsy 
(Delgado-Escueta, 1979). 
Two exceptions were unable to confirm significant impairment of cognition during 
discharges (Prechtl et aI., 1961; Aldenkamp et al., 1996). Prechtl et al. (1961) used a 
choice reaction time task with simultaneous EEG recording, in which five lamps lit 
up in random order. The patient had to push a corresponding button to turn the light 
off, which triggered the next light's onset. Neither generalised nor focal discharges 
increased error rate or reaction time in 12 epileptic patients. However, the mean and 
variance of the interval between correct stimulus and correct response were 
significantly higher during paroxysmal and diffuse flattening of electrical activity 
than during normal electroencephalic activity. 
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Using the CORSI test described earlier (Aarts et aI., 1984) Aldenkamp and 
colleagues (1996) compared cognitive function in three different groups each of 20 
children with epilepsy who were considered seizure free: (1) without evidence of 
EEG discharges, (2) with subclinical epileptiform discharges, (3) with subtle seizures 
revealed by intensive video monitoring techniques. While they found no significant 
impairment of cognition in the group with subclinical discharges only, the third 
group of children showed poorer test results associated with the subtle seizures. Thus 
they were unable to confirm TCI, but rather demonstrated cognitive impairment 
during short and subtle seizures. Unfortunately they gave no information as to how 
the data was analysed nor the data itself. It also remains unclear whether the duration 
of discharges were comparable between the groups. Furthermore, it appears that most 
of their patients did not have sufficiently frequent discharges (i.e. 1 discharge every 1 
- 3 minutes) to allow statistical analysis looking for TCI to be performed. 
Nevertheless, they claimed that TCI "may thus be an artefact, caused by the 
inadequacy of video monitoring techniques". The flaw in this argument is that TCI is 
detectable as a result of enhanced monitoring techniques. It appears merely a 
question of the technique used and not of content. 
Some 50 studies have confirmed the occurrence of TCI in about 500/0 of patients 
investigated (Kooi and Hovey, 1957; Tizzard and Margerison, 1963a; Goode et aI., 
1970; Hutt and Gillbert, 1980; Aarts et aI., 1984; Binnie et aI., 1987: Kasteleijn-Nolst 
Trenite et aI., 1988; Rugland, 1990; for a review see Binnie 2003). However, it has 
become clear that the detectability of TCI in a single patient is dependent on various 
factors. Multiple interactions between these factors exist (see Fig. 1.17), which are 
often complex and overlapping and will be discussed in more detail later. 
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Figure 1.17: Interaction between subclinical epileptiform discharges, 
neuropsychological test and cognitive function. 
1.4.3. Interaction between Discharge and Tel 
1.4.3.1. Effect of Duration of Discharge on Tel 
The duration of the epileptiform paroxysm is one of the most frequently reported 
factors influencing the detection of TCI: the longer the discharge the more likely it is 
to impair performance, (Kooi and Hovey, 1957; Davidoff and Johnson, 1964: Goode 
et aI., 1970; Sellden, 1971; Aarts et aI., 1984; Sengoku et aI, 1990; Opp et aI, 1993). 
Depending on the test used, different critical thresholds have been described below 
which no consistent impairment could be detected: 2 seconds (Tizard and 
Margerison, 1963a; Geller and Geller, 1970),2.5 seconds (Sellden, 1971),3 seconds 
(Goode et aL 1970; Opp et aL 1992). Only Browne et ai. (1974) could not find a 
threshold under which no impairment was seen. However, as mentioned above, his 
patients probably had a mixture of clinical absences and subclinical generalised 3 per 
second discharges. 
There are some reports describing TCI during discharges shorter than 3 seconds in 
single patients (Tizard and Margerison, 1963; Rugland, 1990; Shewmon and Erwin. 
1988 a). Aarts et al. (198.f) and Rugland (1990) e\'en found Tel during single spikes. 
57 
but until recently no studies have specifically addressed the effect of very brief 
discharges. Provinciali et al. (1991) examined the effect of brief generalised 
discharges on shape recognition in 15 patients and found a significantly increased 
error rate during discharges in 9 patients. They did not find the duration of the 
discharges to be influential, and both discharges of < 1 second and of < 2 seconds 
being equally likely to be associated with Tel. Pressler (1997) found evidence of Tel 
during both focal and generalised discharges of 1 -3 seconds duration using a choice 
reaction time test with EEG triggered stimulus presentation (see chapter 1.4.4.1). 
1.4.3.2. Effect of type of discharge on Tel 
Most of the early investigators studied the influence of generalised spike and wave 
activity on cognition (Schwab, 1939, 1941; Tizard and Margerison, 1963; Goode et 
al., 1970; Porter et al., 1974). No significant difference was found when comparing 
the effect of typical 3 Hz spike and wave discharges with that of atypical generalised 
spike wave discharges (Davidoff and Johnson, 1964). Browne et al. (1974) graded 
the 'generalisation' of 3 Hz spike and wave discharges according to the distribution 
of the amplitude and found that both incomplete and complete generalised discharges 
were followed by prolonged reaction times, although the degree of impairment was 
more marked when discharges were fully generalised. Hutt and colleagues (1977) 
examined the effect of different types of EEG activity on reaction time in 20 children 
with epilepsy. They found that bilateral spike-wave discharges have an effect less 
than that of generalised discharges, but greater than those for localised spike-wave 
discharges or for slow waves. Analysis of variance was performed with ensemble 
size and type of EEG activity as main variables and both were found to have 
significant effect. Performance during generalised activity was significantly worse 
than during all other types of EEG activity, while there was no significant difference 
between bilateral spike and wave activity. Generalised bursts of delta or theta acti\'ity 
were apparently associated with Tel in only a fe\\' patients (Aarts et aL 1984). 
During focal discharges either non significant impairment has been reported by a 
number of investigators (Tu\'o, 1958; Prechtl et aL 196 L Sellden, 1971; Hutt et aI., 
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1977; Opp et aI., 1993) or TCI was found as an exception only (Kooi and Hovey. 
1957). 
In contrast, Aarts et ai. (1984) found TCI during focal discharges in more or less the 
same frequency as during generalised discharges. This might be because the CORSI 
test is more demanding that most of the other tests used (see below). Since then, Tel 
during focal discharges has been confirmed by others (Kasteleijn-Nolst Trenite et aI., 
1988; Binnie et aI, 1992; Shewmon and Erwin, 1988a and b; Pressler, 1997). 
It has been suggested that even spikes which cannot be detected using scalp 
electrodes may interfere with cognitive function. Krauss et ai. (1996) examined 
patients who had bilateral depth electrodes implanted to evaluate intractable temporal 
lobe epilepsy. On a verbal and a visuo-spatial memory task, six out of eight patients 
showed a significant decrease in working memory performance during mesial 
temporal spiking, the greatest disruption to spatial and verbal recall being associated 
with left hippocampal spikes. As discharges were not apparent on surface recording 
Tel would have been missed in these patients. 
1.4.3.3. Effect of lateralisation and localisation 
It is well known that the lateralisation and localisation of epileptogenic foci has an 
effect on cognition and learning. Left sided foci in right-handed patients are 
associated with impairment of reading skills (Stores and Hart, 1975) and verbal 
memory (Hermann et aI., 1987), whereas foci on the non-dominant side are more 
likely to cause impairment in visuo-spatial tasks (Mirsky and Van Buren. 1965). 
Aarts et al. (1984) confirmed the existence of such a correlation with respect to Tel 
using verbal and performance versions of the CORSI test. They demonstrated that 
right sided discharges were more likely to produce TCl in the non-verbal version than 
were left-sided ones. Left sided discharges were likewise associated with TCl in the 
verbal version. 
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Shewmon and Erwin (1988) investigated three patients with frequent spikes using a 
visual reaction time task and showed not only localised effects of occipital spikes on 
reaction times, but also that this effect was more pronounced when the stimulus was 
presented in the contralateral visual field or the response made with the contralateral 
hand. Thus, several specific tests are needed to distinguish between disturbances of 
different cognitive functions. 
1.4.3.4. Time of Occurrence of Discharges 
It appears that discharges have most effect when they occur during stimulus 
presentation. Mirsky and Van Buren (1965), using a delayed identification task, 
showed that the impairment was greatest when discharges occurred during stimulus 
presentation, and also when discharges occurred during the second prior to the onset 
of the stimulus. Binnie et al. (1987), using the CORSI test described above. studied 
this matter in further detail in 91 patients and found that discharges disrupted 
performance most when they occurred during stimulus presentation, followed by 
those occurring during the stimulus-response interval and in the 2 seconds preceding 
the stimulus presentation. Discharges occurring only during the response phase did 
not produce a significantly increased error rate. 
One problem in investigating very brief discharges is that they may not occur in 
sufficient number during stimulus presentation to demonstrate an effect. By using an 
EEG triggered stimulus presentation, the stimulus is thus spike-locked and a more 
precise time correlation can be established. Pressler (1997) examined 11 children 
with focal (n = 7) and generalised (n = 4) EEG discharges lasting less than three 
seconds with a choice reaction time task with stimuli triggered by discharges. In 8 out 
of 11 patients, reaction times during discharges were significantly prolonged 
compared to trials without discharges. There was no correlation between the duration 
of discharges and the likelihood of measuring Tel. Even in patients with very brief 
focal discharges, with a maximum duration of less than 1 second, Tel was found in :2 
out of three patients. It is likely that the exact correlation in time between discharge 
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onset and stimulus presentation was responsible for the high number of patients 
displaying TCI during focal and very short discharges. 
1.4.4. Interaction between Cognitive Testing and TCI 
1.4.4.1. Type of Stimulus Presentation and Task Continuity 
Various methods of tasks have been used in TCI testing, including continuous (Aarts 
et aI., 1984, Binnie et aI., 1992), EEG triggered (Schwab, 1941) or intermittent EEG 
triggered stimulus presentations (see below) (Binnie und Lloyd, 1973; Porter et aL 
1973; Shewmon and Erwin, 1988a; Sengoku et aI., 1990; Pressler, 1997). 
A continuous task is the most widely used method (Tizard and Margerison, 1963a; 
Goode et aI., 1970; Aarts et aI., 1984; Binnie et aI., 1987; Porter et aL 1973): EEG 
recording and a neuropsychological test presenting the stimuli in sequence, requiring 
more or less continuous attention from the patient, are performed in parallel 
connected either by pen box or digital interface so that stimuli presentation and 
response of the patient are marked on the EEG record. 
However, tests like the 5-light test (Tizard and Margerison, 1963a and b) or the 
CORSI test (Aarts et aI., 1984; Binnie et aI., 1987) are 'continuous' in that 
continuous attention is required, but both, the stimulus presentation and the required 
response are discrete. Truly continuous performance monitors, such as Goode's 
pursuit rotor (Goode et aI., 1970) or a newer computerised tracking task (Opp et aI., 
1992) appear optimal because there is a complete correlation between the occurrence 
of spikes and performance. In both studies only generalised discharges of 3 seconds 
or longer disturbed performance significantly. On-going performance can probably 
be continued undisturbed during brief or focal discharges (Opp et al.. 1992). 
Therefore tracking tasks are not useful for the clinical evaluation of Tel. 
An intern1ittent task (stimulus presentation with long gaps in bet\\een) has the 
drawback that changes in arousal can occur bet\\'een stimulus presentations. This 
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may cause fluctuations in test results, which is particularly relevant in children \\ith a 
short attention span. 
EEG triggered stimulus presentation on its own (stimulus presentation each time a 
discharge is detected) as used by Schwab (1939) insures a constant time relationship 
between stimulus presentation and discharge. However, EEG triggered stimulus 
presentation carries the risk that discharge probability is influenced by the state of 
arousal. Thus, a decrease in awareness may cause both the epileptiform discharges 
and the cognitive impairment. 
This problem can be reduced by presenting intermittent stimuli in addition to the 
EEG triggered presentations (Shewmon and Erwin, 1988a; Pressler, 1997). These 
intermittent presentations have to be randomised in order to avoid presenting any 
possible timing clues to the patient as to whether a presentation is triggered or not. 
Nevertheless, triggered stimulus presentation remains problematic as it is difficult to 
exclude an effect of alertness on discharge frequency. As discharges are more likely 
to occur during time of reduced alertness, impairment found in test with EEG 
triggered stimulus presentation may be due to fluctuations of alertness rather then 
Tel (Aarts et aI., 1984; Binnie and Marston, 1992). 
1.4.4.2. Type of Task 
Failure to detect TCI can be dependent upon the type of cognitive test used. Simple 
motor tasks such as rhythmic tapping (Shimanzono et al., 1953; Tizard and 
Margerison, 1963a; Davidoff and Johnson, 1964; Mirsky and Van Buren. 1965) are 
relatively unaffected by discharges, whereas tests involving higher cortical functions 
are usually more susceptible. Tasks testing working memory are believed to be 
particularly sensitive (Tizard and Margerison, 1963a; Aarts et aI., 1984; Hutt and 
Fairweather. 1975: Krause et aI., 1997). The CORSI test, a test for verbal and visuo-
spatial short term memory described earlier has been proven to be sensitive to 
subclinical epileptiform discharges. It is the test most 'widely used in the literature for 
62 
Tel testing and can be regarded as a gold standard, showing Tel in 500/0 of patients 
investigated, during both focal and generalised discharges (Binnie, 2003). 
It is well known that when children who suffer from absences are called during an 
absence they sometimes answer adequately immediately after the seizure has ended 
(Shimanzono et aI., 1953), suggesting that although the reaction time may have been 
prolonged, perception and memory of a question was not affected by the absence. 
Although simple reaction time is rarely disturbed due to discharges (Shimanzono et 
aI., 1953; Tizard and Margerison, 1963a; Davidoff and Johnson, 1964; Mirsky and 
Van Buren, 1965), it has been suggested that complex or choice reaction times are 
more sensitive to Tel (Mirsky and Van Buren, 1965). This was confirmed by others 
(Hutt and Fairweather, 1975; Pressler, 1997). 
Sellden (1971) used a binary choice task to investigate generalised and focal spike-
wave discharges. All stimuli were presented randomly with respect to the bursts. 
While focal discharges caused no impairment in performance, generalised paroxysms 
produced significantly more errors but only if the duration was equal to, or longer 
than, 3.5 seconds. The reaction time during discharges was a significantly delayed if 
the discharge exceeded 2.5 seconds. However, the test applied was quite simple and 
patients were tested for only 6 minutes (see chapter l.3.5.2). 
1.4.4.3. Complexity and Difficulty of Task 
The influence of the type of test of cognitive function overlaps with the degree of 
difficulty of the task itself. Using a digit-span test in children with photosensitive 
epilepsy Hutt (1972) found that recall of a sequence of digits was impaired if the 
presentation of the final digit was followed by a 1 or 2 seconds burst of generalised 
spike-wave activity evoked by a flashing light. The degree of impairment was a 
function of the number of digits in the sequence - sequences containing one or two 
digits less than the normal span according to age were less likely to be affected by 
spike and wave discharges than were longer sequences. 
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This was confirmed by Binnie et al. (1987) using the CORSI test who found a non-
specific effect of task difficulty. At a sequence length, which could be reproduced 
with few errors in the absence of discharges, epileptiform activity had little effect on 
test performance. TCI was demonstrable only, or more readily, when the leyel of 
performance required was close to the patient's individual limit. 
Sengoku et al. (1990) tested a boy with Lennox-Gastaut syndrome using different 
reaction time tasks during EEG-triggered stimulus presentation. Although simple 
reaction time was prolonged by bursts of generalised spike and wave (a mean of 0.42 
sec during discharges compared to a mean of 0.34 sec in their absence) this 
difference was even more marked in a choice reaction time task (mean of 1.23 sec 
during discharges compared to a mean of 0.69 sec in their absence). 
1.4.5. Interaction between Cognitive Test and Discharges 
1.4.5.1. Test Situation 
In general there appears to be a bi -directional interaction between epileptiform 
discharges and cognitive function: cognitive testing itself increases concentration and 
thus reduces epileptiform activity. It is well known that different stimuli can block 
absence seizures. In other people, stress or concentration may increase epileptiform 
discharges or even seizure activity (Altafulla and Halgren, 1988). Kooi and Hovey 
(1957) administered the Wechsler Adult Intelligence Scale with synchronous EEG 
recording in 21 patients with subclinical EEG discharges. At rest with eyes closed 
they found interictal discharges in 4.9% of patients, with eyes open in 3.70/0 and 
during testing in only 2%. Suppression of discharges during cognitive testing was 
consistent in all patients with generalised discharges, while this effect was highly 
variable in patients with focal discharges. 
In another study including both children and adults, 45°'0 of patients showed a 
reduction and 16% showed an increase in epileptiform actiyity. during the testing 
compared to during a base line period (Rugland. 1990). In contrast, Kasteleijn-Nolst 
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Trenite et al. (1988) showed that discharge rate in children was lower at rest than 
during the performance of scholastic skills. 
1.4.5.2. Duration of Test 
Kooi and Hovey (1957) attempted to ascertain whether discharges occurred more 
frequently during some parts of the question-response period than with others. The 
trend was toward a higher proportion of activity during questions and between 
questions and responses, than during the response itself. Suppression of discharges 
was greatest near the beginning of each subtest when a fresh task or set of questions 
began and was least between the end of the response and the start of the next 
question. This suggests that a task needs to be presented for a sufficiently long time 
to measure Tel, since it appears that discharges will be suppressed at the beginning 
of testing. 
1.4.5.3. Difficulty of Task 
In addition the difficulty of the tests plays a role. Tizard and Margerison administered 
a simple recognition task (tape test) and a choice reaction time test (5-light test, 
similar to the test described by Prechtl et al. (1961)) daily to two patients for 1 0 days. 
In the tape test the subject had to listen to a recorded series of random numbers, read 
at a rate of 2 per second. The task was to press a bulb as soon as possible when the 
number 6 was heard. As well as investigating the effect of discharges on error rate 
and reaction time (see above) they were interested in the effect of different test 
situations on spike-wave activity (Tizard and Margerison, 1963B). In both patients, 
significantly fewer discharges were recorded during the 5-light test than at rest and 
significantly more during the tape test than at rest. Both patients agreed that the 5-
light test was much more interesting than the tape test. The authors postulated that 
110t only a change in arousal (which should haye been accompanied by a change in 
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autonomic function and background activity, but was not), but also the state of 
divided attention may contribute to changes in discharge frequency. 
Hutt (1972), using the tape test in three different levels of difficulty in children with 
epilepsy confirmed that when the child is 'bored' there is a greater likelihood of 
discharges in the EEG. Conversely, he also showed that when the task passes a 
critical level of difficulty, the amount of discharges strongly increases again. 
Ounsted et a1. (1963) describes the relationship between test difficulty and 
epileptiform activity as U-function: a minimum of discharges in between the 
minimum and maximum of the degree of difficulty. Thus, a test should make 
demands on the upper limit of a patient's capability to ensure that discharges are not 
suppressed and that the test is sufficiently complex and difficult to demonstrate Tel. 
1.4.5.4. Localisation of Discharges 
Until recently the effect of arousal and cognition on EEG activity was believed to be 
non-specific. However in one study, during reading, epileptiform discharges occurred 
relatively less frequently and with a shorter duration over the left hemisphere than the 
right (Kasteleijn-Nolst Trenite et a1., 1990). It seems that cognitive tasks suppress 
epileptiform discharges when they activate a region of the brain within the 
epileptogenic zone (Binnie, 1993). However, discharges from other epileptogenic 
zones not directly activated by the task are increased (Kasteleijn-Nolst Trenite et al., 
1990). This may explain why these authors found an increase in discharges during 
performance of scholastic skills in an earlier study: selectively more discharges 
occurred over the hemisphere less activated by the task. 
1.4.6. Tel in benign partial epilepsy 
Although the definition of benign partial epilepsy is not fully detined (Lerman and 
Ki vity, 1991), the diagnostic criteria proposed include no neurologic or intellectual 
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deficit; family history of epilepsy; onset of seizures after the age of 2 years; brief 
seizures that are stereotyped in clinical manifestation; frequent nocturnal 
manifestation and spontaneous remission in adolescence (Fejerman and Di Blasi, 
1987; Dalla Bernardina et aI., 1992; Lerman and Kivity, 1991). The principal EEG 
criteria include normal background activity, spikes or sharp waves with a particular 
morphology and localisation, activation of epileptiform activity during sleep but not 
during hyperventilation and occasional generalised spike and wave discharges 
(Fejerman and Di Blasi, 1987; Dalla Bernardina et aI., 1992). The classification of 
the International Classification of Epilepsies and Epileptic Syndromes (1989) 
recognises two idiopathic, benign localisation-related epileptic syndromes in 
childhood: benign childhood epilepsy with centro-temporal spikes (BECT) and 
epilepsy of childhood with occipital paroxysms (EOP). In addition Aicardi and 
Chevrie (1982) described an atypical form of Rolandic epilepsy called atypical 
benign partial epilepsy (ABPE) with a similar clinical course with seizures difficult 
to treat and cognitive and behavioural problems common. 
BECT is one of the most common epileptic syndromes accounting for 15-25% of 
childhood epilepsy (Cavazzuti, 1980). It is an age-dependent syndrome with an age 
of onset between 3 and 13 years and a spontaneous remission in all cases around 
puberty. In general seizures are rare and are usually oro facial simple partial seizures 
with or without secondary generalisation. The EEG typically shows frequent focal 
triphasic sharp waves followed by a slow wave over the centro-temporal region. 
These discharges have a tendency to spread and may shift form one hemisphere to the 
other. It is believed that 50% of children with a Rolandic focus as described above 
never have overt clinical seizures (Doose and Baier, 1989). Rolandic discharges are 
found in 1-3% of healthy children (Eeg-Olofsson et aI., 1971; Cavazzuti et aI., 1980) 
and in up to 30% of siblings of children with BECT (Doose and Baier, 1991). 
Treatment of Rolandic seizures is still an issue of controversy. Treatment with 
carbamazepine, sodium valproate or phenytoin did not alter seizure frequency, 
seizure recurrence and duration of active epilepsy in a retrospective study involving 
10 children without treatment and 20 children \\'ith (Ambrosetto and Tassinari, 
1990). 
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Mental retardation, and/or neurological deficits are, by definition, lacking. Ho\\"e\'er, 
several studies have reported impaired cognition and behaviour (Heijbel and 
Bohman, 1975; Piccirilli et aI., 1994; Weglage et aI., 1997). Causes for these 
neuropsychological deficits are likely to be multifactorial and prolonged nocturnal 
discharges, hereditary cerebral maturation disorder causing both the cognitive 
problems and the discharges (Doose, 1993; Doose et aI., 2000). Finally, Colin Binnie 
and co-workers were the first to test a group of 10 children with BECT for transitory 
cognitive using the spatial version of the CORSI test (Binnie et aI., 1992; Binnie, 
1993). Seven children had typical BECT; of the other three, one exhibited typical 
Rolandic spikes, but had no known seizures, one had diurnal absences only, and the 
other developed seizures which were not typical of BECT after the first EEG 
recording. Six of the seven subjects with typical BECT exhibited an increased error 
rate during EEG discharges; this association was significant in four, in the others the 
trend was strong but not significant, as the number of discharges was small. Only one 
of the three children with atypical BECT showed TCI. Behavioural or cognitive 
problems were reported in most of the children including all of those with significant 
evidence of TCI. One child with bilateral discharges also performed the verbal 
version of the CORSI. This totally suppressed the left-sided discharges, and the 
verbal performance was unaffected by the right-sided discharges. During the non-
verbal task, discharges continued on both sides, but TCI were seen only in 
association with those on the right. The authors concluded that, although by 
definition BECT does not cause cognitive deficits, TCI might have an adverse effect 
on psychosocial function in this condition, as indeed all the children in this study 
with TCI had behavioural or cognitive problems. 
1.4.7. Clinical Relevance of TCI 
An important practical issue is whether TCI materially impairs day to day 
psychosocial function and if so whether drug treatment to suppress discharges is 
either desirable or effective (Binnie 2003). Here the tenn, 'psychosocial dysfunction', 
implies disturbance within the patient's educational and social fmme\\'ork. 
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Only few investigations have addressed these issues. Discharges were accompanied 
by a significant increase in errors in 4 out of the 6 subsets when the Revised 
Amsterdam Children's Intelligence Test was applied to groups of children with 
epilepsy under continuous EEG and video monitoring (Siebelink et aI., 1988). 
Furthermore, children with discharges during the IQ test showed an abnormal test 
profile. The same authors were interested in the effects of discharges in day to day 
cognitive performance in children, namely school performance such as reading and 
maths (Kasteleijn-Nolst Trenite et aI., 1988). The occurrence of discharges was 
associated with an increased rate of errors per word read. Interestingly the children 
were actually reading faster during discharges, but less accurately, no hesitations 
being observed by the examiner. The possible relevance of TCI to daily life was 
further highlighted by a study of the effects of subclinical discharges on driving a 
motor car (Kasteleijn-Nolst Trenite et aI., 1987). During discharges there was a 
significant increase in variance of lateral position on the road (i.e. the drivers either 
swerved or failed to follow the contours of the road). There are thus grounds to 
expect that TCI can have an adverse effect on a range of functions necessary for 
normal psychosocial performance. 
1.4.8. Neuropsychological Explanations 
Some general suggestions have been generated by this rather heterogeneous 
collection of studies: Tizard and Margerison (1963 a) postulated that subclinical 
bursts of spike and wave activity reduce the information handling capacity of patients 
with epilepsy. 
Another hypothesis has been that generalised spike and wave activity functions as 
neuronal noise reducing the child's "rate of gain or information" or "channel 
capacity". A choice reaction time task can broken down into four sub-units 
corresponding with each of four successive stages of information processing (Smith, 
1968): (1) time for registration of the stimulus; (2) time for recognition of the 
stimulus; (3) time for organisation of response, e.g. decision time; (-+) time of 
execution of response. In a numerals-keys serial choice RT task \yith three kyels of 
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difficulty it was found that RT was significantly longer during spike and wave than 
during background EEG (Hutt et aI., 1977). The response time during discharges 
increased more with increased level of complexity of the task than the response time 
without discharges. The authors concluded that whilst interictal discharges may affect 
all stages of choice reaction time to some extent, decision (stage 3 above) seems to 
be the most sensitive stage in the progress to be affected (Mirsky et aI., 1973; Hutt. 
1977). Many gradations of performance in information processing and short term 
memory are possible, depending upon the demands of the task in question. According 
to the authors, spike waves behave as a kind of neuronal noise, whose effect is to 
reduce the patient's information-handling capacity. lfthe task is well within the 
patient's normal capacity, little or no change may occur during spike wave 
discharges. If, however the task is one at the very limits of the patient's normal 
capacity, a severe decrement in performance will occur. 
1.4.9. Practical Implications 
It is generally agreed by neurologists and paediatricians that patients should be 
treated for epilepsy only if they have clinical seizures. Treating the EEG, so called 
'EEG cosmetics', is generally not practised. However, some single observations and 
uncontrolled trials revealed an improvement of cognitive functioning by suppressing 
discharges with AEDs in patients with established TCl (Aarts et aI., 1984; Rugland, 
1990). 
A preliminary controlled trial was completed at St Piers Lingfield, a residential 
school for children with epilepsy and special needs (Marston et a1., 1993). Ten 
children aged between 10 and 18 years completed the study; all had frequent 
subclinical discharges. A double-blind placebo-controlled crossover design was used. 
the active treatment being individually planned. taking account of the medical history 
and current medication, with the aim of suppressing epileptiform activity. 
Psychosocial function was assessed using Conners'. teachers' and parents' rating 
scales. Psychological testing was performed to dekct possible adverse effects of 
treatn1ent. EEG recording including 2.+ hr ambulatory monitoring \\3S used to 
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determine whether discharges were suppressed by treatment. In all but one patient the 
trial medication chosen was sodium valproate, and in two instances an increase in 
dosage of baseline valproate therapy. 
During active treatment there was a reduction of discharge rate and an improvement 
in global rating of psychosocial function compared with baseline scores (p< 0.05 for 
both). Formal psychological testing showed no significant change attributable to 
adverse effects of medication. Unfortunately there were unavoidable confounding 
factors. All but one patient (who was seizure-free throughout) showed a reduction 
(mean 32.60/0) of seizure frequency on active treatment. This was, of course, 
unexpected, as medication was already thought to have been optimised. Two children 
with improvement of psychosocial function during the active treatment phase showed 
only a minor reduction of interictal discharges in 24 hours telemetry. It was also 
impossible to exclude the possibility that improvement could be due to a 
psychotropic effect of sodium valproate. Such an effect has been postulated by 
Forsythe et al. (1991). The overall results were in accordance with the hypothesis to 
be tested, namely that subclinical discharges produce Tel, causing psychosocial 
dysfunction which can be ameliorated by the use of medication to suppress 
epileptiform EEG activity. However it was impossible to exclude the possibilities 
that the improvement noted was due either to improved seizure control or a direct 
effect of the medication. This is the first study to present such evidence under 
controlled conditions. It also highlights the problems likely to be encountered in such 
investigations and may serve as a guide to planning of future studies. A second issue 
is whether treatment of Tel, if desirable, is a practical possibility. Epileptiform EEG 
discharges are in general difficult to suppress by chronic AED administration. Drugs 
known to be effective in suppressing interictal discharges are sodium valproate, 
lamotrigine and benzodiazepines. The latter of course are known to produce 




Lamotrigine, a triazine derivatinve (Fig. 1.18) is structurally and pharmacologically 
unrelated to other AEDs. It was initially synthesised as an antifolate agent, based on 
the hypothesis that folate has convulsive properties in animals and that some early 
antiepileptic drugs were considered to have an antifolate effect. However, it 
subsequently emerged that the very weak antifolate activity of lamotrigine was not 
responsible for its antiepileptic properties. It has a molecular weight of 256, a pKa of 
5.5 and relatively low water solubility: O.17g/1 in distilled water. 
CI 
Figure 1.18: Structure of lamotrigine: 3,5-diamino-6-(2,3-dichlorophenyl)-1 ,2,4-
triazine 
1.5.2. Mode of Action 
Antiepileptic drugs may suppress seizure activity by any or a combination of the 
following mechanisms: 
• stabilisation of the neuronal membrane through direct effects on ion flux: 
• enhancement of the effects of inhibitory neurotransmitters, e.g. GABA, either 
directly or via reduction of synaptic GABA transaminase; 
• inhibition of excitatory neurotransmitters such as glutamate. 
Preliminary studies in rats suggested that lamotrigine reduced veratrine-induced 
release of glutanlate and, to a lesser extent of aspartate in cortical slices (Leach et aL 
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1986). However, lamotrigine did not act on the glutamate receptors themselves, but 
on presynaptic ion channels. Xie et al. (1995) showed that the drug is a use 
dependent inhibitor of voltage-gated Na+ currents, producing a marked reduction in 
normalised current with long stimulus duration (which stimulates epileptiform 
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Figure 1.19: Mode of action. Lamotrigine blocks voltage dependent sodium ion 
channels of slow inactivation and thereby reduces excessive glutamate 
release in sustained rapid firing. 
It had no effect on voltage-dependent activation or on fast inactivation, suggesting 
that latnotrigine acts on slow inactivation. Lamotrigine displays a use-dependent 
profile with the inhibition ofNa + channels being nlore pronounced in rapidly fi ring 
neurons. Lmnotrigine prolongs slow inactivation and thereby delaying opening of the 
Na + channels. Even at high concentrations (50 ~mol/L) lamotrigine ha been shown 
not to affect the pattern ofNa + channel activity in normal neurone nor to influ n 
the EPSP-IPSP equence. Therefore does not affect 10 fr quenc naptic 
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transmission mediated through excitatory (i.e. glutamate) or inhibitory transmitters 
(i.e. GABA). 
The affinity oflamotrigine for the inactivated state of the Na1 channel is about 0.012 
mM (Xie et aI., 1995), which compares favourably with effective clinical CNS 
concentrations of about 0.01- 0.03 mM (Leach et aI., 1986). 
In addition to its effect at the voltage-gated Na + channel, lamotrigine also inhibits 
voltage-operated calcium (Ca2+) channels (Wang et aI., 1996). Activation of both Na+ 
and Ca2+ channels results in rising intracellular calcium levels and increased cellular 
metabolic requirement. Increased energy demand and cellular calcium levels 
contribute to excitotoxic cell death, a potential component of permanent cognitive 
dysfunction. The ability to reduce excitability in general, and calcium ion influx in 
particular, may explain the ability of lamotrigine to reduce cognitive impairment 
arising from episodes of ischemia. In vitro studies have shown that lamotrigine 
inhibits glutamate release from rat cortex (Leach et aI., 1991), whereas in vivo studies 
have illustrated the cerebro-protective effects of lamotrigine in rodent models of 
focal ischemia (Smith and Meldrum, 1995). Interestingly lamotrigine is 
approximately twice as potent at inhibiting glutamate release in vitro than inhibiting 
GABA release (Leach et aI., 1986). In contrast, phenytoin is approximately 
equipotent against the two neurotransmitters. 
It is therefore argued that lamotrigine owes its antiepileptic properties to 
enhancement of slow inactivation, blocking prolonged rapid firing, as occurs in 
seizures, but has no effect on normal physiologic glutamate release at lower 
discharge rates. Lamotrigine thus appears to have a specific action against pathologic 
epileptogenic activity without interfering with normal brain function. Other drugs 
active at Na+ channels, such as phenytoin and carbamazepine, have a similar effect 
that is both voltage and use-dependent, but phenytoin does not share the selectiye 
action of lamotrigine on the slow inactivated state (Kuo and Bean, 1994). Moreover. 
these drugs inhibit normal synaptic function, interacting with both NMDA and non-
NMDA receptors (Hood et aI., 1983; Griffith and Taylor, 1988). 
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1.5.3. Pharmacology 
Lamotrigine exhibits linear pharmacokinetic features in adults over the dose range 
50-400 mg. The drug is almost completely bioavailable, with a long half-life (24 hr) 
and linear kinetics (Cohen et al., 1987). The half-life of lamotrigine is increased in 
renal failure; this may be a consequence of inhibition of its metabolism by 
accumulation of the glucuronide. After oral intake, there is rapid absorption, \vith 
maximal concentration (Cmax) occurring at 2 to 3 hours. After a single oral dose in 
normal subjects, peak concentration and area under the curve (AUC) are directly 
proportional to the lamotrigine dose in the range of 15 to 240 mg. The plasma 
elimination half-life (tl/2) is 25-30 hr in drug-free volunteers. Time to Cmax is 
increased after ingestion of food, but half-life and AUC are unaffected. Binding to 
plasma protein is about 550/0. This is not apparently affected by the presence of co-
medication (Miller et al., 1986). Lamotrigine does not affect drug-metabolising 
enzymes in the liver. Consequently, its potential for affecting the metabolism of other 
drugs is low. In patients taking hepatic drugs affecting the cytochrome P450, 
(phenobarbitone, phenytoin and carbamazepine) elimination of lamotrigine is 
increased (t1l2 is reduced) (Binnie et al., 1986). Competitive inhibition of 
glucuronidation by valproate increases the half-life of lamotrigine (Binnie et aL 
1986). Kinetic parameters for normal children are not available. 
Autoinduction of lamotrigine metabolism is so low as to have no clinical 
significance. Lamotrigine does not materially affect the metabolism of other 
antiepileptic drugs, nor that of oral contraceptives (Holdic et al., 1991). An increased 
plasma concentration of carbamazepine-l 0, ll-epoxide (CBZ-E) has been reported by 
some, but not confirmed by others (Binnie et al., 1987; Potter and Donnelly, 1998; 
Besag et aL 1998). 
There appears to be true pharmacodynamic synergy between lamotrigine and 
valproate in typical absence seizures, West syndrome, and Lennox-Gastaut 
syndrome, i.e. an effect in excess of their kinetic interaction (Be sag et al., 1995: 
Veggiotti et al., 1994). Lamotrigine appears to potentiate many unwanted effects of 
carbamazepine, like double vision or ataxia, in patients with carbamazepine levels in 
the upper therapeutic range. This appears not to be related to epoxide levels, although 
75 
the symptoms usually disappear if the dose of carbamazepine is reduced. There may 
also be a pharmacodynamic interaction responsible for the occurrence of tremor 
reported in patients taking lamotrigine and sodium valproate (Reutens et aI., 1993). 
1.5.4. Adverse Effects 
The oral mean effective dose (EDso) in mice and rats is in the range of 1.9-3.9 mg/kg. 
with corresponding plasma concentrations of the order of 1.5 }lg/ml (Miller et aI., 
1986). The safety profile of lamotrigine in standard toxicological studies is excellent, 
the only problems described in animals is a cardiotoxic metabolite in dogs and 
accumulation in the kidney in white male rats. These were not found in humans. 
As outlined above lamotrigine reduces glutamate release presynaptically, hence 
NMDA-activation is reduced. Non-competitive inhibitors of the NMDA receptor 
such as phebncyclidine (PCP) and MK801, induce short term memory loss and 
psychosis. In contrast, lamotrigine did not induce PCP-like central nervous system 
(eNS) effects (Leach et aI., 1991) when given orally to rats at doses of20 to 160 
mg/kg. Preclinical single-dose studies showed that lamotrigine had less effect on 
ocular and manual tracking, peak saccadic velocity, and body sway than 
carbamazepine, phenytoin, or diazepam (Cohen et aI., 1985; Hamilton et aI., 1993). 
In controlled add-on trials, central nervous system effects occurred more often on 
lamotrigine than on placebo. These included, in order of frequency, asthenia, 
diplopia, headache, somnolence, ataxia, dizziness, nausea, and nervousness. 
However, in a meta-analysis of the first four trials, none of these effects were 
statistically significant compared to placebo (Betts et aI., 1991). In subsequent 
controlled and open studies, dose-related central nervous system side effects have 
been reported approximately in 10% of patients (Schapel et aI., 1993). 
The most comInon idiosyncratic reaction has been a drug rash, leading to withdra\\al 
of some 2.30/0 of patients in open studies (Betts et al.. 1991). This is usually a mild 
maculopapular eruption of delayed hypersensitivity type. Its incidence appears related 
to the initiation dose. It usually occurs within the first two to six weeks of 
administration and disappears rapidly \\-hen the drug is withdrawn. The rash is most 
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common in children, on monotherapy or when combined with sodium valproate, and 
is less frequent when the drug is combined with enzyme inducers. In comparative 
monotherapy studies, withdrawals because of rash were more frequent with 
carbamazepine than with lamotrigine (Brodie et aI., 1995). Some patients have been 
successfully re-challenged starting on very low doses without recurrence of the rash 
(Besag et aI., 2000). Rare serious events possibly associated with lamotrigine 
included Stevens-Johnson syndrome (0.110/0), neutropenia (0.04%) and 
thrombocytopenia (0.03%). In controlled trials no adverse effect related to the weak 
antifolate action of lamotrigine has been detected. 
Sudden unexplained death is a well documented complication of epilepsy, 
particularly in young adults with uncontrolled seizures. This risk is smaller for 
patients taking lamotrigine (Yuen, 1992). A few deaths have been recorded in 
patients taking lamotrigine following a rapid progressive illness with status 
epilepticus, disseminated intravascular coagulation and multiorgan failure. It is 
believed this was caused by the underlying status epilepticus rather then by 
lamotrigine as other cases with similar courses were independent of antiepileptic 
medication (Yuen, 1992). 
Toxicity 
There is no reported experience of deliberate overdosage with lamotrigine but some 
patients with lamotrigine concentrations of ~ 15 Ilg/ml have reported sedation, ataxia, 
diplopia, nausea and vomiting. 
Teratogenicity 
Animal models sensitive to the teratogenic effects of valproate and carbamazepine 
offer no evidence of fetal malformations caused by lamotrigine. Currently, 
lamotrigine is not recommended for use by pregnant women. 
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1.5.5. Efficacy 
As is usual, the second and early third phase studies were performed using 
lamotrigine as add-on therapy in adult patients with resistant partial and secondarily 
generalised seizures. 
Increasing experience has indicated that the efficacy of lamotrigine is not limited to 
the restricted indications for which product licenses were first obtained. An analysis 
of pooled data of the first 677 adult patients entered into open clinical trials showed 
that a greater percentage of patients (mean, 32%) achieved a ~50% seizure reduction 
than in the controlled studies (Binnie, 1994). It has become apparent that Lamotrigine 
is effective in partial, secondary generalised and primary generalised seizures in 
adults and children including atonic seizures and atypical absences (Fig. 1.20). 
In addition to evaluating its effect on seizures, a number of studies have also 
examined the effect of lamotrigine on EEG activity. In one study five patients who 
had frequent interictal discharges had a reduction of 78 - 980/0 in discharge rate 
following a single oral dose of 120 mg or 240 mg lamotrigine. Six patients with 
photosensitivity showed a marked reduction in response to photic stimulation (Binnie 
et aI., 1986). Another study involved a double-blind, cross-over design with placebo, 
oral diazepam, lamotrigine 120 mg or 240 mg in six patients. Both treatments 
significantly reduced interictal spikes as compared with placebo, but lamotrigine was 
less effective than diazepam (Jawad et aI., 1986). These findings have been 
confirmed by others (Chevalier et aI., 1995; Marciani et aI., 1995). In a recent study 
on the effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive 
functions in 13 adults with drug-resistant focal epilepsy a significant reduction of 
discharges was found from baseline (Placidi et aI., 2000). Using a ambulatory spike 
and wave monitor Besag (1995) evaluated the effect of lamotrigine on spike and 
wave discharges in 17 children and adolescents with epilepsy. There was a reduction 
of discharges of more than 80% compared with baseline in 8 patients. This was not 
always correlated with a reduction of overt seizures. Eriksson and colkagues (2001) 
described a significant reduction of duration of discharges in 12 patients with 
Lennox-Gastaut syndrome. Longer discharges (>30 sec) were more likely to be 












All sz. Partial sz. GTCS Typical 
abs. 
o Paediatric (n=285) 
o Adult (n=677) 
Atypical Myoclonic Atonic 
abs. 
Figure 1.20: Efficacy of lamotrigine in children and adults. Patients with 500/0 
reduction of seizure frequency over 12 week treatment with 
lamotrigine. (after Binnie, 1994 and Besag et al. , 1995) 
Sz: seizures, GTCS: Generalised tonic-clonic seizures. 
First monotherapy studies comparing lamotrigine and carbamazepine or lamotrigine 
and phenytoin showed no difference in the efficacy between the drugs for partial 
seizures with or without secondary generalisation and for primary generalised 
seizures (Brodie, 1996). One-hundred and fifty-one patients with newly diagnosed 
epilepsy in eight UK centres completed a 48-week randomised, double-blind, 
parallel-group trial (Brodie et al. , 1995). The proportion of patients maintained 
seizure free during at least 24 weeks of treatment was almost the same in patients 
receiving lamotrigine (39%) or carbamazepine (380/0). Overall fewer patients on 
lamotrigine than on carbamazepine withdrew because of adverse events. 
1.5.6. Use in Children 
Pooled data from fi ve multicenter, open-label add-on studies with similar protoco l 
were analysed to assess the effi ciency and tolerability of lamotrigine in children 
(Besag et al. 1995). A total of 285 children w1der th age of 13 ar wer includ d. 
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All of them had treatment-resistant epilepsy and most had two or more seizure types. 
Seizure frequency and global evaluation were assessed at the end of four successiye 
12-week periods of therapy. Seizure frequency was reduced by 500/0 or more in 34°0 
of the patients. Lamotrigine was effective in all seizure types examined, particularly 
in typical and atypical absence seizures (Fig. 1.20). Atonic seizures also responded 
well. Improvement was well maintained during the treatment period. The commonest 
reported side effects were somnolence (16.80/0), rash (16.50/0), vomiting (12.3%») and 
seizure exacerbation (11.60/0). Adverse experience led to withdrawal of treatment 
from 36 patients (12.60/0). 
Particular efficacy has been claimed in the Lennox-Gastaut syndrome, most notably 
by Timmings and Richens (1992), where 10 of 11 patients achieved a 2500/0 seizure 
reduction. Chevalier et al. (1995) reported 85-95% seizure reduction in 10 of 16 
patients with Lennox-Gastaut syndrome, and 70-90% reduction in EEG discharges 
during 24-hour monitoring. Similar efficacy has been described in a double-blind, 
placebo controlled crossover study in 27 children and young adults with drug-
resistant epilepsy, mostly Lennox-Gastaut syndrome (Eriksson et aI., 1998). 
Reports of its use in infantile spasms (West's syndrome) are as yet inconclusive. In 
one study lamotrigine was combined with sodium valproate and 5 of 30 patients 
become and remained seizure-free (Veggiotti et aI., 1994). 
Adverse experiences in children are similar in nature and incidence to those in adults 
(Table 1.2). Drug rash has been commoner than in adults (16.5% in pooled data -
Besag et aI., 1995). This may partially reflect the fact that the largest paediatric trial 
used a dose escalation more rapid than that now recommended. 
Table 1.3 shows the recommended regimens for administration of lamotrigine in 
adults and children. 
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Incidence (%) 
Adverse events paediatric (n=285) adult (n=677) 
Somnolence 16.8 17 
Rash 16.5 6.4 
Vomiting 12.3 6.2 
Aggravated reactions 11.6 2.5 
Ataxia 6.0 14.3 
Headache 6.0 13.1 
Hyperkinesia 5.6 0.3 
Table 1.2: Adverse events of lamotrigine reported in pooled paediatric and adult 
populations in open-label add-on studies. 
Children, mg/kg daily Adults and children 
> 12 y, mg daily 
Co- Enzyme None VPA* Enzyme None VPA* 
medication inducers inducers 
1st 2 weeks 2 0.5 0.2 50 25 12.5 
2nd 2 weeks 5 1 0.5 100 50 50 
Maintenance 5-15 2-10 1-5 200-400 100-200 100-200 
* in mono- or combination therapy, VPA: Sodium Valproate 
Table 1.3: Regimens for administration of lamotrigine [in mg]. 
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1.5.7. Effects on cognitive function and behaviour 
A number of open and controlled studies have shown that lamotrigine is less likely to 
produce cognitive deficits commonly associated with AED. Additionally, when 
lamotrigine is used as an add-on therapy, any pre-existing cognitive problems are not 
exacerbated and in some cases are clearly improved (Buchanan, 1995). 
Animal studies 
Animal studies have shown not only that lamotrigine has minimal CNS depressant 
effects (see above), but also that it may have positive effect on cognitive function. 
Mechanisms of cognition and memory are poorly understood at the molecular level. 
However, long-term potentiation is a form of synaptic plasticity that may form a 
basic mechanism for memory and learning (Bliss and Collingridge, 1993). Two 
recent studies (Xiong and Stringer 1997; Otsuki et aI., 1998) reported that at 
anticonvulsant doses, lamotrigine had no effect on either the induction or the 
maintenance of long-term potentiation. In the gerbil, temporary bilateral occlusion of 
the common carotid arteries impairs escape from the Morris water maze and 
subsequent histological examinations reveal severe deterioration of hippocampal 
neurons (Wiard et aI., 1995). Gerbils pre-treated with lamotrigine are significantly 
better at escaping from the water maze and have significantly less ischemic cerebral 
injury. In developing rats, repeated administration of lamotrigine did not impair 
performance (bar holding test and rotorod test) and spontaneous behaviour (open 
field test) compared to control siblings (Mikulecka et ai., 2004). 
Taken together the existing preclinical data suggest that lamotrigine treatment does 




Volunteer studies have the advantage of fewer confounding factors thereby providing 
an early insight into the cognitive effects of an AED. A number of volunteer studies 
have been conducted that indicate that acute administration of lamotrigine is not 
associated with cognitive impairment (Cohen et aI., 1985; Hamilton et ai., 1993). In 
five normal subjects and five patients with age-associated memory impairment, 
lamotrigine improved immediate and delayed visual memory. Curiously, list learning 
and finger tapping were impaired, whereas digit symbol, similarities, digit span, 
Corsi and Stroop test were unaffected. Five volunteers received lamotrigine (initial 
dose 3.5 mg/kg, then titrated to a maximum of7.1 mg/kg) in a single-blind manner 
and were assessed for change in cognitive function after 2 and 4 weeks (Martin et ai., 
1999). There was no significant change in any of the neurocognitive measures 
relative to baseline performance. The effects of lamotrigine and carbamazepine were 
compared in 23 volunteers in a 10-week, cross-over study (Meador et aI., 2001). The 
neuropsychological battery in this study consisted of 19 instruments yielding 40 
variables including both subjective and objective measures. Lamotrigine was 
associated with better performance or fewer side effects in 1 7 of the variables, while 
there were no statistical differences seen in the remaining variables. The authors 
concluded that lamotrigine produces significantly fewer unwanted cognitive and 
behavioural effects than carbamazepine. A recent study with parallel design by 
Aldenkamp and co-workers in 30 volunteers showed evidence for a selective effect 
of cognition in one out of 12 measures, relative both to placebo and to valproate 
(Aldenkamp et aI., 2002). However, this study has been criticised by other (Dodrill, 
2002). 
Although these studies support the favourable cognitive profile of lamotrigine, data 
from healthy volunteers should be treated with caution. The drug exposure periods 
are usually short and the dose smaller than in clinical practise. Furthermore, the 
number of subjects is usually very small. It is possible that chronic treatment results 
in different types of cognitive impairment that cannot be observed during short-term 
treatment. 
Patients with epilepsy 
In patients with epilepsy open clinical studies and controlled studies have found few 
or no cognitive side effects compared to other AED or placebo. 
A double-blind, randomized cross-over study in adult patients with epilepsy has 
reported no significant effect on cognitive function of lamotrigine compared with 
placebo when used as adjunctive therapy (Banks et aI., 1991). Similar results were 
reported by others (Smith et aI., 1993; Placidi et aI., 2000). 
In one controlled study with patients with newly diagnosed epilepsy the effects of 
lamotrigine on cognitive functioning have been compared with those of 
carbamazepine (Brodie et aI., 1999). Patients completed tests consisting of verbal 
learning and memory tests (Verbal Learning I and II, Delayed Recall, and 
Recognition) and attention and mental flexibility (Semantic Processing I and II, Trail 
Making test, Logical Reasoning and Stroop Test) at baseline and then periodically for 
up to 48 weeks. Significant differences favouring lamotrigine over carbamazepine 
were observed with Semantic Processing, Verbal Learning, and Stroop Test. The 
authors concluded that lamotrigine may have a favourable long-term effect on 
cognitive function when compared with carbamazepine. 
Several uncontrolled studies reported improved concentration, verbal and non-verbal 
communication, school or work performance, and behaviour, particularly in children 
with learning difficulties (Gibbs et aI., 1992; Uldall et aL 1993; Fowler et aI, 1994; 
Uvebrant and Beuziene, 1994; Buchanan, 1995). In 50 children with intractable 
epilepsy, 21 showed a reduction in absence and complex partial seizures and 5 of 
these became seizure-free (Uvebrant and Beuziene, 1994). After lamotrigine was 
added to existing therapy, parents of 24 of these children reported an improvement in 
their children's "mental state," including longer attention span, improved alertness, 
and emotional stability. Eight of thirteen autistic children in this study showed 
reduced symptoms after the addition of lamotrigine therapy. This improvement was 
apparently unrelated to seizure control. 
Conflicting results have been reported by Ettinger and colleagues (1998): se\'en 
patients \vith epilepsy and mental retardation lamotrigine add-on caused both positi\e 
and negati\'t~ psychotropic effects. These findings were based on the observations of 
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parents and supervising staff. Positive effects included reduced irritability and more 
compliance with simple instructions; negative effects included behavioural 
deterioration with temper tantrums, restlessness, and hyperactivity. 
Aggressive behaviour has been associated with lamotrigine, particularly in children 
with learning difficulties (Besag et aI., 1995; Beran and Gibson, 1998). In the above 
mentioned multicenter study (Besag et aI., 1995) 2.5% of children were found to 
have behavioural side effects. The authors questioned however, whether this could at 
least partially be attributed to patients becoming more alert, active, and demanding 
(Besag et aI., 1995, Besag, 2004). This is arguably not an adverse effect but a 
necessary stage in the rehabilitation of such patients following improved seizure 
control. 
Quality of Life 
A number of patient assessment questionnaires exist to test the impact of epilepsy 
and AED treatment on quality of life. 
In a placebo-controlled add-on study, patients with difficult-to-treat epilepsy were 
assessed with the Health Related Quality of Life inventory and a small cognitive test 
battery. They found a significant improvement of scores on happiness and mastery in 
a quality-of-life study during active treatment (Smith et aI., 1993). This improvement 
was considered to be independent of seizure control. 
The Side Effect and Life Satisfaction (SEALS) inventory is a patient-completed 
questionnaire containing five categories: Cognition, Dysphoria, Temper, Tiredness, 
and Worry. It has been developed to evaluate the effect of epilepsy and AED 
treatment on cognition and affect (Gillham et aI., 1996; Gillham et aI., 2000). It was 
validated in a large study comprising 923 patients, 256 of whom were newly 
diagnosed with epilepsy (Gillham et aI., 1996). The trials compared the short-term 
effect of lamotrigine with carbamazepine on seizure frequency and quality-of-life. It 
was found that patients receiving lamotrigine showed a greater improvement in the 
SEALS, over four weeks of treatment, than patients taking carbamazepine. 
Randomized controlled clinical trials have further indicated the positive impact of 
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lamotrigine on aspects of quality of life. In a recent comparative study, lamotrigine 
and phenytoin were similarly effective in seizure control in a group of newly 
diagnosed patients with untreated partial or generalized tonic-clonic seizures. 
However, significant differences between the two AEDs were observed on quality-
of-life measures (Steiner et aI., 1999). Treatment with lamotrigine resulted in a 
reduction in mean total SEALS scores, indicating an improvement in aspects of 
health-related quality of life. Conversely a slight increase in SEALS scores was 
recorded in the PHT group. The authors concluded that lamotrigine displayed a lower 
incidence of central nervous system side effects when compared with phenytoin 
(Steiner et aI., 1999). Similar results were found in another large randomised study 
comparing lamotrigine with carbamazepine in newly diagnosed patients evaluated 
with SEALS. Dosages were adjusted according to efficacy, adverse events and 
plasma concentrations, the median daily doses being lamotrigine 150mg or 
carbamazepine 600mg (Brodie et al., 1995). Patients were evaluated at baseline and 
after 4, 12, 24 and 48 weeks of treatment. 133 patients completed the study (73 
lamotrigine, 60 carbamazepine). The cognition subscale as well as other subscales 
showed improvements in the lamotrigine group at 48 weeks compared to baseline. In 
contrast, deterioration in the cognitive subscale was seen in the patients randomised 
to carbamazepine. 
Mood 
A related issue is the effect of lamotrigine on mood. Ketter et al. (1999) divide the 
mood and affect profiles of antiepileptic drugs into two separate classes: The first 
class cause sedation and are used for their anxiolytic and antimanic effects, e.g., for 
the treatment of agitation and aggression. These effects are assumed to be related to 
the enhanced of GABA-mediated inhibition. Benzodiazepines, barbiturates, and 
sodium valproate belong to this class of drugs. The major eNS side effects are 
fatigue and cognitive slowing. The second class has an opposite, i.e" activating 
effect, associated with increased glutamate excitatory neurotransmission. This class 
of drugs is used for its anergic profiles, e.g., for the treatment of depression, apathy, 
and hypersomnia. Their assumed effect is cognitive activation. Lamotrigine belongs 
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to this class of drugs (Ketter et aI., 1999; Reijs et aI., 2004). The major side effects 
are hyperactivity, hyperirritability, and possibly insomnia. In psychiatry, lamotrigine 
is used for the treatment of depression (Ketter et aI., 1999). Mood improvements 
have been reported in several open clinical studies in epilepsy patients (Smith et aI., 
1993; Brodie et aI., 1995; Schapel and Chadwick 1996; Besag 2000). In a controlled 
trial of interictal depression, lamotrigine monotherapy was associated with earlier 
and greater improvement compared with valproate monotherapy (Edwards et al., 
2001). Recently it has been suggested that lamotrigine also has a broad spectrum 
efficacy in bipolar disorder (Calabrese et ai., 1998). In a controlled study it was well-
tolerated and had a similar effect to lithium, particularly for prophylaxis of 
depression (Calabrese et aI., 2003). The reported effects on quality of life and 
behaviour may be partially related to and explained by these mood effects. 
It remains however unclear whether the improvement of psychosocial function is due 
to suppression of interictal discharges or due to an independent psychotropic effect 
(Besag, 1995; Binnie, 1994). 
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Chapter 2: Aims of the study 
The aims of this study were 
1. to examine factors influencing the incidence of interictal EEG discharges in 
children with well-controlled epilepsy (chapter 4); 
2. to measure effect of lamotrigine on of interictal EEG discharges in children 
with well-controlled epilepsy (chapter 5); 
3. to measure effect of lamotrigine on behaviour in children with well-controlled 
epilepsy (chapter 6); 
4. to measure effect of lamotrigine on cognition in children with well-controlled 
epilepsy (chapter 7); 
5. to measure effect of interictal EEG discharges on behaviour and cognition in 
children with well-controlled epilepsy (chapter 8). 
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Chapter 3: Methods 
Many aspects of cognitive and behavioural tests, patient recruitment and analysis 
were common to most parts of the research. To avoid repetition, they are described in 
this section, and referred to in subsequent chapters. Methods specific to each study 
are included in the relevant chapters. 
3.1. Methodological Principles of Testing Neuropsychological 
Functions 
3.1.1. Intelligence Tests 
An intelligence test provides a general assessment of the child's development or 
intellectual status. It is the first stage in evaluating the child's cognitive function and 
may be used as an initial background against which to interpret other test 
performance and reported behavioural and educational problems. 
The most common test used for school children is the WISC-R III (Wechsler 
Intelligence Scale for children-Revised version). It originated from the WISC 
(Wechsler, 1949), a downward extension of adult intelligence scales and was 
designed for the age range of 6 years to 16 years and 11 months. The test consists of 
12 subtests divided equally into verbal and performance scales. The verbal scale is 
comprised of Information, Similarities, Arithmetic, Vocabulary, Comprehension and 
Digit Span subtests and the performance scale includes the Picture Completion, 
Picture Arrangement, Block Design, Object Assembly, Coding, and Maze subtests. A 
short version of the test includes the subtests Similarities, Vocabulary, 
Comprehension, Block Design and Object Assembly. As there is a clear learning 
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effect the test should not be repeated before 12 months. Administration time of the 
full test lasts approximately 60 to 90 minutes; for the short version 40 to 60 minutes. 
The instrument was constructed from the premise that intelligence may be defined as 
an individual's capacity to understand and cope with the world (Wechsler, 1974). 
The author emphasises that this definition requires an assessment instrument that 
appreciates the global nature of intelligence and avoids placing undue emphasis on 
anyone ability in assessing overall intellectual capacity. The subtest tasks therefore 
attempt to identify specific areas of delayed development or cognitive impairment. If 
specific discrepancies are very marked the full IQ may not give an accurate picture of 
the child. 
The tests generate standardised scores for Full Scale (FIQ), verbal (VIQ), and 
performance IQ (PIQ), individual subtests-scaled scores, and test-age equivalents. 
The psychometric properties of the WISC-R have been extensively researched. 
Outstanding reliability is reported, with consistently strong internal consistency 
reliability coefficients (Wechsler, 1974). 
In this study the short version of the WISC-R III were performed by all children at 
baseline to assess their overall intellectual abilities and mental age. IQ testing was 
performed while the child was wearing the ambulatory EEG recorder whenever 
possible in order to correlate performance with the occurrence of subclinical 
epileptiform discharges. 
3.1.2. Computerised neuro-psychological test-battery 
In order to test the effects of drugs on cognition a number of functions have to be 
tested. This is not only because a drug may affect one or several functions but also 
because there are individual responses in different patients. 
The FePsy test battery (Fe = iron, psy = psychological) is a computerised neuro-
psychological test battery. The development started by Binnie and co-workers in the 
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1970s with the development of memory tests with simultaneous EEG registration 
(Aarts et aI., 1984). Subsequently a cognitive test battery has been built up to (1) 
assess cognitive function in patients with epilepsy; (2) measure cognitive side effects 
of antiepileptic drugs; (3) measure effects of subclinical epileptiform discharges; and 
(4) used preoperatively during assessment for Neurosurgery (Aldenkamp et aI., 1987; 
Aldenkamp et aI., 1990). The battery includes parallel test versions in which stimuli 
are selected randomly from a larger pool, tests which are sensitive to subtle changes 
and the option for simultaneous registration of the EEG. Results are stored in a 
database and can be passed to an ASCII file for subsequent analysis. For this study 
two subtests of this battery were used, a recognition memory test and the 
computerised visual searching task for repeated testing. 
The following cognitive domains have been established as being particularly 
vulnerable in patients with epilepsy: speed of information processing, memory, 
alertness, sustained and focused attention, and motor fluency. Some studies also 
mention language and problem solving (Aldenkamp et aI., 1987, 1990). The battery 
used in this study covers all of these domains, with particular emphasis on memory. 
Continuous Performance Test (Tracker test) 
The tracker test is a computerised test of sustained attention and vigilance. A small 
white square is seen on the touch screen. The patient has to keep a finger pressed on 
the white square whilst it moves randomly around the screen. The square stays white 
whilst a finger is on it, and becomes orange when it is off (Figure 3.1). There are 
three parts to the test but only the Adaptive Touching Task was used. The variable of 
interest was the difficulty level achieved (speed of 1-20), based on achieving more 
than 400/0 of the time on target. It was performed without EEG co-registration. 
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Figure 3.1: Continuous performance test: A little white square is seen on the touch 
screen. The patient has to keep a finger pressed on the white square whilst it moves 
randomly around. The square turns orange when the finger is no longer on it. 
Verbal and Non-verbal Recognition Test 
These computerised memory test exists in a simultaneous and a serial form. In this 
study only the simultaneous form was used. In the verbal version a pre-set number of 
4-1etter words are presented (learning phase) with a presentation time of 1 second per 
item. After a delay of 2 seconds, the screen display changes to show one of these 
words with distractors. This target item then has to be identified. In the non-verbal 
version abstract figures are used instead of words. The degree of difficulty can be 
varied, e.g. the memory set can consist out of 2, 4 or 6 words and out of 3 or 4 
figures. The number of items used were be decided before the fust test according to 
the results of the WISC-R III and a short reading test, then staying the same 
throughout the study. Both number of correct responses and the length of time over 
which the test is performed were recorded. 
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Serial Matching to Sample Tests (SMTS-16) 
The Serial Matching to Sample Tests SMTS-16 has been developed by Coleshill 
(PhD by S.G.Coleshill, 1999). It is a computerised YES-NO delayed recognition test 
with a 1 minute distractor interval which samples recognition memory across a range 
of 1 - 3 minutes. There are two versions: ' Words ' and ' Faces', which have been 
shown to be sensitive to hemispherically lateralised cognitive deficits in patients with 
temporal lobe epilepsy (Coleshill et aI., 2004). Both versions are composed of two 
subtests with different items. In each subtest the patient is shown 8 items (either 
words in the ' word' test or faces in the 'face' test) at the start of the test followed by 
the 1 minute distractor interval. Sixteen words or faces then appear individually (8 
items and 8 distractors) and the patient tries to determine whether each appeared in 






Figure 3.2: Serial Matching to Sample Tests SMTS-16 ' Words ' : a) presentation of a 
series of items (here words), followed by a one min distractor interval (patient has to 
call out letters a and b). In the recognition phase the patient is presented with a eri 
of 16 words and d) has to determine whether he has seen this item before or not. 
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Each subtest comprises of 16 stimuli (8 targets and 8 distractors). The main outcome 
measure of the tests is the number of words correctly identified as having appeared 
before minus the number of words incorrectly identified as having appeared before 
(discrimination score). The tests also measures bias to one response (yes or no). If 
there is no response bias then C=O, maximum bias values range from -2.5 (liberal) to 
+ 2.5 (conservative). 
Computerised Visual Searching Task 
This test has been adapted from the Goldstein's visual searching task. It discriminates 
successfully between brain damaged individuals, normal and psychiatric patients. 
The task consists of finding a centred grid pattern out of 10 surrounding patterns, 
only one of which is identical (Figure 3.3). Grid patterns are displayed in a 
checkerboard fashion and are numbered from 1 to 10. In a second version for older 
children 24 pattern are presented. The central target pattern is denoted by an arrow on 
the right side and is selected from each of the four quadrants to balance the location 
of the matching grid. The test consists of20 trials (the 10 patterns change after 10 
trials). Responses are recorded by typing the correct number from the keyboard. The 
main outcome measure is the median response time in milliseconds, but the error rate 
is also collected. The test gives an indication of the accuracy of information 
processing and mental speed. Time scores from this test have proven useful in 
evaluating cognitive effects of anticonvulsants in patients with epilepsy. A marked 
age dependent effect has been found, with control subjects performing over twice as 
fast at 18 years of age as at 8 years of age (Alphers and Aldenkamp, 1990). 
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Figure 3.3: CYST: twenty-four numbered grid patterns are displayed in a 
checkerboard fashion. The central target pattern is denoted by an arrow on the right 
side and the patient has to find the matching grid (here number 13). 
Binary Choice Reaction Time Test (Tiger Test) 
The ' Tiger test' is a computerised binary choice reaction time task. In this task a 
tiger's head is shown on the left or right hand side of the computer screen (Figure 
3.4) and the patient has to respond as quickly as possible by pressing either the '\' & 
'/' keys on the keyboard with the corresponding left or right hand. The speed of 
presentation is self-paced, a response is instantly followed by substitution of another 
block in either the same or the opposite position. Thirty tiger stimuli are presented 
each side, with positions pseudo-randomised, so that the stimulus is not presented 
consecutively on one side more than three times. The median reaction speed and 
accuracy for each hand will be recorded. By introducing a decision component (right 
or left) the reaction tilne reflects not only motor speed but also the decision making 
process. 
95 
Figure 3.4: Tiger test (binary choice reaction time test): stimulus presentation on the 
left side'\'key has to be pressed. 
3.2. Methodological Principals of Behavioural Measurements 
3.2.1. Conner's Parent and Teacher Rating Scales 
Children with epilepsy may suffer from a number of problems which affect their 
behaviour and learning. The Conners' Parent and Teacher Rating Scales were 
developed to characterise patterns of children's behaviour. They are derived from 
two questionnaires, one completed by parents and one by teachers (Conners, 1989). 
They are relatively brief instruments standardised on the normal population. Both 
exist in a short version (often used as a clinical instrument to assess hyperactivity) 
and a long version, mainly used in research to assess hyperactivity and other 
behavioural abnormalities. They have been used in numerous investigations of 
children with epilepsy over the last 15 years (Cull et al., 1996; Ferrie et aI. , 1996; 
Arnan et aI., 1992; Stores, 1978). 
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The Conners Teacher Rating Scale (CTRS) has either 28 or 39 items. In this study 
the 39 item questionnaire was used. It includes six subscales labeled as I) anxious-
passive, II) asocial, III) conduct problem, IV) daydream-attention, V) emotional-
indulgence and VI) hyperactivity. Each item is rated with one of four responses: not 
at all (code 0), just a little (code 1), pretty much (code 2) or very much (code 3) and 
is rated depending upon the degree to which the behaviour is present in the patient 
during the preceding month. It was standardised on normal Canadian children aged 4 
to 14 years (Conner et aI., 1989). Normative data are available separately for groups 
formed by age and gender. The scales are factor analytically derived scales for 
assessing problem behavior in children. Raw scores are translated into T -scores by 
sex and age. The T -scores have a mean of 50, a standard deviation of 10 and higher 
scores denote more serious behavior problems. 
The teachers' scale allows assessment of the child over a period in different 
situations by comparison with a normal range. In school the child is confronted with 
age appropriate tasks and experiences and must function in a complex social system 
posing many problems of adaptation that teachers are accustomed to observing. 
The Conners' Parent Rating Scale (CPRS) has either 48 or 93 items In this study the 
93 item questionnaire was used (appendix b). The parents' rating scale includes eight 
subscales designated as I) antisocial, II) anxious-shy, III) conduct disorder, IV) 
hyperactive-immature, V) learning problem, VI) obsessive-compulsive, VII) 
psychosomatic and VIII) restless-disorganized. As for the CTRS, each item is rated 
with one of four responses; not at all, (code 1), just a little (code 2), pretty much 
(code 3) or very much (code 4). Normative data for the CPRS 93 are based on a 
sample of normal children aged 6 to 14 years. 
Test-retest reliability coefficients for the CTRS-39 range from 0.72 to 0.91 over 1 
month (Conner, 1969). Over a year the reliability remains at a moderate leveL 
ranging from 0.33 - 0.55 (Glow et aL 1982). The reliability of the CPRS-93 over one 
year ranges from OAO for the psychosomatic scale to 0.70 for the hyperactive-
immature subscale (Glow et aL 1982). Inter-rater reliability has been assessed in 
abnorn1al groups only and is reported to be between OA6 and 0.94 for different 
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domains (Conner, 1989). Although acceptable, parent-teacher correlation's tend to be 
slightly lower than mother-father and teacher-teacher correlation's. Additionally. 
" 
mothers' ratings of their children's behaviour have been shown to correlate 
significantly with teachers ratings, whereas fathers' ratings do not (Schaughency and 
Lahey, 1985). Internal consistency as assessed by the alpha reliability coefficients 
vary from 0.61 - 0.94 for the CTRS-39. There are no similar published data for the 
CPRS-93. 
3.2.2. Statistical analysis 
The distribution of the between patients variability for the composite Connor's 
rating scale score has a standard deviation of approximately 5 units with a mean 50. 
128 patients would be required for a parallel group study, to be able to detect a 
change in the composite score of 2.5 units, with 80% power and a 2-sided test at 50/0 
significance. For a crossover study design, the between patient variability is removed, 
and an estimate of the within patient variability would be required. This is not 
available in this patient population, although, it can be assumed that a smaller 
number of patients would be required than for a parallel group study. It was 
considered that 60 or more patients, randomised equally between the two treatment 
groups should suffice to enable this study to achieve its objectives. 
Composite scores were calculated from the teacher's version and the parent's 
versions of the Connor's Rating Scale by finding the mean score of each of the sub-
scales for the parents' and teachers' scale separately, and then taking an unweighted 
mean of the two resulting means. Missing values were accounted for by adjusting the 
denominator in the individual sub-scale mean calculations. It was assumed that the 
composite score were approximately normally distributed. 
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3.3. Methodological Principles of Tel Testing 
3.3.1. Requirement of Tel Tests 
The computerized neuropsychological TCI tests described here were developed by 
Steven Coleshill (S.G. Coleshill, PhD 1999) and are used by the Department of 
Clinical Neurophysiology at King's College Hospital, London in the clinical 
assessment of the cognitive effects of subclinical EEG discharges. In addition to this 
study they are currently employed in a series of studies at King's College Hospital, 
on the effect of stimulation-induced epileptiform discharges and of the cognitive 
effects of both temporal lobectomy and vagus nerve stimulation. 
The primary purpose of the test is to enable continuous cognitive testing with 
simultaneous EEG recordings, so that the effects of small fluctuations in cognition 
can be correlated in real time with EEG changes. 
According to Aarts et al. (1984) a routine test for TCI should fulfil the following 
criteria: (1) The task must not so suppress epileptiform activity so that testing is 
impossible (see section 1.3.5). (2) The test must be acceptable for administration over 
a period sufficiently long for the effect, if any, of an adequate number of discharges 
to be observed. In practice, patients must generally be willing to perform the task for 
at least half an hour. (3) The difficulty must be adaptable to the patient's level of 
performance. Easy tasks are relatively insensitive to TCI, but increasing task 
difficulty may either decrease or increase the amount of epileptiform activity. (4) The 
task must test cognitive activity continuously. If it is intermittent, discharges may fall 
in the intervals between trials. (5) The test should have face validity. The clinical 
relevance is more obvious if the cognitive impairment demonstrated is of practical 
relevance, as for instance impaired verbal memory in a school child or increased 
reaction time in a motorist. (6) The test should differentiate between different 
psychological functions and between different regions of the brain. 
As Tel testing is using a within-subjects methodology it is crucial to ensure 
equivalence of stimulus items used in each test. In order to demonstrate that there is a 
difference between cogniti\'e performance with and \\"ithout EEG discharges. the 
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variability in the pool of test items within tests must be minimized. For example, 
significance may be attached, within an individual subject, to the finding of impaired 
performance in a small number of trials which coincide with epileptiform discharges, 
relative to performance over the majority of trials where there were no epileptiform 
discharges (baseline). For TCI findings to be valid in such cases, it needs to be shown 
that observed differences in cognitive performance with and without EEG discharges 
are not attributable to the relative difficulty of the test items in each case. 
Computer hardware and software 
Test programmes were written using QuickBasic 4.5 compiler with PCX 
Programmers Toolkit - a graphics interface and libraries (Genus Microprogramming 
Inc, USA, 1991). The test and analysis programmes described in this thesis have been 
designed by S.G. Coleshill (1999). Test programming was a collaborative venture of 
S.G. Coleshill and Mr Les Law. The tests were run on a Compaq desktop 486DX/40 
MHz computer with a Ranger 5117 VGA high resolution 17 inch colour monitor 
with flat square tube (Aydin Controls (UK) Ltd). The MicroTouch capacitance 
touchscreen was attached to the monitor, and the interface was driven by TB driver 
software (Touch-Base Ltd, UK). 
3.3.2. Type of cognitive test 
The NGRAMS measures working memory. An event is an occurrence of something 
at a particular time in a particular place. Therefore, the major constituents of most 
events are (i) their contents or identity (what?), (ii) their spatial location (where?), 
and (iii) their occurrence in time (when?). Working memory models invariably 
assume that working memory consists of dissociable storage and rehearsal processes, 
with allocation of resources controlled by a 'central executive'. The Baddeley model 
(1986, 1992a) posits dual working memory mechanisms for rehearsal and 
n1aintenance of vi suo-spatial material 'the visuo-spatial sketchpad', and for verbal 
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material 'the articulatory loop', which includes a subvocal rehearsal system, and a 
phonological store. With Ngrams tasks it is clear that subjects use articulatory 
rehearsal for unequivocal verbal tasks such as Words, but not for the Corsi. Baddeley 
(1986) has suggested however, that implicit eye movements to target locations, as in 
the Corsi, may serve as a rehearsal mechanism for spatial locations. Working 
memory tasks have been reported in a small number of experiments to be sensitive to 
hippocampal damage or disruption (Friedman and Goldman-Rakic, 1988). 
In verbal working memory, articulatory rehearsal appears to be mediated by frontal 
regions, with storage mediated by posterior regions (Awh et aI., 1996). Significant 
areas of activation are typically BA 7 and BA40 in the parietal cortex, and three 
regions in the frontal cortex, corresponding to BA44 (Broca's area), and BA6 
(premotor and supplementary motor area). 
Spatial working memory and spatial selective attention probably share the underlying 
neural circuitry (Awh et aI., 1996). The Corsi Block-Tapping Task (Corsi, 1972), 
described below in section 5.5.2., is widely considered to be the best available non-
invasive test of right hippocampal function (Kolb and Whishaw, 1990), although 
many investigators have found Corsi's data difficult to replicate (Baddeley and 
Warrington, 1970; Goldstein and Polkey, 1993). There is good recent evidence that 
the right prefrontal cortex mediates temporal order information for spatial locations 
(Kesner et aI., 1994), and considerable evidence that the frontal cortex is specialized 
for temporal order information (Eslinger and Grattan, 1994; Petrides, 1991; 
Shimamura et aI., 1990). 
3.3.3. Co-registration of EEG 
All cognitive tests were performed during EEG monitoring to co-register EEG 
events, test stimuli and touch response. The Medelec® Profile EEG system by 
Taugagreining was used for recording and analysis. Sixteen chlorided sil\'er 
electrodes were placed according to the Modified Maudsley placement at Fp2, Fp 1. 
F4, F3, F8, F7, C4. C3. P4, P3, T .. L T3, T6, T5, 02. 01. The signal was acquired 
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against the mid parietal electrode pz reference, filtered (1 to 70 Hz), and analogue to 
digital converted (sampling frequency 256 hz, 12 bit resolution). ASCII text output 
from the touch screen and from the test computer was relayed to the EEG recorder in 
real-time. Memory-resident software enables inputs from the test computer to use the 
standard facilities of a digital EEG machine to annotate the EEG display. The record 
is annotated using the manufacture's EEG data acquisition software without 
modification. This is achieved by means of a memory resident program that generates 
an interrupt when data appear at the serial port and enters these in the keyboard 
buffer. The effect is equivalent to the technician keying in even markers and 
comments during the recording. The markers for stimulus presentation are pre-set, so 
that when the EEG is analysed for epileptiform discharges (Figure 3.5) the reviewer 
is able to mark the sheet (Figure 3.6). However, the markers for identity and location 
of items are masked so the EEG reviewer is blinded to the results of the test. 
3.3.4. Ngrams Test 
The Ngrams test battery has been developed from the computerized 'Modified Corsi' 
test, described by Aarts et al (1984). It has been employed until recently for the 
clinical evaluation of TCI (see section 1.3.) at The Maudsley Hospital, Department of 
Clinical Neurophysiology. The Modified Corsi test is based in turn on the original 
Corsi Blocks test (Corsi, 1972). The Modified Corsi test uses 2 working memory 
tasks, one verbal (sequences of 4-letter words), the other nonverbal (sequences of 
Corsi Blocks). In both tasks sequences of items are shown on a computer monitor. 
Reproductions of the verbal or nonverbal sequences were indicated by selection of 
items with a light-pen (for full details see Aarts et aI., 1984). 
The name 'Ngrams' is a play on the word 'engram', which refers to the supposed 
neural representation of learning and memory in the brain. The name also refers to 
the fact that the number (n) of items or characters (grams) in the presentation of a 
stimulus string for recall varies. 
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Words for Ngrams-words were selected from the 'CELEX Database' of Baayen & 
Piepenbrock (1993) according to similar word frequency, salience, age-of-
acquisition, word imagery and concreteness (Coleshill 1999). Words used in Ngrams 
were balanced for these attributes. They appear to be the most potent or influential in 
terms of recognition and recall. 
There are several advantages of the Ngrams compared to the Modified Corsi, only 
some of which are relevant to this study: (1) stimulus material which may potentially 
be differentially sensitive to cognitive changes in different brain regions, e.g., 
amygdala, hippocampus, lateral temporal and frontal cortex, etc.; (2) option to test 
stimulation-induced epileptiform discharges: (3) the verbal and nonverbal stimulus 
items in the Ngrams are optimised in terms of the balancing of stimulus attributes 
and have been empirically quantified (Coleshill, 1999); (4) including reaction time 
and serial position analysis as measurements (for full details see PhD data, S.G. 
Coleshill, 1999). 
The duration of the TCI test is of crucial importance as cognitive testing can suppress 
ID, but usually discharges will return after a while. Furthermore a certain number of 
trials have to be measured in order to be able to perform statistical analysis. Similarly 
to the traditional Corsi test (Aarts et al. 1984), each subtest consists of 40 trials, 4 of 
which are practice trials. The test was self-paced and depending on the memory 
capacity and speed of each child lasted between 30 and 45 min. 
The test consists of presenting a sequential string of items on the touch-screen within 
a 3x4 spatial array. Recall of the string (item, order of item, location and order of 
location) was indicated by the subject by touch-selecting items from a menu of 12 
possibles, then entering them into the array. Items appeared in a pseudo-randomised 
sequence. Pseudo-randomisation was used to minimise heterogeneities and 
unpredictable interactions between stimuli, which would make some trials more 
difficult to remember than others. It can be used as a working memory test or in 
combination with real-time EEG co- registration as a TCI test. 
The test may be considered as a series of trials, each comprising, first the 
presentation of the stimulus sequence (duration 3-5 sec), then a one-sec stimulus-
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response interval, followed by the response phase with variable duration. Before the 
next trial there is an intertrial interval of 4 sec. 
Figure 3.7 illustrates a trial of Words: a) the patient is presented with an empty 
spatial array for 1 sec. b) Stimulus presentation begins with the first item 'SKIN' 
being shown within the spatial array for 1 sec. c) After the first item extinguishes the 
second item 'HAIR' appears, d) than the third 'WALL'. The screen then cleares 
during a 2 sec stimulus-response interval e) before showing two 3x4 spatial arrays, 
on the left the menu array, on the right the clears original array. f) Stimulus response. 
The task requires reproduction of the string 'SKIN-HAIR-WALL' from stimulus 
presentation in sequence order. The first item 'SKIN' is touch selected from the 
menu on the left of the screen, then touched into the location within the spatial array. 
g) The second item 'HAIR' in the string recalled from stimulus presentation is 
selected from the menu then touched into the location within the spatial array. h) The 
final third item 'WALL' in the string recalled from stimulus presentation is selected. 
Trial ends. The screen is cleared for a 4 sec intertrial interval before the next trial 
begins. 
Figure 3.8 illustrates a trial ofNgrams-corsi: a) the patient is presented with an empty 
spatial array for 1 sec. b) Stimulus presentation begins with the first items being 
shown within the spatial array for 1 sec. c) After the first item is extinguished the 
second item appears, d) then the third. The screen then clears during 2 sec stimulus-
response interval e) before showing two 3x4 spatial arrays on the left the menu array, 
on the right the cleared original array. f) Stimulus response. The task requires recall 
of the string from stimulus presentation in sequence order. The first item is touch 
selected from the menu on the left of the screen, then touched into the location within 
the spatial array. g) The second item in the string recalled from stimulus presentation 
is selected from the menu then touched into the location within the spatial array. h) 
The final third item in the string recalled from stimulus presentation is selected and 
touched into the spatial array. The screen then clears for a 4 sec intertrial interval 
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PAGE NUMBERING AS IN THE 
ORIGINAL THESIS 
Chapter 4: Factors influencing the incidence of interictal 
discharges 
4.1. Summary 
Objective: This chapter aims to document the frequency of interictal EEG discharges 
in children with well-controlled epilepsy and assesses the effects of a number of 
intrinsic and extrinsic factors on the incidence of interictal discharges. 
Method: Children with well-controlled epilepsy underwent ambulatory EEG 
recording which was analysed visually. Neurological examination, detailed history, 
parents and teachers' behavioural scales (Conners' rating scales) and IQ tests were 
performed and compared to the results of the EEG. 
Results: Thirty-three out of fifty children had interictal discharges. The incidence 
was significantly higher in boys (p<O.Ol) and in children with idiopathic partial 
epilepsy (p<0.05) and lower in children taking sodium valproate (p<0.05). Age of 
onset of epilepsy, age, presence of neurological abnormalities, IQ and behaviour did 
not influence the incidence of discharges. In addition, there was a significant 
interaction between the factors gender and type of epilepsy. 
Conclusion: Our data suggest that interictal discharges are very common even in 
children with well-controlled epilepsy. Gender and type of epilepsy may influence 
the incidence of interictal discharges. 
1.20 
4.2. Introduction 
Interictal discharges or subclinical epileptiform discharges in repeated EEG 
recordings occur in up to 900/0 of patients with ongoing epilepsy (Ajmone Marsan 
and Zivin, 1970). As some discharges are accompanied by transient changes in motor 
(Tassinari et aI., 1998) or cognitive function (Aarts et aI., 1984, Binnie and Marston, 
1992), the distinction between clinical and subclinical events may depend on the 
assessment method used. Factors affecting interictal discharges in adults with 
epilepsy include the proximity ofEEG recording to seizures (Ajmone Marsan and 
Zivin, 1970, Sundaram et aI., 1990) and seizure frequency in the preceding year 
(Sundaram et aI., 1990). Neither age at the time of the recording, neurological status 
and aetiology of epilepsy influenced the frequency of interictal discharges (Sundaram 
et aI., 1990), nor did drug levels (Gotman and Marciani, 1985). Adults are less likely 
to have interictal discharges than children, particularly if the epilepsy first presented 
in adulthood (Ajmone Marsan and Zivin, 1970, Salinsky et aI., 1987). Some 
childhood epilepsy syndromes are known to be associated with frequent interictal 
discharges, for example benign epilepsy with centro-temporal spikes, the commonest 
idiopathic epilepsy syndrome of childhood. The effect of anticonvulsants is still 
unclear. A survey of clinical trials in epilepsy (Gram et ai., 1982) has shown that 
two-thirds of rigorously designed controlled trials include EEG recordings but only 
half of these present a statistical analysis of the findings. 
The fluctuating nature of both spontaneous seizures and interictal discharges make it 
difficult if not impossible to draw meaningful conclusions from random routine EEG 
recordings (Milligan and Richens, 1981). Subclinical EEG discharges occur at 
anytime within a 24-hour period but random 20 minutes EEG recordings sample only 
a small fraction of the activity occurring during a 24 hour period (Stevens et ai., 
1972). It is known that this pattern is frequently modulated by extrinsic or intrinsic 
factors which influence the overall discharge probability (Kellaway et ai., 1980. , 
Binnie et aL 1984). Assessments of the therapeutic response based on random EEGs 
are therefore likely to be inaccurate (Binnie, 1982). The fluctuating nature of 
interictal discharges explain why they are not observed in each random EEG 
recording in individual patients (Ajn10ne Marsan and Zivin. 1970. Salinsky et aL 
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1987). The circadian pattern and day-to day variability of interictal discharges are 
relevant to the use of long-term EEG recording as a means of assessing therapy. 
The incidence of EEG discharges in children with well-controlled epilepsy has not 
been adequately documented. This is of importance for two reasons: 1) EEG are 
frequently requested in such children to monitor success of treatment and to estimate 
the risk of seizure recurrence if AED are withdrawn (Duncan, 1987) and 2) interictal 
discharges can cause transitory cognitive impairment (TCI) and therefore may have 
consequences for the psychosocial function of children with epilepsy (Aarts et aI., 
1984, Binnie and Marston, 1992; Marston et aI., 1993). 
The aims of this chapter were to evaluate interictal discharges in children with well-
controlled epilepsy and correlate incidence and frequency of discharges to gender, 




For this chapter a subgroup of well-controlled patients were included in the analysis. 
Well-controlled epilepsy was defined as being seizure-free over the last three months 
or having had only one seizure per month in this period, but where seizure control 
was considered optimal and no further modification to the anti -epileptic drug 
regimen was planned. For patient recruitment see chapter 3.5 
4.3.2. Procedure 
Physical and neurological examination, routine and ambulatory EEG as well as IQ-
tests (WISC-R III, Wechsler Intelligence Scale for children-Revised version) were 
performed. In addition a detailed history was obtained including family history, 
seizure history, social history and medication. The Conners' rating scales for parents 
and teachers were used to evaluate behaviour. A score over 70 (+2 SD) in at least one 
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subscore was considered as abnormal. Seizures and epileptic syndromes were 
classified according to the International League against Epilepsy classification of 
epilepsy syndromes (1981, 1989). 
Discharges were quantified in each patient during the eyes-open phase of a 12 to 24 
hour period as discharge frequency (number per hour) and discharge time per hour 
(duration in seconds per hour). For details of ambulatory EEG monitoring and 
quantification of EEG discharges see section 3.4. 
4.3.3. Statistical analysis 
The following factors were correlated with the presence of ID in the ambulatory 
recording using the chi-square test (2-tailed): 
1. Age of the patient at the time of the recording: (a) 7-9 years, (b) 10-13 years 
and (c) 14-17 years. 
2. Gender. 
3. Age of onset: (a) < 4 years, (b) 5 - 7 years and (c) > 8 years. 
4. Type of epilepsy: (a) idiopathic partial, (b) idiopathic generalised, (c) 
symptomatic partial and (d) symptomatic generalised. 
5. Intelligent quotient: (a) < 84, (b) 85 - 115 and (c) > 115. 
6. Behaviour: (a) normal, (b) abnormal. 
7. Neurological examination: (a) normal, (b) abnormal. 
8. Antiepileptic drugs: (a) none, (b) carbamazepine, (c) valproate, (d) other 
antiepileptic drugs, including combinations. 
9. Seizures in the 4 weeks preceding the recording: (a) no, (b) yes. 
10. Frequency of seizures in the last year: (a) none, (b) 1 - 10 and (c) > 10. 
The interaction between was analysed using binary logistic regression for qualitati\'t~ 
variables and ordinal logistic regression for quantitati\,e variables (SPSS 10). 
Statistical significance \\'as accepted at the k\'el ofp<0.05. 
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4.4. Results 
4.4.1. Clinical findings 
Fifty patients were included in the study (30 males, 20 females; median age: 11 years 
with a range of 7 - 17 years). Fourteen children had idiopathic partial epilepsy (9 
benign epilepsy of childhood with centro-temporal spikes, 3 benign epilepsy with 
occipital paroxysms, 2 atypical benign partial epilepsy), 11 children had idiopathic 
generalised epilepsy (6 childhood absence epilepsy, 1 juvenile absence epilepsy, 4 
juvenile myoclonic epilepsy) and 25 symptomatic partial epilepsy. Six patients were 
not receiving antiepileptic drugs, 23 were on carbamazepine monotherapy, 13 on 
sodium valproate monotherapy, 1 on phenytoin monotherapy, 1 on vigabatrin 
monotherapy and 6 on a combination (carbamazepine and vigabatrin, carbamazepine 
and valproate, carbamazepine and acetazolamide, clobazam and ethosuximide, 
valproate and phenytoin). Most children (780/0) were seizure free during the three 
months preceding recrutment. Of the 11 children with seizures eight (160/0) had one 
seizure in the last four weeks and only two patients had seizures in the last week. 
Table 1 summarises the patients' demographics. 
Number of patients 50 
Age - median (years) 11 (range 7-17) 
Gender - male 30 (60%) 
Positive family history 11 (220/0) 
IQ - median 94 (range 60-135) 
Age of onset (years) 6 (range 0-15) 
Seizures in last 
4 weeks 8 (160/0) 
1 week 2 (4%) 
Table 4.1: Characteristics of patients 
12.+ 
4.4.2. EEG findings 
The mean duration of the ambulatory EEG recording was 18.12 hours (SD ±4.46). 
Thirty-four (66%) children had subclinical discharges in the awake state. Discharges 
were generalised in 7 patients, focal in 15 (right sided in 6, left sided in 3 and 
bilateral in 6) and both focal and generalised in 12 patients (with focal discharges 
right sided in 7, left sided in 2 and bilateral in 3). In children with interictal 
discharges the median frequency of discharges was 4.25/hr (range 0.6 to 115 .6/hr. SD 
26.83) and the median duration of discharges was 5.45 sec/hr (range l.0 to 140.8 
sec/hr, SD 34.20). 
There was a high correlation between frequency of discharges and duration of 
discharges (Pearson's Correlation Coefficient r=0.962; n=51; p<O.OOl). The 
relationship of interictal discharges to various factors described previously is 
summarised in Table 2. Age, age of onset, IQ and presence of behaviour problems or 
neurological abnormalities did not influence interictal discharges. However, there 
was a tendency for children with idiopathic epilepsy and interictal discharges to have 
more behavioural problems (11 out of 19) than children with idiopathic epilepsy but 
without interictal discharges (1 out of 6). This difference did not quite reach the 
statistical significance (X2=3.105; df=l; p<O.l). Boys showed significantly more 
interictal discharges than girls (X2=6.551; df=l; p<O.Ol). The incidence of discharges 
was higher in patients with idiopathic partial epilepsies (X2=6.257; df=2; p<0.05) than 
patients with idiopathic generalised epilepsies or symptomatic partial epilepsies. 
Patients taking sodium valproate had significantly fewer discharges than patients not 
taking AED or taking other AEDs (X2=9.823; df:---3; p<0.05). 
There was a tendency for patients with a close proximity to seizures to have ID. Of 
the 8 children with seizure in the last four weeks prior to study entry. 7 (88%) had ID. 
whereas 26 out of 42 (62%) children without seizures in this period had discharges. 
This difference was not significant perhaps because the number of patients with 
seizures was sn1all (X2= 1. 962; df= 1: ns). The incidence of idiopathic partial epilepsies 
was not significantly higher among boys (9 out of 30 boys - 300/0) than among girls (5 
out of 20 - 250/0). 
No. of No. of patients ID frequency 
patients in with ID mean [Vhr] 
this category {Chi-sguare} {ANOVA} 
Total 50 33 (670/0) 11.3 
Age (years) 
(a) 7-9 14 10 (71 %) 29.2 (b) 10-13 19 12 (630/0) 5.8 (c) 14-17 17 11 (65%) 4.5 
Gender 
(a) male 30 **24 (80%) 17.0* (b) female 20 9 (45%) 1.6 
Age of onset (years) 
(a) 0 - 4 17 11 (650/0) 12.8 (b) 5 - 7 17 11 (650/0) 16.9 (c) > 8 16 11(69%) 5.0 
Type of epilepsy 
(a) idiopathic partial 14 *13 (93%) 28.4 
(b) idiopathic generalised 11 6 (550/0) 3.4 
(c) symptomatic partial 25 14 (56%) 5.5 
IQ 
(a) < 85 17 12 (71 %) 5.0 
(b) 85 - 115 25 16 (640/0) 18.7 
(d) > 115 8 5 (63%) 4.0 
Behaviour 
(a) normal 27 18(67%) 10.2 
(b) abnormal 23 15 (65%) 13.5 
Neurological examination 
(a) normal 44 28 (64%) 12.5 
(b) abnormal 6 5 (830/0) 6.3 
Antiepileptic drugs 
(a) none 6 5 (83%) 21.1 
(b) carbamazepine 23 18 (780/0) 18.5 
(c) sodium valproate 13 * 4 (310/0) 0.4 
(d) other, incl. combinations 8 6 (75%) 3.5 
Seizures in last 4 weeks 
(a) no 42 26 (62%) 10.2 
(b) yes 8 7 (880/0) 20.4 
Seizures in last year 
(a) no seizures 15 10 (67%) 9.6 
(b) 1-10 seizures 28 20 (710/0) 11.7 
(b) > 11 seizures 6 3 (500/0) 17.4 
*p<0.05, **p<O.OI 
Table .... 2: Relationship of interictal discharges (ID) to age, gender, family history. 
neurological examination. IQ, behaviour, age of onset type of epilepsy. antiepileptic 
drugs and seizures frequency. 
1~6 
Naturally, children with idiopathic generalised epilepsy were significantly more 
likely to receive sodium valproate (8 out of 11 ) and children with partial epi lepsy 
were significant more likely to receive carbamazepine (9 out of 14 with idiopathic 
partial epilepsy and 13 out of 25 with symptomatic partial epilepsy) (i=27 .973 ; 
df=6 ; p<O.OOl). 
As the distribution of discharge frequency was not normal, data were divided into 
three approximately equal groups (no ID, 1-19 ID per hour, more than 20 ID per 
hour). There was a significant main effect for the factors 'gender ' (F(1 ,33) = 9.30; 
p<O.O 1) and ' type of epilepsy ' (F(1 ,33) = 9.80; p<O.O 1) on the number of discharges 
but not for the factor ' antiepileptic drugs ' . In addition, to the main effect there was a 
significant interaction between gender and epilepsy (F(2 ,33) = 3.35; p<0.05). Boys 
with idiopathic partial epilepsy had more discharges than girls with idiopathic partial 
epilepsy; this gender difference was not evident for idiopathic generalised or 
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Figure 4.3: Distribution of frequency of discharges (per hour) in respect to gender 
and type of epi lepsy. CI : confidence interval. 
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4.5. Discussion 
The results of this study show that two thirds of children with well-controlled 
epilepsy have interictal discharges which occur significantly more often in boys than 
girls and in benign partial epilepsy. Our group of patients with well-controlled 
epilepsy appear representative of the population of school-age children with epilepsy: 
nearly 500/0 symptomatic epilepsies, 250/0 idiopathic partial epilepsies and 250/0 
idiopathic generalised epilepsies (Cavazzuti, 1980); the latter including 
approximately 13% childhood absence epilepsy, 10% juvenile myoclonic epilepsy 
and 20/0 juvenile absence epilepsy. As expected there were more boys than girls and 
the IQs were within the normal range but somewhat below average (Ellenberg et aL 
1986; Rodin, 1989). 
There is evidence that the risk of seizure recurrence after AED withdrawal is 
increased if discharges are present beforehand. In adults the finding of discharges in 
an EEG is of uncertain prognostic significance (Overweg et aI., 1987). In contrast, in 
children with epilepsy, EEG abnormalities (slowing or epileptiform) correlate with a 
higher rate of seizure recurrence after drug withdrawal (Caviedes and Herranz, 1998, 
Emerson et aI., 1981, Shinnar et aI., 1985). Thus, it was surprising that epileptiform 
discharges were found in 690/0 of children with well-controlled epilepsy. 
The incidence and the frequency of ID were both significantly higher in boys and in 
patients with benign partial epilepsy. Gender differences in epilepsy have been 
reported in animal studies (Standley et aI., 1995, Todorova et aI., 1999). In NMDA-
induced seizures in rats, the initial severe seizure was similar in males and females, 
but male rats developed a significantly higher ongoing seizure activity than female 
rats (Standley et aI., 1995). Recently a study in patients with refractory temporal lobe 
epilepsy found a greater volume loss of the brain in quantitative MRI in men 
compared to women suggesting that men are more vulnerable to seizure-associated 
brain damage than woman (Briellmann et aI., 2000). 
It is well known that children with benign epilepsy with centro-temporal spikes have 
frequent interictal discharges occurring in up to 700/0 of these children during 
wakefulness and in almost all during drowsiness and sleep (Degen et aI., 1988, 
HolIncs, 1992). Furthermore, there was a significant interaction between gender and 
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type of epilepsy: boys with benign partial epilepsy were most likely to have 
discharges compared to girls or boys with other types of epilepsy. 
It is generally believed that disappearance of interictal discharges from the EEG 
parallels an improvement in seizure control although the evidence for this is 
controversial. Binnie reported only a very weak association between changes in 
seizure frequency and in the amount of interictal discharges seen in 1244 routine 
EEGs (Binnie, 1982). However, in a study of 26 patients with partial epilepsy who 
had 13-hour EEGs, there was a positive correlation between seizure frequency and 
the amount of interictal discharges (Autret et aI., 1983). Similarly, Sundaram and 
colleagues (1990) found discharges significantly more often in patients with seizures 
in the two days before the recording and with more than 12 seizures per year. We 
found a tendency for children with seizures within the last four weeks to be more 
likely to have interictal discharges, but none of our patients had seizures within 2 
days of the EEG recording. We could not confirm a correlation between the number 
of seizures per year and incidence of interictal discharges. 
There is evidence that interictal discharges are associated with cognitive and 
behavioural problems in children with epilepsy. Stores and colleagues (Stores, 1973) 
demonstrated significantly more behavioural disturbances in boys with left temporal 
discharges than in boys with epilepsy but without inter-ictal discharges. Dodrill and 
Wilkus (Dodrill and Wilkus, 1976) found in adults with epilepsy a significant 
association between lower intelligence scores and the presence of discharges, 
especially generalised discharges occurring more than once per minute. In our group 
of patients there was no difference between children with and without interictal 
discharges in respect to their behaviour. Children with symptomatic epilepsy are 
more much likely to have behavioural problems then children with idiopathic 
epilepsy, probably as a result of the combination of a brain lesion and seizure related 
factors rather than epilepsy related factors alone (Rutter et aI. 1970). 
Similarly children with and without interictal discharges did not differ in their IQ. 
However the IQ is only a very rough measurement of cognitive function. In addition, 
only patients with an IQ > 60 were analysed. Thus, \\e found no evidence that 
interictal discharges is a marker or cause of behavioural or cognitive problems in 
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children with well-controlled epilepsy attending mainstream school. This needs to be 
evaluated in further studies involving Tel testing. The only way to establish whether 
discharges are causing cognitive and behavioural problems in children with epilepsy 
or are co-existing phenomena of an underlying defect, is by finding an improvement 
of cognition and behaviour when EEG discharges are suppressed. 
For seizures other then absences, there is generally not a clear relationship between 
control of seizures and interictal discharges (Duncan, 1987; Milligan and Richens. 
1981). In fact some drugs, for example carbamazepine, are known to cause 
deterioration in the EEG while at the same time improving seizure control (Wilkus et 
ai., 1978). There is some evidence that barbiturates (Kellaway et aI., 1978), sodium 
valproate (Adams et ai., 1978) and lamotrigine (Binnie et aI., 1986; Marciani et al.. 
1996) may suppress interictal discharges more than other AEDs. In concordance with 
this we found significantly fewer interictal discharges in patients on sodium valproate 
compared to other AEDs or patients not on AEDs. This is at least partially due to the 
fact that children with absence epilepsy are likely to be on sodium valproate. It is 
well recognised that in contrast to other epilepsy types there is a clear association 
between control of seizures and interictal discharges in typical childhood epilepsy 
(Duncan, 1987). It was not surprising therefore that in the factorial analysis no 
significant difference between AEDs was found. 
The interaction between interictal discharges and AED in childhood absence epilepsy 
also explains why in our study children with idiopathic partial epilepsy were more 
likely to have interictal discharges than children with idiopathic generalised epilepsy 
_ since more than half of the latter are children with absence epilepsy. It is well 
recognised that patients with symptomatic epilepsy, particularly temporal lobe 
epilepsy, frequently lack interictal discharges in the surface recording. As idiopathic 
partial epilepsy syndromes are age related this may explain that other studies looking 
at interictal discharges in adults have not found a difference related to type of 
epilepsy (Sundaram et aL 1990). 
This finding has implications for the management of children with epilepsy as it 
n1akes evident that in individual patients, an EEG is not helpful for the decision 
whether or not to stop AEDs. 
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Chapter 5: Effect of lamotrigine on interictal discharges 
5.1. Summary 
Objective: To document the spontaneous fluctuations of interictal discharges, and to 
evaluate the effect of lamotrigine on interictal discharges in children with well-
controlled epilepsy. 
Method: Sixty-one patients aged 7-17 years were included in a double blind. 
placebo-controlled, cross-over study. Lamotrigine or placebo was added to the 
current antiepileptic drug regime in each treatment period of 12 weeks. Ambulatory 
EEG recordings were carried out during baseline, placebo and drug phases. The 
amount of interictal discharges was compared between baseline and placebo to 
estimate spontaneous fluctuations and between placebo and lamotrigine to estimate 
the effect of the drug. 
Results: 70% of patients had interictal discharges at baseline. Thirteen patients 
withdrew before trial completion. The spontaneous fluctuations of discharges in 
ambulatory recordings were considerable; frequency and duration varied more within 
than between subjects. Lamotrigine reduced the duration of discharges per hour 
(p<0.05), but not the total number per hour. Twenty-two out of 35 patients with 
interictal discharges showed a reduction of duration of discharges in the lamotrigine 
phase. 
Conclusion: Inter- and intra-individual variations of interictal discharges make it 
difficult to evaluate the effect of antiepileptic drugs on discharges even if prolonged 
EEG recordings are used. Lamotrigine appears to have an effect on the termination 
rather than the initiation of discharges. 
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5.2. Introduction 
Interictal or 'subclinical' epileptiform discharges occur in up to 90% of patients with 
ongoing epilepsy although they not necessarily in every EEG recording (Ajmone 
Marsan and Zivin, 1970). Aarts et aI. (1984) defined discharges as subclinical where 
'the available methods of clinical observation ... fail to show any changes in the 
patient'. Such discharges are often not truly subclinical as they have been shown to 
cause brief disruptions of cognitive performance (see chapter 8). This leads to the 
question as to whether treatment of discharges with AED improves psychosocial 
function (see chapter 6 and 7). In order to do this the effect of AED on interictal 
discharges must first be established having in mind the nature of spontaneous 
fluctuation of such discharges. A survey of clinical trials in epilepsy (Gram et aL 
1982) showed that two-thirds of rigorously designed controlled trials included EEG 
recordings but only half of these presented an analysis of the findings, which were 
mostly negative. 
The effect of anticonvulsant is still unclear (see section 1.3.7.2), but most AEDs 
which suppress discharges have a negative effect on cognition or behaviour. 
Lamotrigine is a wide-spectrum antiepileptic drug that is effective in all forms of 
epilepsy. The pharmacokinetic profile may be considered ideal when the drug is used 
as monotherapy; kinetic interactions complicate dosing schedules when it is used for 
add-on treatment. It is better tolerated than most long-established antiepileptic drugs, 
and in particular is said to have few or no effects on cognition and behaviour. 
Lamotrigine has also been shown to suppress interictal discharges in patients with 
epilepsy (Binnie et aI., 1986; Erikson et aI., 2001). For more details on lamotrigine 
see section l. 5. 
The variability of both spontaneous seizures and interictal discharges make it 
difficult to draw conclusions from random routine EEG recordings (Milligan and 
Richens, 1981). The temporal variability of EEG phenomena in children with 
epilepsy has not been adequately documented. Drug effects therefore may be 
undetectable unless the discharges show little intra-individual variability. Fe\\' 
studies address day-by-day variability of interictal discharges in patients with 
secondary epilepsy (Martins da Silva et aL 1984) or primary generalised epilepsies 
(Burr and Stefan, 1987) and only one included a fe\\' children (Mayr et aI., 1989). 
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The objective of this part of the study was to determine the range of spontaneous 
fluctuations of interictal discharges and whether lamotrigine had an effect on 




Patients were recruited from pediatric outpatient clinics at three study sites: Guy's 
Hospital, King's College Hospital and The National Centre for Young People with 
Epilepsy (NCYPE, former St Piers Lingfield), UK. Patients aged 7 to 17 years were 
eligible if they had a confident diagnosis of epilepsy and were seizure free or were 
having occasional seizures but in whom the responsible clinician or parent/careers 
felt that further adjustments to AEDs was not warranted. For more details on patient 
recruitment and inclusion criteria see section 3.5. 
5.3.2. Procedure 
This was a double blind, randomised, placebo-controlled, cross-over study with 
lamotrigine. See section 3.6 for study protocol (Figure 3.7 and Table 3.2) and dosage 
regime (Table 3.1). 
5.3.3. Efficacy and Safety Assessments 
See section 3.4 for assessment of interictal discharges and section 3.6 for safety 
assessment. 
5.3.4. Statistical analysis 
The outcome variables were the percentage change in the number of EEG discharges 
per hour and in the duration of discharges in seconds per hour. To determine the 
spontaneous fluctuations of interictal discharges. discharge frequency and duration at 
baseline and on placebo were compared using the Wilcoxon signed ranks test. It \vas 
expected that the data would be skewed, as a large proportion of children with well-
controlled epilepsy will have few discharges or none at all. Therefore, values were 
transformed as suggested by Burr and Stefan (Burr and Stefan, 1987). Instead of 
using the transformation d" = dO.2 , first values of 0.00 were recorded as 0.001 in order 
to perform analysis on all data and then values were log transformed. The same 
transformation and tests were used to examine the effect of lamotrigine by 
comparing discharge frequency and duration on placebo and lamotrigine. 
ANCOV A (general linear model, SPSS 10.0 for Windows) was used to test for a 
possible order effect and chi-square test to determine whether epilepsy-related 
factors influenced the effect of lamotrigine. In an "as-treated" analysis of changes in 
the frequency of discharges, data of patients who stopped the treatment early 
included data obtained only before treatment was discontinued. Analysis was by 
intention to treat. All tests were 2-tailed. 
Safety evaluation used descriptive analysis of the frequency with which patients 
reported specific adverse events. 
5.4. Results 
5.4.1. Clinical findings 
Of the 64 children screened, 61 patients were included (39 males, 22 females; mean 
age: 11.5 years, range 7-17 years). All patients underwent randomisation and entered 
the single-blind baseline phase; 31 were randomised to receive first lamotrigine and 
then placebo and 30 the reverse order. However, two children were not enrolled in 
the treatment phase: one had deterioration in seizure control and the parents of one 







64 patients screened 
>1 3 excluded - IQ too low 1 \/ 
61 randomised 
2 withdrew 
--7 1 AlE 




7 withdrew 2 withdrew ~ 5 AlE 2 consent WID 2 consent WID 
\/ 






trial 22 completed trial 
Figure 5.1: Trial profile 
Screen 
Baseline - wks 1-4 
Escalation - wks 5-8 
Phase 1 - wks 5-17 
x-over - wks 18-21 
Phase 2 - wks 22-31 
Taper wks 32-35 
Legend: AlE: adverse events, WID withdrawn, P/V protocol violation, wks: weeks. 
The characteristics of both groups were similar (Table 5.1); a few more children in 
the group lamotrigine/placebo had seizures in the three months preceding baseline 
and were somewhat younger when their epilepsy began, but these differences were 
not significant. Sixteen children had idiopathic partial epilepsy (ten benign epilepsy 
of childhood with centro-temporal spikes, three benign epilepsy with occipital 
paroxysms. three atypical benign partial epilepsy), 19 children had idiopathic 
generalised epilepsy (one infantile myoclonic epilepsy, nine childhood absence 
epilepsy, three juvenile absence epilepsy, six juvenile myoclonic epilepsy) and 26 
symptomatic partial epilepsy. 
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Seven patients were not receiving antiepileptic drugs, 23 were on carbamazepine 
monotherapy, 21 on sodi urn val proate monotherapy, one on ethosuximide 
monotherapy, one on phenytoin monotherapy, one on vigabatrin monotherapy and 
seven on a combination (carbamazepine and vigabatrin, carbamazepine and 
valproate, carbamazepine and acetazolamide, clobazam and ethosuximide, sodium 
valproate and phenytoin). 
Most children (770/0) were seizure free during the three months preceding baseline. 
Eight children had up to two partial seizures per month, two between three and five 
absences per month and four had more than six absences per month, but no more 
than three absences on anyone day (Table 5.1). One patient had five partial seizures 
three months prior to baseline during a febrile illness, but only two per month in the 
two months prior to entry. 
Thirteen children were withdrawn from the study (including the two children who 
did not enter the treatment phase): seven had adverse events (including one in the 
single blind placebo phase), parents of five children withdrew consent (including one 
in the single blind placebo phase) and one had protocol violations. Eight of these 
children had discharges. Four children were in the placebo/lamotrigine 
randomisation group and nine in the lamotrigine/placebo randomisation group; this 
difference was not significant (l=2.24; df=l; ns). 
A plasma lamotrigine level was available in 24 children, in 24 the sample was either 
lost or the blood test failed and 13 were withdrawn from the study before the 
maintenance dose was reached. The mean plasma lamotrigine concentration among 
patients who received the prescribed total daily maintenance dose for their weight 
was 5.9 ~g/ml (SD ±3.5). Ten children had a level of ~ 5 ~g/ml and 14 children a 
level >5 ~g/ml. There was no correlation between the plasma concentration of 
lamotrigine and discharge frequency or duration. 
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Characteristic LTG/Placebo Placebo/L TG 
Number of patients 31 30 
Age in years - mean (range) 11.4 (7-17) 11.7(7-17) 
Sex - male number 20 (65%) 19(630/0) 
Race 
White 23 25 
Black 5 2 
Other 3 3 
IQ (WISC) - mean (SD) 93.1 (17.2) 98.6 (22.l) 
VerballQ 96.6 (16.0) 105.3 (20.1) 
Non-verbal IQ 90.5 (17.4) 90.3 (23.1) 
Age of onset in years - mean (range) 5.5 (0-15) 7.8 (3-15) 
Type of epilepsy 
IGE 8 11 
IPE 10 6 
SPE 13 13 
Concomitant antiepileptic drugs 
None 3 4 
Carbamazepine 12 11 
Sodium valproate 10 11 
Other* 3 0 
Any combination 3 4 
Seizures/month t 
No seizures 22 (710/0) 25 (830/0) 
1-2 seizures 5 (16%) 1 (3%) 
3 -5 seizures 3 (10%) 1 (3%) 
~ 6 seizures 1 (30/0) 3 (10%) 
ID in initial ambulatory EEG 21 (680/0) 21 (700/0) 
Table 5.1: Baseline characteristics of patients 
Legend: LTG, lamotrigine; ID, interictal discharges. *Other antiepileptic drugs 
included ethosuximide, phenytoin and yigabatrin: t in 3 months prior study.) 
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The seIzure frequency did not change significantly during the study (Table 5.2). 
Forty-seven patients were seizure free at baseline (77%), 40 during the placebo phase 
(78%) and 39 during the lamotrigine phase (81 %). In the three months preceding 
baseline the mean seizure frequency was 3.43 (SD 13.4, range 0-90) seizures per 
month, during the placebo phase 3.24 (SD 10.38, range 0-50) seizures per month and 
during the lamotrigine phase 3.21 (SD 14.69, range 0-90). The wide range was 
caused by patients with absence seizures. If these were excluded the ranges changed 
to 0-5 seizures per month at baseline, 0-8 during placebo and 0-3 during lamotrigine. 
Seven patients had a reduction of seizures of more than 500/0 during the lamotrigine 
phase compared to placebo and five patients had a reduction of seizures of more than 
50% during the placebo phase compared to lamotrigine. 
Seizure type improved selzure- worse 
free 
Simple partial 2 
Complex partial 2 1 2 
Absences 3 2 
OTCS 1 
Myoclonias 1 1 
Total 3 5 7 
Table 5.2: Effect of lamotrigine on seizure frequency compared to placebo 
Adverse events were evaluated for 59 patients after exclusion of the two patients who 
were withdrawn in the single blind baseline phase. Apparent treatment related 
adverse events were observed in 23 of 59 patients (39%) during the lamotrigine 
phase and in 19 of 52 patients (370/0) in the placebo phase (Table 5.3). Adverse 
events led to withdrawal from the study of six patients (one in placebo phase): in five 
due to a rash and in one due to dizziness and nausea. The latter was later found to 
have a high phenytoin level of 31.7 Ilg/ml. Of the seven children who de\'eloped a 
rash during the lamotrigine phase, three were on sodium \'alproate, two on 
carban1azepine and two on no other antiepileptic drugs. The rash was mild \\"ithout 
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involvement of the mucous membranes in all but one patient (co-medication: sodium 
valproate) who developed a high temperature and involvement of mucous 
membranes. Full blood count and liver function in this patient were normal. The 
study medication was stopped and the symptoms disappeared within three days. In 
one patient the study medication was reduced from 300 mg per day to 200 mg per 
day because of persistent headaches. All other adverse events were mild and 
transient. 
Number of patients (%) 
Adverse Event Lamotrigioe (0=59) Placebo (0=52) 
Cold or viral illness 9 (15) 9 (17) 
Rash 7 (12) 2 (4) 
Nausea 5 (8) 2 (4) 
Injury or accident 4 (7) 0 
Pharyngitis 4 (7) 1 (2) 
Headache 1 (2) 2 (4) 
Dizziness 0 2 (4) 
Abdominal pain 0 2 (4) 
Patients withdrawn 6 (10) 0 
Table 5.3: Most frequently reported drug related adverse events 
Adverse events reported by three or more patients in either phase are listed. Some 
patients reported more than one adverse event. Patients who withdrew during single-
blind placebo phase are not included. 
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5.4.2. EEG findings 
All 61 children had an initial ambulatory EEG recording, 50 children had two and 48 
had three ambulatory EEG recordings. The mean duration of the recording at 
baseline was 18.15 hours (SD ±4.67), 16.80 hours (SD ±5.29) on placebo, and 16.73 
hours (SD ±4.97) on lamotrigine. 
In the initial ambulatory EEG recording 19 (31 %) children had no discharges and 42 
(69%) had discharges during the eyes open phase. In children with discharges the 
median number of discharges was 3.85/hr (range 0.6 to 115.6/hr, SD 24.68) and the 
median duration of discharges was 4.75 sec/hr (range 1.0 to 140.8 sec/hr, SD 33.78). 
These discharges were generalised in 11 patients, focal in 12 (right sided in seven, 
left sided in three and bilateral in seven) and both focal and generalised in 15 patients 
(with focal discharges right sided in seven, left sided in three and bilateral in four). 
There was a high correlation between frequency and duration of discharges 
(Pearson's Correlation Coefficient r=0.887; n=61; p<O.OO 1). 
As expected, neither the frequency nor duration of discharges were normally 
distributed. Figure 5.2 a) and b) demonstrates this for discharges at baseline, this was 
similar for discharges at placebo and lamotrigine. After data values of 0.0 set to 0.01 
log [In] transformation of the EEG data was performed. This resulted in a near 
normal distribution of the frequency and duration of discharges for the patients 
having discharges. Inclusion of children without discharges still resulted in a skewed 
distribution (Fig. 5.3 a) and b) for discharges at baseline). Thus, where statistics were 
applied to the whole group non-parametric tests were used. 
Looking at individual patients, ten out of 48 patients (210/0) completing the study had 
no discharges at either phase, 21 (440/0) had a reduction of frequency of discharges, 8 
(170/0) had no change and 9 (19%) had an increase of discharges frequency. 
Twenty-three (480/0) patients had a reduced duration of epileptiform discharges 
whilst 25 (520/0) patients either had no change or an increase of discharge duration 
(including 10 patients without discharges in either lamotrigine or placebo phase). 
There was a considerable spontaneous variation in both the number of discharges per 
hour and the duration of discharges per hour (Fig. 5.4 a) and b)). This was true for 
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Figure 5.3 a): Distribution of frequency of discharges at baseline after data values of 
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Figure 5.3 b): Distribution of duration of discharges at baseline after data values of 
0.0 set to 0.01 and log transformation. 
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b) Duration of discharges at placebo [In] 
Figure 5.4: (a) Duration and (b) frequency of discharges in ambulatory EEG 
recordings at baseline and placebo. Data after values of 0.0 set to 0.001 and log 
transformation. Lines estin1ated 950/0 confidence regions. 
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Frequency and duration varied more within than between subjects. The variation was 
greater for patients with frequent discharges compared to patients with few 
discharges. Both the number of discharges per hour and the duration of discharges 
per hour were higher at baseline compared to placebo, but this difference was not 
significant (discharge frequency: z= -1.418; ns and discharge duration: z= -1.005: ns) 
(Table 5.4). Although the first ambulatory (at baseline) recording showed most 
discharges, subsequent recordings showed no order effect. 
Baseline Placebo Lamotrigine 
Total number of patients 61 50 48 
No. of patients with discharges 42 (69%) 36 (72%) 32 (67%) 
Median number/hr (±SD) 3.9 (±24.7) 1.6 (±49.7) 1.8 (±26.7) 
Wilcoxon Ranks Test* ns ns 
Median duration sec/hr (±SD) 4.8 (±33.8) 2.8 (±52.0) 1.8 (±40.9) 
Wilcoxon Ranks Test* ns p < 0.05 
Table 5.4: Interictal discharges at baseline and after each treatment phase 
*Comparison was done on all patients by means of percentage changes rather than 
absolute changes in that data were log transformed before analysis after values of 0.0 
were changed to 0.001. 
There was a statistically significant reduction of the duration of discharges in 
seconds per hour during lamotrigine treatment compared to placebo (z = -2.~31: 
p<0.05), but not of the number of discharges per hour (z= -1.308, ns) (Table 5.4). 
Generalised and focal discharges were equally reduced by lamotrigine. Figure 5.5 
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Figure 5.5: EEG findings at placebo and response to active treatment 
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The effect on discharges was independent of the type of epilepsy: 7 out of 13 (540/0) 
patients with idiopathic partial epilepsy, 6 out of 14 (43%) idiopathic generalised epilepsy 
and 8 out of 21 (380/0) with symptomatic partial epilepsy had a reduction of interictal 
discharges (i=0.816; df 2; ns). Eleven patients had no discharges during either the 
placebo or the lamotrigine phase. Five patients had a 100% reduction of discharges on 
lamotrigine, whereas two patients had interictal discharges during the lamotrigine phase 
but not during the placebo phase. 
There was a significant difference in the effect of lamotrigine on interictal discharges in 
patients with or without seizures. Of the 21 children with seizures during the study, 13 
(620/0) had a reduction of both frequency and duration of discharges. In contrast, of the 27 
seizure-free children only 8 (30%) had a reduction of frequency of interictal discharges 
(i=5.00; df-1; p<0.05) and 10 (37%) had a reduction of duration of interictal discharges 
(X2=2.93; df 1; p<O.l). There was no correlation between the effect oflamotrigine on 
discharges and the number of seizures during the study. As the number of patients with a 
reduction of seizures of more than 500/0 on lamotrigine compared to placebo was too small 
(n=7) no correlation between reduction of seizures and reduction of interictal discharges 
was possible. 
5.5. Discussion 
Our group of patients with well-controlled epilepsy appear in many respects to be typical 
of the population of school-age children with epilepsy: 400/0 symptomatic epilepsies, 250/0 
idiopathic partial epilepsies and 300/0 idiopathic generalised epilepsies (Cavazzuti, 1980). 
As expected there were more boys than girls and the IQ was within normal range but 
somewhat below average (Rodin, 1989). 
The quantification of discharge frequency can be done either visually or by automated 
analysis. The difficulty of the latter, even if using the more recent models, lies in 
differentiating true cerebral activity from muscle activity and other artefacts. Visual 
analysis is obviously very laborious and time consuming, but is more accurate and reliable, 
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particularly if the discharge rate is low. As our study involved only 61 patients and some of 
them had no discharges we opted for the latter method. 
Conflicting results in studies on EEG abnormalities in patients with epilepsy may be 
explained by the fluctuating nature of interictal discharges. The rate and extent of interictal 
discharges can vary considerably from one moment to the next or from one day to the next. 
A random 20 minutes EEG recording samples only a small fraction of the activity that may 
occur during an entire day (Stevens et aI., 1972). The results of our study show that the 
day-to-day variability of interictal discharges is considerable even in children with mild or 
well-controlled epilepsy and prolonged EEG recordings are essential to evaluate the effect 
of a drug on interictal discharges. This confirms the findings in adults with active epilepsy 
(Martins da Silva et aI., 1984; Burr and Stefan, 1987; Mayr et aL 1989). 
The frequency and duration of discharges per hour were higher during the baseline than the 
placebo recording. Although most conditions like time of the day, weekday, examination 
room and people involved were constant, it was unavoidable that the children were excited 
or anxious before they had the first ambulatory recording. Their sleep therefore may have 
been disturbed before or during the recording. Sleep deprivation causing drowsiness during 
the daytime is known to enhance the frequency of discharges in patients with epilepsy 
(Mattson et aI., 1965; Veldhuizen et aI., 1983). Anxiety or other causes of arousal itself 
suppress interictal discharges in most patients, but may enhance them in some (Rugland, 
1990). These effects may be diminished by the familiarisation with the study procedures. 
Yet we found no order effect with fewer discharges between the second and third EEG 
recordings. This could mean that, after dealing with the uncertainties of the first EEG, the 
subsequent EEGs were much less affected by the factors described above giving a more 
reliable picture of actual amount of discharges. This has implications for future studies, 
particular AED studies, insofar that children should be familiarised with the 
EEG/ambulatory recordings before the actual study data are ascertained as has been done 
here. 
The overall tolerance for lamotrigine was good with numbers of reported side effects 
similar to other studies (Culy and Goa, 2000: Messenheimer et aI., 2000). As expected the 
most common side effect was a drug rash in seven patients during the lamotrigine phase. 
This rash led to withdrawal in five patients. This is a relatively high incidence compared to 
newer studies is be explained by the faster introduction of lamotrigine in our study. in 
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accordance with the recommendations at the time. The recommended dose titration has 
since been slowed which has decreased the incidence of rash (Wong et aI., 1999). 
Lamotrigine reduced significantly the duration of discharges per hour, but not the total 
number per hour. However, these figures include ten patients with no interictal discharges 
at any time of the study. This is in contrast to other studies, where the effect of lamotrigine 
on discharge frequency was considerable. Binnie et ai. (Binnie et aI., 1986) reported a 
reduction of 78-980/0 in discharge rate following a single oral dose of lamotrigine and a 
marked reduction in response to photic stimulation. Seven out of ten patients had a 
reduction of discharges during a seven-day administration of lamotrigine in a double-blind 
placebo-controlled study (Binnie et aI., 1987). Using an ambulatory spike and wave 
monitor Besag (1994 ) evaluated the effect of lamotrigine on spike and wave discharges in 
17 children and adolescents with epilepsy. There was a marked reduction of discharges of 
more than 80% compared with baseline in eight patients. These findings in patients with 
on-going epilepsy have been confirmed by others (Chevalier et aI., 1995; Marciani et aI., 
1996). 
One explanation for the conflicting results on the effect of lamotrigine on discharges arises 
from different study designs. As discussed above baseline recordings show more 
discharges than subsequent recordings. If discharge frequency under lamotrigine were 
compared to a baseline recording (Besag, 1994; Marciani et aI., 1996) part of the effect 
might be due to the familiarisation of the patients to the procedures rather an effect of the 
drug. The intra-patient variability of interictal discharge frequency further complicates the 
assessment of AED effects. This is particularly important in patients who have few 
discharges in whom drug effects are difficult to demonstrate. Furthermore, the numbers of 
patient in most of the above mentioned studies were small. More importantly. in all these 
studies patients had active, usually severe epilepsy and frequent discharges. Our results 
suggest that the effect of lamotrigine on interictal discharges differs in patients with 
uncontrolled seizures. 
Besag found no association between the reduction of discharges and the reduction of overt 
seizures (Besag, 1994). In our study the number of patients with a 50% seizure reduction 
on lamotrigine was too small for statistical analysis. More recently, a double blind. 
placebo-controlled, cross-over study on the effect of lamotrigine on interictal discharges in 
children with drug-resistant epilepsy has been published (Eriksson et aI., 2001). Twelyc 
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patients aged 4-12 years, most of them with Lennox-Gastaut syndrome, had 24-hour 
telemetry EEG recordings during baseline, placebo and lamotrigine phases. Similar to our 
results only the duration not the frequency of discharges was significantly reduced. Ten of 
12 patients showed a reduction of duration of interictal discharges on lamotrigine by a 
mean of 810/0. It is also important to note, that these patents were recruited from a larger 
group of patients who had responded to lamotrigine with a reduction of seizures or 
improvement of behaviour. They also noted that particularly long discharges of a duration 
of more than 30 seconds were significantly reduced, whereas shorter periods of discharges 
or single discharges were not affected. As none of our patents had discharges of this 
duration it is not surprising that the mean reduction in our group of patient was less. 
Thus, it appears that in humans lamotrigine has an effect on the termination rather than on 
the initiation of discharges. This confirms the findings in animal studies which suggest that 
lamotrigine is a use dependent inhibitor ofNa+ currents and thus acts on the slow 
inactivated state terminating interictal discharges (Xie et ai., 1995). 
In conclusion, inter- and intraindividual variations of discharges make it difficult to 
evaluate the effect of antiepileptic drug on discharges without prolonged EEG recordings. 
Lamotrigine has a moderate suppressive effect on interictal discharges in children who are 
seizure-free but may be more effective in reducing discharges in patients with ongoing 
seizures or drug resistant epilepsy. 
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Chapter 6: Effect of lamotrigine and interictal discharges 
on behaviour 
6.1. Summary 
Objective: It is generally agreed that children should be treated for epilepsy only if 
they have clinical seizures. The aim of this study was to examine whether 
suppressing interictal discharges affect behaviour in children with epilepsy. 
Methods: In a double blind, placebo-controlled, cross-over study, 61 children with 
well-controlled or mild epilepsy were randomly assigned to add-on therapy with 
either lamotrigine followed by placebo or placebo followed by lamotrigine. 
Ambulatory EEG recordings and behavioural assessments were performed during 
baseline and at the end of placebo and drug phases. The null hypothesis was that 
lamotrigine would not affect behaviour in patients with a reduction of EEG 
discharges. 
Results: Global rating of behaviour improved only in patients who showed a 
reduction in either frequency (p<0.05) or duration of discharges (p<0.05) during 
active treatment, but not in patients without a change in discharge rate. This 
improvement was mainly seen in patients with partial epilepsy (p<0.005). 
Conclusion: Our data suggest that suppressing interictal discharges can improve 
behaviour in children with behavioural problems and epilepsy, particularly partial 
epilepsy. Focal discharges may be involved in the underlying mechanisms of 
behavioural problems in epilepsy. 
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6.2. Introduction 
Children with epilepsy are at a higher risk of developing behavioural problems and 
psychiatric disorders than their healthy peers (Rutter et ai., 1970) or than children 
with other chronic disease (Hoare, 1984). This is not only important for children with 
uncontrolled epilepsy and learning difficulties but also for that majority of children 
with epilepsy whose seizures respond well to antiepileptic drugs (AEDs) and who are 
educated in mainstream schools. Even those children have been found to have more 
learning and behavioural problems in school compared to matched controls and 
achieve less than expected for their age and IQ (Seidenberg et aI., 1986; Aman et aI., 
1992). 
Increased behavioural problems in children with epilepsy are a consequence of a 
number of interacting influences including underlying brain lesion, age of onset, 
AEDs, psychosocial issues, seizure type and frequency, and interictal EEG 
abnormalities (Kwan and Brodie, 2001; Hoare, 1984). See section 1.2.3.6 and 1.4 for 
more details. The only way to determine whether discharges cause cognitive and 
behavioural problems in children with epilepsy or are co-existent due to a common 
cause, is by determining whether cognition and behaviour improve when EEG 
discharges are suppressed. It is generally agreed by neurologists and paediatricians 
that patients should be treated for epilepsy only if they have clinical seizures. 
Treating the EEG, so called 'EEG cosmetics', is generally condemned. 
In order to test this view a double-blind, placebo-controlled, cross-over trial was 
carried out to assess the effect of suppressing interictal discharges on behaviour in 
children with epilepsy. The null hypothesis was that suppression of discharges would 
not be associated with a change in behaviour. To avoid the confounding factor of 
changing seizure frequency on behaviour only patients were included who were 
seizure free or who had infrequent seizures. It was essential to exclude an 
independent psychotropic effect of the drug on behaviour and thus both patients with 
and without interictal discharges were included. Consequently it was possible to 





Patients were recruited from paediatric outpatient clinics at three study sites: Guy's 
Hospital, King's College Hospital and The National Centre for Young People with 
Epilepsy (NCYPE, former St Piers Lingfield), UK. Patients aged 7 to 17 years were 
eligible if they had a confident diagnosis of epilepsy and were seizure free or were 
having occasional seizures but in whom the responsible clinician or parent/careers 
felt that further adjustments to AEDs was not warranted. For more details on patient 
recruitment and inclusion criteria see chapter 3.5. 
6.3.2. Procedure 
This was a double blind, randomised, placebo-controlled, cross-over study with 
lamotrigine. See section 3.6 for study protocol (Figure 3.7 and Table 3.2) and dosage 
regime (Table 3.1). 
6.3.3. Efficacy, Safety and Behaviour Assessments 
See section 3.4 for assessment of interictal discharges and section 3.6 for safety 
assessment. The methodology of assessment of efficacy (suppression of ID), safety 
and behaviour has been outlined in sections 3.4, 3.6 and 3.2.1 respectively. As 
described in section 3.5 these assessment were carried out at entry to the trial and the 
end of each treatment phase - either lamotrigine or placebo. 
6.3.4. Statistical analysis 
Statistical methods for the discharge data are outlined in section 3.4 and 5.3. Changes 
in global rating of behaviour were analyzed by repeated measurement multivariate 
analysis of variance (ANCQY A) bct\veen treatment groups (lamotrigine and 
placebo), with response to lamotrigine as covariant (\\"ith or without reduction of 
subclinical epileptiform discharges number/duration). To identify the most relevant 
behavioural subscale the univariate test was used. The following variables were 
considered as within-subject factors: order of randomization, occurrence of seizures, 
lQ and type of epilepsy. SPSS 10.0 for Windows was used for all statistical analyses. 
A p-value of <0.05 was considered significant. All statistical tests used were 2-tailed. 
Analysis was by intention to treat. 
Changes in global rating of behaviour were analyzed by repeated measurement 
multivariate analysis of variance (ANCOV A) between treatment groups (lamotrigine 
and placebo), with response to lamotrigine as covariant (with or without reduction of 
discharges). To identify the most relevant behavioural subscale the univariate test 
was used. A p-value of <0.05 was considered significant. All statistical tests were 2-
tailed. Analysis was by intention to treat. 
6.4. Res ults 
Of the 64 patients screened, 61 were enrolled in the study and randomly assigned to 
receive first lamotrigine and then placebo or vice versa (figure 5.1). Thirteen children 
were withdrawn from the study, including two children who did not enter the double-
blind treatment phase. Eight of these children had discharges. Patients in both groups 
had similar demographics and baseline characteristics (table 5.1). 
Details on seizure frequency and results of ambulatory EEG recordings see chapter 5. 
The effect of lamotrigine on seizures and ID is detailed in chapter 5. 
In summary twenty-one (440/0) patients had a reduced frequency of discharges, whilst 
16 (330/0) patients either had no change or an increase in the frequency of discharges 
and 11 (23) patients had no discharges during either lamotrigine or placebo phase. 
Twenty-three (480/0) patients had a reduced duration of discharges whilst 14 (290/0) 
patients either had no change or an increase of discharge duration and 11 (230/0) 
patients had no discharges in either lamotrigine or placebo phase. The effect of 
lamotrigine on discharges was silnilar across the types of epilepsies. 
The n1ean behavioural scores at baseline as assessed by both parents and teachers for 
the whole group were all within the normal range (50 ± 1 SO) (table 6.1). Taking 
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scores of more than two SD above the mean as abnormal in individual patients(the 
higher the score, the more disturbed the behaviour), 13 (220/0) had at least one 
abnormal score in the parental assessment and 20 patients (33 %) had at least one 
abnormal score in the teachers' assessment (Table 6.1). 




Antisocial 42.28 5.78 0 
Anxious/shy 52.02 12.15 6 (10) 
Conduct disorder 48.38 10.50 5 (8) 
H yperacti ve/immature 47.75 10.08 4 (7) 
Learning problem 47.65 9.17 2 (3) 
Obsessive compulsive 50.85 10.95 5 (8) 
Psychosomatic 5l.63 9.13 3 (5) 
Restless/ disorganized 52.98 10.25 3 (5) 
Teachers scale 
Asocial 53.53 13.20 6 (10) 
Anxious passive 53.72 10.13 5 (8) 
Conduct problem 5l.60 10.70 4 (7) 
Daydream/attention 57.40 13.23 13 (22) 
Emotional/indulgence 54.60 12.09 7 (12) 
H yperacti vi ty 52.65 9.74 5 (8) 
Table 6.1: Behavioural scores at baseline 
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Frequency of interictal discharges Duration of interictal discharges 
With Without With Without 
reduction reduction reduction reduction 
Mean SD Mean SD F Mean SD Mean SD F 
Global score -1.34 4.56 .47 3.48 2.17* -1.16 4.49 .39 3.54 2.50* 
Parental sub-scores 
Antisocial -2.72 4.96 -0.18 4.17 .33 -2.58 4.86 -0.19 4.27 0.01 
Anxious -1.44 7.36 0.05 4.66 .01 -1.47 7.15 0.14 4.76 0.l2 
Conduct disorder -3.39 6.35 -1.36 4.23 5.67* -2.74 6.80 -1.86 3.62 4.39* 
Hyperactive -2.00 6.24 -0.82 5.61 .97 -1.68 6.22 -l.05 5.64 0.69 
Learning problem -1.39 7.16 -0.23 3.65 2.86 -0.89 7.29 -0.62 3.23 2.43 
Obsessive 0 6.42 0.45 5.54 2.80 0.53 6.64 0.00 5.24 2.83 
Psychosomatic -2.78 10.25 -0.45 6.59 2.94 -3.53 10.48 0.33 5.59 4.40* 
Restless -2.61 4.12 -1.77 6.88 .01 -2.58 4.00 -l.76 7.05 0.01 
Values shown are calculated by subtracting the score during placebo phase from the corresponding score during lamotrigine phase so that a 
negative score reflects an improvement in behaviour and a positive score a worsening. * p<0.05 
Table 6.2 a) Observed changes in global score as well as parental behavioural subscale T -scores during placebo and lamotrigine phases 
comparing patients \vith and without a reduction of inter ictal discharges on lamotrigine: Only patients with a reduction of 10 
showed an improvement of the global behavioural score. 
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Frequency of interictal discharges Duration of interictal discharges 
Without With Without 
With reduction 
reduction reduction reduction 
Mean SD Mean SD F Mean SD Mean SD F 
Teacher sub-scores 
Asocial 1.67 4.63 0.82 9.74 0.67 1.32 4.75 1.10 9.89 0.57 
Anxious passive 1.00 4.16 0.95 6.61 2.52 0.53 4.54 1.38 6.45 2.76 
Conduct problem -1.44 11.43 1.32 6.42 1.82 -0.79 11.47 0.86 6.19 1.22 
Daydream -1.00 9.49 2.27 8.11 0.01 -0.95 9.22 2.38 8.29 0.07 
Emotional -2.06 12.14 2.64 8.14 1.33 -1.42 12.12 2.29 8.17 0.55 
H yperacti vi ty -2.00 10.57 0.86 6.16 1.61 -1.42 10.58 0.48 6.03 0.98 
Values shown are calculated by subtracting the score during placebo phase from the corresponding score during lamotrigine phase so that a 
negative score reflects an improvement in behaviour and a positive score a worsening. 
Table 6.2 b): Observed changes in teachers' behavioural subscale T-scores during placebo and lamotrigine phases comparing patients with 
and without a reduction of interictal discharges on lamotrigine: patients with a reduction of ID showed an improvement of the 
global behavioural score. 
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Whilst there was no difference in global rating of behaviour (combining parents' and 
teachers' scale) when comparing placebo and lamotrigine for the total group of 
patients (ANCOVA: F=0.79; df=14; ns), there was a significant improvement in 
global rating of behaviour in the children who showed a reduction of discharges 
during the lamotrigine phase (ANCOVA: frequency of discharges: F=2.17; df-14; 
p<O.OS; duration of discharges: F=2.S0; df-14; p<O.OS). 
This improvement was seen across all parental subscales (range of mean difference 
for parental scale 0 to -3.9) and in 4 out of 6 subscales in the teachers' scale (range 
of mean difference for teachers' scale + 1.2 to -3.4). It was significant for the parental 
conduct disorder subscale (p<O.OS) and parental psychosomatic subscale (p<O.OS) 
(table 6.1 a and b). None of the teachers' subscales individually showed a significant 
difference in the univariate test. 
df F P value 
Place bo-Lamotri gine 14 0.788 ns 
Placebo-Lamotrigine discharge number 14 2.168 <O.OS 
Placebo-Lamotrigine discharge duration 14 2.S02 <O.OS 
Place bo-Lamotrigine randomisation 14 0.787 ns 
Place bo-Lamotrigine seizures 14 1.087 ns 
Placebo-Lamotrigine IQ 14 0.704 ns 
Placebo-Lamotrigine type of epilepsy 14 1.128 ns 
Table 6.3: ANCOV A: Difference between groups and effect of covariates and 
within-subject factors 
This effect depended largely on whether patients had a partial or generalized epilepsy 
(ANCQVA: F=3.S3; df=14; p<O.OOS). Patients with partial epilepsy were more likely 
to show an improvement of behaviour when discharges were suppressed whereas a 
change of behavioural rating in patients with generalized epilepsy was independent 
of the effect on discharges. There was no difference between idiopathic partial 
epilepsy and syn1pton1atic partial epilepsy. 
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A similar difference was seen depending on which drug the patient was on 
(ANCOVA: F=2.78; df=28; p<O.OOl). Patients with carbamazepine were more likely 
to have an improvement of behaviour if discharges were suppressed than patients 
with sodium valproate or other drugs. However, patients with partial epilepsy 
showed a similar effect whether on carbamazepine or on other drugs. There was no 
order effect due to randomization (ANCOVA: F=1.01; df 14; ns) nor presence of 
seizures (ANCOV A: F=0.26; df 14; ns). A sub-analysis of children without seizures 
at baseline (n=35) showed the same trends in the behavioural scales and similar 
results in the general linear modelling: a significant change in the global rating of 
behaviour during active treatment for patients with a reduction in frequency of 
discharges (ANCOVA: frequency of discharges: F=4.16; df=14; p<0.05) or duration 
of discharges (F=4.82; df 14; p<O.O 1). Table 6.2 summarises the results of the 
ANCOVA. 
6.5. Discussion 
In this study suppression of interictal discharges was associated with improved 
global rating of behaviour in children with behavioural problems and well-controlled 
epilepsy. This is the first study to present such evidence in patients with epilepsy 
under controlled conditions. The controlled study design with standardized 
behavioural questionnaires and an appropriate number of patients avoided 
methodological pitfalls as recently discussed (Kwan and Brodie, 2001). 
Single observations and uncontrolled reports have claimed an improvement of 
cognitive functioning by suppressing discharges with AEDs in patients with epilepsy 
(Rugland, 1990; Aarts et ai., 1984). Our group has previously performed a 
preliminary study using sodium valproate or clobazam add-on to suppress discharges 
in ten children with uncontrolled epilepsy. A reduction of discharge rate was 
associated with improvement in global rating of psychosocial function in eight out of 
ten children (Marston et aL 1993). However, all but one patient showed an 
unexpected reduction in seizure frequency on active treatment thereby making it 
difficult to interpret the results. To remove this confounding factor in the present trial 
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only patients were included who were either seizure free or were having few 
seizures. There were no significant differences between patients with and without 
seizures. In clinical practice, occasional seizures are not considered to represent any 
substantial seizure burden and these patients are often regarded as well controlled. 
Generalized spike-and-slow-wave discharges may be accompanied by subtle clinical 
changes (TCI) as demonstrated on close assessment including psychological 
monitoring (Binnie, 2003). To exclude these children would involve ignoring a major 
group of subjects who might benefit from the treatment proposed. Even though all 
patients had a degree of behavioural and/or cognitive dysfunction reported by 
parents, this was not reflected by the baseline scores of the total group of patients. 
Nevertheless, due to the design of the study the conclusions necessarily apply to 
children with some concern about learning or behaviour. They can not be taken to 
apply to children about whom no such concerns are expressed. Nevertheless, it is the 
case where the concerns are expressed or not depends upon the norms and 
expectations of parents and teachers - which may vary. 
In clinical research, behavioural scales, such as the Conner Rating scale or the 
Achenbach Child Behaviour Checklist, are often employed to compare t-score before 
and after intervention quantitatively rather than qualitatively defining what is a 
normal or abnormal score (Aman et aI., 1992; Weglage et aI., 1997; Stores et aI., 
1998). This may obtain a significant result which mayor may not be clinically 
relevant, but this problem is inherent to all research using behavioural scales in 
children with mild problems. 
My findings are in contrast to a recent study in eight children with learning and 
behavioural problems whose behaviour did not improve on active treatment with 
sodium valproate (Ronen et aI., 2000). However, only four patients had a reduction 
of discharges and more importantly no separate analysis was performed for patients 
with and without reduction of discharges. 
It was mainly patients with partial epilepsy who benefited from discharges 
suppression. In this study lamotrigine had a similar effect on discharges in both 
partial and generalized epilepsy. Although more patients with idiopathic partial 
epilepsy had frequent discharges, many patients with symptomatic partial epilepsy 
had no discharges or a low discharge frequency, making a relationship between 
baseline discharge frequency and magnitude of rating change unlikely. 
Patients on carbamazepine were also more likely to show an improvement in 
behaviour when discharges were suppressed compared to patients on other drugs. 
This was due to the choice of first line AEDs in partial and generalized epilepsy 
rather than due to an independent effect as carbamazepine is not associated with the 
improvement in partial epilepsy. It remains unclear whether the combination of 
lamotrigine and sodium valproate may cause more behavioural dysfunction than 
other combinations. It is well established that AED poly therapy itself is a risk for 
behavioural dysfunction in children with epilepsy (Bourgeois, 1998). By adding 
another drug into the current regime of our patients it is possible that behavioural 
problems were accentuated in some. Nevertheless, there was a significant 
behavioural improvement in the lamotrigine group in the patients with a reduction of 
discharges. 
Lamotrigine is one of the few AEDs, which suppresses discharges (Besag, 1994; 
Eriksson et aI., 2001). It does not appear to affect cognition adversely in patients with 
epilepsy (Besag, 1995; Meador and Baker, 1997). In a recent study low dose 
lamotrigine had a positive effect on reaction time measurements and on one out of 
six mood scales in healthy volunteers. However the number of volunteers tested was 
small (Aldenkamp et aI., 2002). Furthermore, several uncontrolled studies reported 
improved cognition and behaviour (Gibbs et aI., 1992; Uvebrant and Bauziene, 1994; 
Besag, 1994; Buchanan, 1995). In a double blind adjunctive study primarily in 
children with Lennox-Gastaut syndrome and uncontrolled epilepsy significant 
behavioural improvement and increased alertness were noted in all 17 "respondern" 
(>500/0 seizure reduction) during active treatment (Erikson et aI., 1998). This 
improvement was apparently unrelated to seizure control. 
An overall effect of lamotrigine could not be confirmed but rather an indirect effect 
via suppression of interictal discharges. The changes on the behavioural scale seen in 
our patients cannot be attributed to drug effects alone as they are confined to those 
subjects who showed a reduction of epileptiform activity on lamotrigine, and were 
not seen in those \vho showed no reduction or had no discharges. 
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In psychiatry, LTG is used for the treatment of depression (Ketter et aL 1999) for its 
anergic profiles, e.g., for the treatment of depression, apathy, and hypersomnia. Their 
assumed effect is cognitive activation. Mood improvements have been reported in 
several open clinical studies in epilepsy patients (Smith et aI., 1993; Brodie et aI., 
1995; Schapel and Chadwick 1996; Besag, 2000). In a controlled trial of interictal 
depression, LTG monotherapy was associated with earlier and larger improvement 
compared with valproate monotherapy (Edwards et aI., 2001). Recently it has been 
suggested that LTG also has a broad spectrum efficacy in bipolar disorder (Calabrese 
et aI., 1998). In a controlled study it was well-tolerated and had a similar effect to 
lithium, particularly for prophylaxis of depression (Calabrese et aI., 2003). The 
reported effects of quality of life and behaviour may be partially related to and 
explained by these mood effects. 
How are interictal discharges and psychosocial disturbances related? Interictal 
discharges and behavioural problems could both be caused by an underlying 
pathology, and thus be co-existing but independent phenomena. However, in this 
cross-over study the patients acted as their own controls and only those with a 
reduction in discharges showed an improvement of behaviour. Interictal discharges 
may cause fragmented sleep, a well recognized cause of cognitive and behavioural 
problems (Stores et aI., 1998; Cortesi et aI., 1999). In a recent study using 
lamotrigine no improvement of nocturnal discharges or neuropsychological function 
could be found (Placidi et aI., 2000). Finally, interictal discharges may cause 
psychosocial disturbances by directly interacting with cognitive and behavioural 
function. Using EEG-linked cognitive tests, TCI has been found in 500/0 of patients 
with sufficient discharges (Binnie and Marston, 1992). Generalized bursts lasting at 
least 3 seconds are most likely to produce demonstrable TCI, but they are also found 
during briefer and focal discharges (Aarts et aI., 1984; Shewmon and Erwin, 1988). 
TCI may impair day-to-day psychosocial function (Marston et aL 1993). It is well 
established that children with focal EEG abnormalities and/or complex partial 
seizures are particularly vulnerable to psychiatric and behavioural disturbance 
(Bagley, 1973: Hoare, 1984; Weglage et aL 1997). Our results provide evidence for 
the first time that particularly focal discharges may playa role in the underlying 
n1echanisms of behavioural problems. 
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Chapter 7: Effect of lamotrigine on cognition 
7.1. Summary 
Objective: There is evidence that lamotrigine does affect cognition in healthy 
volunteers or adults with epilepsy. This chapter addresses cognitive effects of 
lamotrigine in children with epilepsy. 
Method: In a double blind, placebo-controlled, cross-over study, 61 children with 
well-controlled or mild epilepsy were randomly assigned to add-on therapy with 
either lamotrigine followed by placebo or placebo followed by lamotrigine. Each 
treatment phase was 8 weeks, the cross-over period 6 weeks. A cognitive test battery 
was performed during EEG monitoring at baseline and at the end of placebo and 
drug phases. The paired student t-test was used for statistical analysis (2-ided) with a 
p-value of 0.01 considered significant. 
Results: We found no significant difference in continuous performance, binary 
choice reaction time, verbal and non-verbal recognition, computerised visual 
searching task, verbal and spatial delayed recognition and verbal and non-verbal 
working memory between placebo and lamotrigine treatment phase. Results were not 
influenced by the reduction of interictal discharges during active treatment. 
Conclusion: Results of this study suggest for the first time in a controlled manner 
that lamotrigine in the usually recommended doses has no significant cognitive 
effects in children. 
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7.2. Introduction 
There is evidence that AED treatment has a greater impact on cognitive function and 
behaviour than previously suspected. Bennet and Stores (1984) showed that children 
receiving any antiepileptic drug had impaired concentration and poorer processing 
ability, and were less alert than those receiving no treatment. Cognition, defined as 
the ability to acquire, retain, process and act upon information, depends on many 
factors in the person's overall physical and mental state (e.g. pain, arousal, sensation 
and emotion). AEDs can act on all of these factors and thereby indirectly affect the 
cognitive process. 
The following cognitive domains have been established as particularly vulnerable in 
patients with epilepsy: speed of information processing, memory, alertness, sustained 
and focused attention, and motor fluency. Some studies also mention language and 
problem solving (Aldenkamp et aI., 1987, 1990). 
There are over 100 studies looking at the cognitive side effects of AEDs. most of 
them in adults. Nevertheless there is still much uncertainty because of methodical 
shortcomings in most studies. These include: small sample size, short observation 
period, open label studies, no or inappropriate controls, no or inadequate 
randomisation and inappropriate statistical methods (Devinsky, 1995; Kwan and 
Brodie, 2001; Brunbech and Sabers, 2002; Loring and Meador, 2004). The situation 
is even more uncertain in children with epilepsy (Loring and Meador et aI., 2004) 
although studies in rats have demonstrated potentially serious effects of AEDs on the 
developing brain, including apoptotic neurodegeneration (Olney et aI., 2002). Even 
modest cognitive side effects in children may have significant consequences because 
they can influence learning of new skills and the ability to develop social strategies. 
There is convincing evidence that phenobarbitone has a negative effect on IQ in 
children with epilepsy (Farwell et aI., 1990. 1992) which appears to have a long-term 
effect on academic achievement even after drug withdrawal (Wolf et al., 1981). The 
effects of other established AEDs in children are largely unclear due to the above 
mentioned methodical problems. Cognitive impairment is likely to occur with 
phenytoin and clonazepam, but is less evident with sodium valproate. and 
carbamazepine. Further, there are very few studies of the more recently introduced 
AEDs in children using formal testing (Loring and Meador, 2004). 
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Studies in adults and children suggest that lamotrigine is better tolerated than most 
long-established antiepileptic drugs. Sedation and other CNS side effects in 
particular are less common and quality-of-life studies suggest that it has 
comparatively few cognitive side effects (Steiner et aI., 1999; Gillham et aI., 2000; 
Jacoby et aI., 1996). However, only limited data exists on formal cognitive test 
performances in adults. Meador et aI. (2001) examined the effect of lamotrigine on 
healthy volunteers. They assessed cognitive and behavioural effects of 
carbamazepine and lamotrigine in 25 healthy adults using a double-blind, 
randomized crossover design with two 1 O-week treatment periods avoiding many of 
the above problems. Direct comparison of the two AEDs revealed significantly better 
performance on 19 (48%) variables for lamotrigine but no changes for 
carbamazepine. Differences spanned both objective cognitive and subjective 
behavioural measures, including cognitive speed, memory, mood factors, sedation, 
perception of cognitive performance, and other quality-of-life perceptions. 
Comparison of lamotrigine with non-drug average (placebo) revealed better 
performance on one (2.5%) variable for non-drug average and on one (2.5%) 
variable for lamotrigine. The authors concluded that in contrast to carbamazepine, 
lamotrigine produces no adverse cognitive and behavioural effects in healthy 
volunteers. They did not interpret the better performance of lamotrigine in one 
variable compared to placebo as evidence for a positive effect of lamotrigine on 
cognition as it was only one out of 19 variables. Similar results were found by others 
(see section 1.1.3.5 for the following studies: Martin et aI., 1999; Aldenkamp et aI., 
2002). 
In a randomised, placebo-controlled, double-blind, cross-over, add-on study of 
lamotrigine in adult patients with refractory epilepsy, 54 patients completed a small 
cognitive test battery including three tests of concentration and psychomotor 
performance (Smith et aI., 1993). The lamotrigine dosage was 400 mg/day (patients 
receiving enzyme-inducing drugs only) or 200 mg/day (patients receiving an 
enzyme-inducing drug and valproic acid). Patients were tested at baseline and at the 
end of each treatment period with no significant difference between lamotrigine and 
placebo shown. The same result was found in a number of small studies in adult 
patients with epilepsy (Banks et aI., 1991; Placidi et aI., 2000). 
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There are open studies and single case reports in children suggesting that lamotrigine 
has a similar CNS profile in children. However, no randomised and controlled 
studies have been published so far. This is the first placebo controlled study on the 




Patients were recruited from pediatric outpatient clinics at three study sites: Guy's 
Hospital, King's College Hospital and The National Centre for Young People with 
Epilepsy (NCYPE, former St Piers Lingfield), UK. Patients aged 7 to 17 years were 
eligible if they had a confident diagnosis of epilepsy and were seizure free or were 
having occasional seizures but in whom the responsible clinician or parent/careers 
felt that further adjustments to AEDs was not warranted. For more details on patient 
recruitment and inclusion criteria see chapter 3.5. 
7.3.2. Procedure 
This was a double blind, randomised, placebo-controlled, cross-over study with 
lamotrigine. See chapter 3.6 for study protocol (Figure 3.7 and Tab. 3.2) and dosage 
regime (Tab. 3.1). 
7.3.3. Neuropsychological test battery 
The following cognitive tests were performed at baseline and the end of both placebo 
and LTG treatment phase during EEG monitoring. All tests were considered suitable 




Continuous performance test 
FEPSY Verbal and Non-verbal Recognition Tests 





FEPSY Computerised Visual Searching Task 
Binary choice reaction time 
N -Grams memory test: words and corsi (also used for TCI testing) 
See chapter 3.1 for details about the cognitive test battery. 
7.3.4. Statistical analysis 
Data were explored by plotting test results at placebo and lamotrigine for each test. 
As the main purpose of this part of the study was to compare lamotrigine with 
placebo, the primary analysis was a series of paired t-test for placebo versus 
lamotrigine across the neuropsychological variables. As 13 variables were examined 
the level of significance was increased to 0.0 l. If the correct Bonferroni method (c= 
k!/2!(k-2)!) were to be used, only a p-value of 0.001 would be considered significant. 
As we were concerned to detect for a deterioration of cognition, a significance level 
of 0.01 errs on the side of caution. An ANCOV A with Greenhouse-Geisser test was 
used to examine period and carry-over effects as well as to examine whether the 
presence or absence of interictal discharges influenced the result Creduction of 
discharges' as between-subject factor). If significant differences between placebo 
and active treatment were detected an ANCOVA would be used to exclude effects 
due to multiple comparisons. To inspect the consistency of the findings the data was 
also analysed by comparing the raw means for all variables using the non-parametric 
Sign test. 
7.4. Results 
Of the 64 children screened, 61 patients were included (39 males. 22 females; mean 
age: 1l.5 years, range 7-17 years). All patients underwent randomisation and entered 
the single-blind baseline phase: 31 were randomised to receiYe first lamotrigine and 
then placebo and 30 the reverse order. However. two children \\'cre not enrolled in 
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the treatment phase: one had deterioration in seizure control and the parents of one 
withdrew consent. Figure 5.1 illustrates the trial profile. The characteristics of both 
groups were similar (Table 5.1). The seizure frequency did not change significantly 
during the study (Table 5.2). Forty-seven patients were seizure free at baseline 
(77%),40 during the placebo phase (78%) and 39 during the lamotrigine phase 
(81 %). In the three months preceding baseline the mean seizure frequency was 3.43 
(SD 13.4, range 0-90) seizures per month, during the placebo phase 3.24 (SD 10.38. 
range 0-50) seizures per month and during the lamotrigine phase 3.21 (SD 14.69, 
range 0-90). 
Adverse events were evaluated for 59 patients after exclusion of the two patients who 
were withdrawn in the single blind baseline phase. Apparent treatment related 
adverse events were observed in 23 of 59 patients (390/0) during the lamotrigine 
phase and in 19 of 52 patients (37%) in the placebo phase (Table 5.3). 
Figures 7.1 -7.8 show the box plots comparing placebo with lamotrigine for all tests. 
For tests measuring scores or correct responses (Tracker test: figure 7.1, FEPSY 
recognition tests: figure 7.2, SMTS-16 faces and words: figure 7.3, CYST score: 
figure 7.4, Ngrams compound scores: figure 7.7) a higher value signifies an 
improvement. For reaction times (CYST reaction time: figure 7.5, Tiger test: figure 
7.6, Ngrams corsi and words reaction time; figure 7.8) a higher value signifies a 
deterioration of cognitive function. None of the tests show an obvious difference 
between placebo and lamotrigine phase. Some of the tests have extreme values, 
particularly the tracker test, the SMTS-16 tests, the tiger test and the CYST. 
Therefore an additional nonparametric analysis is appropriate. 
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N= 41 41 
Placebo Lamotrigine 
Figure 7.1 : Box plot for Tracer test (continuous performance score): no obvious 
difference between placebo and lamotrigine. 0 : outliners (cases with 
values between 1. 5 and 3 box lengths from the upper or lower edge of the 
box), *: extremes (cases with values more than 3 box lengths from the 
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Verbal- LTG Non-verbal- LTG 
Figure 7.2 : Box plot for FEPSY Recognition test: verbal and non- erbal cr. 
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Figure 7.4: Box plot for CYST test (score) : no obvious difference b tween p\ac bo 
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Figure 7.5: Box plot for CYST (median reaction time): no obvious difference 
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Left hand - LTG Right hand - LT G 
Figure 7.6: Box plot for Tiger test (choice reaction time) no obvious differ nc 
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N= 41 41 41 41 
Spatial - placebo Spatial - LTG Words - placebo Words - LTG 
Figure 7.7: Box plot for NgrmTIs working memory spatial and words (compound 
score): no obvious difference between placebo and lamotrigine. Legend: 


















N = 41 41 41 
Spatial - placebo Spatial - LTG Words - placebo Words - LTG 
Figure 7.8: Box plot for NgrmTIs working memory (reaction time): no ob IOU 
di fference bet en plac bo and ImTIotrigine . Leg nd : Figur 7.1 
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Baseline Placebo Lamotrigine 
Mean ±SD mean ±SD mean ±SD 
Tracker 5.84 l.50 6.43 l.23 6.36 l.14 
Recognition verbal 18.20 3.71 19.58 3.35 19.08 3.50 
Recognition non-verbal 14.49 3.34 15.05 3.84 15.05 3.52 
SMTS-16, faces c 0.08 .25 0.14 .24 0.03 .29 
SMTS-16, faces d 2.10 .81 2.41 .60 2.23 .72 
SMTS-16, words c 0.12 .28 0.16 .24 0.02 .25 
SMTS-16, words d 2.24 .80 2.56 .68 2.43 .78 
CYST, corr 22.63 2.10 23.l6 1.49 23.43 l.19 
CYST, median * 8.16 3.47 6.98 l.94 7.40 2.24 
Tiger right * 0.45 .14 0.41 .11 0.41 .09 
Tiger left * 0.42 .14 0.39 .11 0.38 .08 
Corsi comp 0.73 .16 0.79 .15 0.81 .13 
Words comp 0.66 .13 0.67 .14 0.67 .12 
Corsi RT * l.43 .79 l.05 .33 l.13 .34 
Words RT * 3.67 l.53 3.37 1.49 3.61 l.08 
Table 7.1: Mean scores and reaction times of neuropsychological tests. 
* higher score signify a worse result (reaction times). 
Comparison of mean values of performance at placebo with lamotrigine revealed 
slightly better performance on lamotrigine in two variables (CVST score, Ngrams 
corsi compound score), no change in three (Tiger right hand reaction time, FEPSY 
recognition non-verbal score, Ngrams words compound score) and slight 
deterioration of performance in eight (Tracer score, FEPSY recognition verbal score, 
SMTS 16 faces and words, CYST reaction time, Tiger left hand reaction time, 
Ngran1s corsi reaction time, Ngrams words reaction time). None of these differences 
were significant at a 0.01 level (Table 7.2). 
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Paired t-test Sign test 
Mean () SD t-test: p Z P value 
Tracker score 0.00 l.10 1.00 1.00 
Recognition verbal 0.71 2.35 0.07 -1.64 0.10 
Recognition non verbal 0.26 3.08 0.60 -0.74 0.46 
SMTS-16, d faces 0.17 0.74 0.14 0.00 l.00 
SMTS-16, d words 0.15 0.66 0.17 -1.44 0.15 
CYST, score -0.26 l.15 0.14 0.26 
CYST, median RT * -0.34 1.56 0.l4 0.00 1.00 
Tiger left * 0.01 0.06 0.52 -0.31 0.76 
Tiger right * 0.02 0.06 0.06 -l.19 0.23 
Corsi comp score -0.01 0.08 0.34 -.47 0.64 
Words comp score 0.00 0.07 0.66 -0.15 0.88 
Corsi reaction time * -0.08 0.25 0.05 -2.14 0.03 
Words reaction time * -0.22 1.19 0.23 -1.83 0.07 
Table 7.2: Effect of LTG on cognitive function: mean differences between placebo 
and lamotrigine with results of paired-t tests and the non-parametric Sign 
test. No significant p value on a 0.01 level was found. Mean b: mean 
difference. * are tests which are a negative value score signifies 
deterioration and a positive score improvement of performance (reaction 
times). In all other tests negative values signify improvement and a 
positive score deterioration. 
An ANCOVA with repeated measures was used to examine period and carry-over 
effects. Test values of first, second and third test session were compared with 
randomisation as between-subject factor. Table 7.3 gives the mean values of all 
cognitive variables according to test session and the corresponding ANCOV A F and 
p values. In ten out of 13 variables each consecutive session produced a better result. 
Only in two variables (tracker test and non-verbal recognition test) was the second 
session better than the third and in one (SMTS-16 faces) was the first s~ssion better 
than the second and the third best. Comparison using ANCOV A vvith repeated 
measures reveals a significant overall period effect (F(26.98)=1.6.+; p<O.05). Four 
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out of thirteen variables showed a significant Greenhouse-Geisser test (p<0.05): 
Tiger test (right and left hand), CYST score and reaction time. All the significant 
variables showed the typical learning profile, with each consecutive session 
improving. However, when randomisation is taken into account, there was no 
significant difference between sessions (F(26,98)=1.07; p=OA). 
In the delayed recognition test (SMTS-16) there was no relevant bias during baseline. 
placebo or lamotrigine in either of the tests (faces and words). The C response bias 
scores were within a small range around neutral bias (Table 5A). There was no 
significant change in bias comparing placebo with lamotrigine. 
Faces Words 
Mean SD Mean SD 
Baseline 0.8 ± 0.25 0.12 ± 0.28 
Placebo 0.14 ± 0.25 0.16 ± 0.24 
Lamotrigine 0.3 ± 0.29 0.2 ± 0.25 
Table 7.3: Bias in delayed recognition test (SMTS-16). Bias was small at all phases 
(baseline, placebo and lamotrigine) and did not change significantly 
during active treatment. 
The Sign tests similarly showed that the number of means favouring one condition 
over the other was not significant in any of the 13 variables (Table 7.2). The means 
favoured lamotrigine over placebo in 5 variables and favoured placebo over 
lamotrigine in seven variables (scores were even in one variable). Thus, no condition 
was superior over the other in any of the variables. 
Twenty-one and 23 patients had reduction of number and duration of interictal 
discharges during lamotrigine compared with placebo (see chapter 5). Table 7.5 lists 
the mean differences between lamotrigine and placebo according to reduction of 
discharges or no reduction of discharges during active treatment. There was no 
significant difference between the two patient groups in respect to cognitive side 
effects during lamotrigine treatment (number of discharges: F(26.86)=1.95: ns: 
duration of discharges: F(26,86)=1.81 ;ns). 
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15t seSSIon 2nd seSSIOn 3rd seSSIOn ANCOVA ANCOVA 
(session) (session *rando ) 
Mean SD mean SD mean SD F Sig. F Sig. 
Tracker score 5.84 1.50 6.47 1.01 6.33 1.34 0.39 0.65 0.39 0.65 
Recognition verbal 18.20 3.71 19.27 3.86 19.39 2.92 0.28 0.65 0.55 0.50 
Recogn ition non verbal 14.49 3.34 15.38 3.67 14.71 3.68 0.60 0.51 0.54 0.54 
SMTS-16, d faces 0.08 0.25 0.05 0.29 0.12 0.25 2.37 0.11 2.47 0.10 
SMTS-16, d words 2.10 0.81 2.26 0.73 2.38 0.59 2.57 0.09 0.53 0.58 
CYST, score 22.63 2.10 23.06 1.52 23.53 1.12 5.83 O.Olt 0.84 0.43 
CYST, median RT * 8.16 3.47 7.26 2.12 7.11 2.08 5.38 O.Olt 1.29 0.28 
Tiger left * 0.45 0.14 0.41 0.11 0.40 0.09 5.05 O.Olt 0.14 0.85 
Tiger right * 0.42 0.14 0.39 0.11 0.38 0.08 6.03 O.Olt 0.74 0.46 
Corsi comp score 0.73 0.16 0.78 0.15 0.82 0.13 1.00 0.36 1.30 0.28 
Words comp score 0.66 0.13 0.67 0.13 0.67 0.13 1.02 0.32 1.07 0.31 
Corsi reaction time * 1.43 0.79 l.14 0.35 1.04 0.32 2.36 0.12 1.74 0.19 
Words react ion time * 3.67 1.53 3.51 1.12 3.47 l.47 1.96 0.16 0.66 0.47 
-
~ ___ L-. _____ 
-
Table 7.4: Mean values of cognitive variables according to test session. Comparison with ANOVA with repeated measures: Four variahles 
were significant for session (tGreenhouse-Geisser test: p<0.05), but none when randomisation (rando) is taken into account. * 
higher score signify a worse result (reaction times). 
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- --~ 
Reduction of No reduction of Reduction of No reduction of 
number ofID number ofID duration of ID duration of ID 
Mean 8 SD Mean 8 SD Mean 8 SD Mean 8 SD 
Tracker score .05 .89 -.05 1.28 .00 .89 .00 1.30 
Recognition verbal .88 2.29 .57 2.44 .89 2.22 .55 2.50 
Recognition non verbal .24 2.31 .29 3.65 .50 2.50 .05 3.58 
SMTS-16, d faces .21 .75 .14 .73 .25 .75 .10 .73 
SMTS-16, d words 
-.04 .70 .32 .60 -.04 .68 .34 .61 
CYST, score -.05 .83 -AI 1.34 -.05 .79 -A4 1.39 
CYST, median RT * -.32 1.43 -.35 1.68 -.35 1.36 -.33 1.75 
Tiger left * .00 .05 .01 .07 .00 .05 .01 .07 
Tiger right * .01 .04 .02 .07 .01 .04 .02 .07 
Corsi comp score .01 .07 -.03 .08 -.01 .09 -.02 .06 
Words comp score -.01 .06 .00 .08 -.01 .07 .00 .08 
Corsi reaction time * -.11 .26 -.05 .24 -.12 .26 -.04 .24 i 
I 
Words reaction time * -.07 1.47 -.34 .92 -.26 1.52 -.19 .79 
I 
- - -- - -
L _ _ 
- -
Table 7.5 Mean differences (mean 8) of cognitive tests according to suppression of interictal discharges during active treatment. 
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7.5. Discussion 
This is the first controlled study evaluating cognitive side effects of lamotrigine in 
children with epilepsy using formal cognitive testing. We found no significant 
cognitive impairment during active treatment compared with placebo. 
Our findings are in concordance with previous reports in healthy volunteers (Cohen 
et aI., 1985; Hamilton et aI., 1993; Martin et aI., 1999; Meador et aI., 2000; 
Aldenkamp et aI., 2002) and adults with epilepsy (Banks et aI., 1991 Smith et aI., 
1993; Brodie et aI., 1999; Placidi et aI., 2000). Conflicting results have been 
reported by Ettinger and colleagues (1998): in seven patients with epilepsy and 
mental retardation, LTG add-on caused both positive and negative psychotropic 
effects as described by parents and supervising staff. No formal cognitive testing or 
behavioural scales were used. Due to the double blind, placebo-controlled, cross-over 
design, patient selection and comprehensive test battery we have avoided several 
methodological pitfalls described earlier (Devinsky, 1995; Kwan and Brodie, 2001; 
Brunbech and Sabers, 2002; Loring and Meador, 2004). 
We found a significant period effect comparing the three different test sessions with 
performance improving in each consecutive session. This improvement can be 
explained by a learning effect but a placebo effect has to be considered also. Even if 
tests thought to be appropriate for serial testing like a choice reaction time or the 
CYST we found a clear learning effect. This illustrates the importance of appropriate 
randomisation and control group as in our study. It also demonstrates the fallibility 
of studies where the cognitive function of the active drug phase is compared to 
baseline for example in the study by Placidi et aI., (2000). Here the effects of 
lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions were 
compared with baseline in 13 adults with drug-resistant focal epilepsy. They did not 
find a significant difference; however, any deterioration may have been masked by 
placebo and retest effect. Due to an evenly randomised cross-over design we have 
avoided this confounding factor. 
Several uncontrolled studies have reported improved psychosocial functioning 
during lamotrigine treatn1ent in patients with epilepsy. This included concentration, 
school or work performance and beha\'iour, particular in patients \\'ith learning 
difficulties. In 50 children with intractable epilepsy. 21 sho\\'ed a reduction in 
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absence and complex partial seizures with 5 patients becoming seizure-free 
following addition of lamotrigine (Uvebrant and Beuziene, 1994). The parents of 24 
of these children reported an improvement in their children's "mental state" , 
including longer attention span, improved alertness, and emotional stability. 
Although they found that the improvement was apparently unrelated to seizure 
control in some patients, this factor was not controlled for. Eight of thirteen autistic 
children in this study showed reduced symptoms after the addition of LTG therapy. 
In a double blind, placebo-controlled, parallel study parents and caregivers of 130 
children and adolescents with Lennox-Gastaut completed the Epilepsy and Learning 
Disability Quality of Life (ELDQOL) questionnaire at baseline and after 16 weeks of 
add-on lamotrigine treatment. Significant improvement was noted in mood and 
sociability in the lamotrigine group (Jacoby et al., 1996). Eriksson and colleagues 
performed a combined open-phase and controlled-phase (double blind, placebo-
controlled, cross-over) study with lamotrigine in patients with Lennox-Gastaut 
syndrome (Eriksson et al., 1998 and 2001). Of the 27 patients completing the open 
phase, 17 had a reduction of seizures, improvement of behaviour or motor skills 
(responder group) and 10 were classified as 'non-responder' with no improvement 
during the open phase. Fifteen patients of the responder group completed the 
controlled phase. Parents and staff members reported improvement in behaviour of 
all patients during lamotrigine, compared with the placebo phase. This correlated 
with a reduction of interictal discharges in most patients, where only half of 
responders had a more than 50% reduction of seizure frequency. However, no formal 
testing was performed and obviously due to the inclusion criteria for the controlled 
phase there is selection bias. 
Similar positive findings have also been described by others (Betts et aL 1991: 
Gibbs et al., 1992; Uldall et al., 1993; Fowler et aI, 1994; Buchanan, 1995). 
Several confounding factors have to be considered in the open studies without formal 
testing: (1) bias in patient selection (2) placebo effect, (3) reduction of seizure 
frequency during active treatment, (4) spontaneous fluctuations of seizure variables 
and EEG abnormalities (5) spontaneous fluctuations of cognition and behaviour in 
patients with learning difficulties It is well established that a higher seizure 
frequency is associated with an impairment of cognition and behayiour (Keith et aL 
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1955; Dikmen and Metthews, 1977; Farwell et aI., 1985; Dodrill, 1986; Singhi et aL 
1992). Thus, it is likely that a reduction of seizure frequency may result in 
improvement of cognitive function and behaviour. Even a small change of seizure 
frequency may have an impact or changes in seizure severity may have cognitive 
effects in some patients even if the absolute number of seizures did not change. 
Overall many of their patients did have a reduction in seizure frequency which must 
have influenced their results. 
Furthermore, it is unclear whether EEG discharges improved in these patients. A 
drastic improvement in behaviour and cognition has been described in patients with a 
reduction of discharges even when no change in seizure frequency was observed 
(Besag 1995). 
Most controlled studies in either healthy volunteers or adult patients with epilepsy 
could not confirm an improvement in cognitive performance using formal and 
controlled testing. Only Aldenkamp and colleagues (2002) found evidence for a 
selective effect of cognitive activation. There are however, several methodological 
shortcomings: 1) A very small dose of LTG was used, not comparable to VPA in the 
same study or in fact to the doses used to treat epilepsy. 2) Differences were not 
consistent, some changes being better for placebo than for LTG and others worse for 
placebo than for LTG. This is particularly inconsistent for visual reaction time where 
the dominant showed an opposite result to the non-dominant hand. 3) This raises the 
question as to whether the statistical method used was appropriate. As 12 factors 
were analysed, at least 3 could be significant on a 0.05 level by chance, but only one 
out of 12 cognitive test measurements was actually significant. No findings achieved 
the p< 0.001 level of confidence. Moreover, by using a t-test rather than ANCOV A 
possible confounding factors were not taken into account, such as hand dominance. 
4) The number of volunteers in this study with parallel design was smalL only 10 per 
treatment group, which in view of point 3) is particularly relevant. Thus, the findings 
may have been due to chance and may lack clinical relevance. 
We could not confirm such an improvement of cognitive function in any of our 
variables. Most of our patients were seizure-free and in the remaining patients 
seizure frequency did not change significantly. This has two implications: (1) seizure 
frequency was not a confounding factor in contrast to many open studies described 
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above. (2) Lamotrigine suppresses interictal discharges better in patients with se\'ere 
or on-going epilepsy (see chapter 5). There is evidence that interictal discharges are 
associated with cognitive impairment (see chapter 8) and a reduction of discharges 
may be associated with an improvement in cognition similar to the improvement we 
described in chapter 6. Thus, the effect of lamotrigine on interictal discharges and 
consequently cognition may be clinically relevant in patients with more severe 
epilepsy but not in patients with mild or well-controlled epilepsy. 
However, our study had the disadvantage of polytherapy in most patients. It is well 
recognised that poly therapy is associated with more cognitive problems (Thompson 
and Trimble, 1982; Trimble 1987; Duncan et al., 1990). Thus, a possible positive 
effect on cognitive performance may have been counter-balanced by the negative 
effect ofpolytherapy. 
In contrast, aggressive behaviour has been associated with lamotrigine, particularly 
in children with learning difficulties (Besag et al., 1995; Beran and Gibson, 1998). In 
an international, multicenter study 2.50/0 of children were found to have behavioural 
side effects. The authors contributed this behaviour least to patients becoming more 
alert, active, and demanding (Besag et al., 1995). They argued that this may be a 
necessary stage in the rehabilitation of such patients following an improvement in 
seizure control. Insomnia has also been reported in a small proportion of patients 
(Sadler, 1999), but most of these patients were taking a relatively high dose of 
lamotrigine. In addition, 'being more alert' and 'suffering from insomnia' are 
changes which relate to the same process. 
It has been suggested that the mode of action of lamotrigine is the cause for the lack 
of cognitive side effects: lamotrigine reduces glutamate release and consequently 
neuronal activity through inhibition of voltage-gated sodium (Na1) channels in the 
slow-inactivated state (Xie et aL 1995). Lamotrigine displays a use-dependent 
profile with the inhibition ofNal channels being more pronounced in rapidly firing 
neuron during epileptic discharges, but presumably not affecting neuronal firing 
under normal conditions. In addition to its effect at the voltage-gated Na1 channeL 
lamotrigine also inhibits voltage-operated calcium (Ca21) channels (\\' ang ct aL 
1996). Activation of both Na1 and Ca21 channels results in rising intracellular 
calcium levels and an increased cellular metabolic requirement. Increased energy 
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demands and cellular calcium levels contribute to excitotoxic cell death, a potential 
component of permanent cognitive dysfunction. The ability to reduce excitability in 
general, and calcium ion influx in particular, may explain the ability of LTG to 
reduce cognitive impairment arising from episodes of ischemia. In vitro studies have 
shown that lamotrigine inhibits glutamate release from rat cortex during hypoxia 
(Leach et al., 1991), whereas in vivo studies have illustrated the cerebroprotective 
effects of lamotrigine in rodent models of focal ischemia (Smith and Meldrum 1995). 
Mechanisms of cognition and memory are poorly understood at the molecular level. 
However, longterm potentiation is a form of synaptic plasticity that may form a basic 
mechanism for memory and learning (Bliss and Collingridge, 1993). It has more 
recently been reported that at anticonvulsant doses, lamotrigine had no effect on 
either the induction or the maintenance of long-term potentiation (Xiong and 
Stringer, 1997; Otsuki et al., 1998). In the gerbiL temporary bilateral occlusion of the 
common carotid arteries impairs escape from the Morris water maze and subsequent 
histological examinations reveal severe deterioration of hippocampal neurons. 
Gerbils treated with LTG are significantly better at escaping from the water maze 
and have significantly less ischemic cerebral injury (Wiard et al., 1995). Taken 
together the existing preclinical data suggests that LTG treatment does not result in 
any cognitive impairment and can protect against excitotoxic and ischemic insults. 
The subjective improvement of cognition in quality of life described in open and 
controlled studies (Smith et al., 1993; Brodie et al., 1995; Schapel and Chadwick 
1996) may also be explained an improvement in mood (see chapter 6). 
In conclusion, the results of our study suggest that lamotrigine has no significant 
cognitive side effects in children with mild epilepsy. Further studies are needed in 
patents with newly diagnosed epilepsy to evaluate a possible positive effect of 
lamotrigine on cognition. 
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Chapter 8: Effect of interictal discharges and TCI on 
cognition 
8.1. Summary 
Objective: There is evidence that interictal discharges are associated with cognitive 
impairment in patients with epilepsy. It is unclear whether such impairment is due to 
the discharges (transitory cognitive impairment or TCI) or whether both are a 
symptom of an underlying brain pathology. The aim of this chapter was to examine 
relationships between interictal discharges, TCI and cognitive performance. 
Method: Children with mild or well-controlled epilepsy were tested between one 
and three times using a comprehensive cognitive test battery including TCI testing 
during EEG monitoring. They were grouped according to the occurrence of interictal 
discharges and results of TCI testing into three groups: (1) no interictal discharges; 
(2) interictal discharges, but no TCI; (3) interictal discharges and TCl. Cognitive 
performance was compared between the three groups using one-way ANOVA. 
Results: Sixty patients were tested on a total of 158 occasions. Interictal discharges 
were found in 54% of any cognitive test session, but only in 37% of sessions were 
the number of discharges sufficient for analysis. Of these TCI was found in 63% on 
the first session, in 61 % in the second and 50% on the third session in a total of 21 
patients. Fourteen patients had consistent TCI results in all the sessions: 10 had TCI 
in all sessions, and 4 had no TCI in any session. There was a significant correlation 
between the side of discharges and the type of cognitive deficit (spatial or verbal), 
after correcting for hemisphere dominance. There was a tendency for patients with 
interictal discharges to have a poorer performance than patients without discharges 
and for patients with TCI to have worse performance compared to patients \vithout 
TCI. This difference was significant for 3 variables of working memory. 
Conclusion: Results of this study suggest Tel occurs in approximately half of those 
patients who have sufficient discharges to be tested, even if their epilepsy is \\'ell 
controlled. Interictal discharges are associated with cogniti\'e impairment 
particularly affecting working memory, in children \vith epilepsy. TCl is likely to be 
one of the causative factors for this. 
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8.2. Introduction 
There is convincing evidence that interictal discharges may be associated with 
cognitive impairment in patients with epilepsy. Subclinical or interictal discharges 
are defined as epileptiform EEG discharges not accompanied by clinical events using 
available methods of clinical observation (Aarts et al., 1984). Although this 
definition is controversial and not accepted by some (Besag, 1995; Aldenkamp and 
Arends 2004) is used in this study. 
Kl0ve (1956) found an association of left temporal discharges with lower verbal IQ 
score, while discharges on the right were associated with lower performance abilities. 
Patients with frequent discharges did more poorly in a performance measure of the 
Wechsler Adult Intelligence Scale than patients with infrequent discharges (Parsons 
and Kemp, 1960). These findings were confirmed by Dodrill and Wilkus (1976) in a 
large study grouping 90 patients according to the presence or absence, average rate 
(more or less than 1 per min), and topographic distribution of discharges (focal or 
generalised). They found that performance and full scale IQ were significantly lower 
in patients with discharges, particularly in the high frequency and generalised 
discharge groups. However, these studies provide no evidence as to whether 
discharges are temporally related to intellectual deficits. Moreover, the question as to 
whether or not there is a causal relationship cannot be evaluated by simple 
associations (see Figure 8.1). 
'brain pathology' 




















Figure 8.1: Possible interaction between interictal discharges, brain pathology and 
cognitive impairment. 
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It has been argued that the EEG abnormalities simply indicate the relative severity 
and distribution of cerebral pathology or pathophysiology among groups rather than 
reflecting a specific cause. 
In 1939 Schwab developed a method to measure visual reaction times during EEG 
recording. He found delayed or missing reactions during EEG discharges compared 
to presentations occurring without discharges. About 50 studies subsequently 
confirmed a direct temporal association between EEG discharges and brief 
impairment of cognitive function detectable with appropriate psychological testing 
(for reviews see Aarts et aI., 1984, Binnie, 2003). This was termed TCI (Transitory 
cognitive impairment); see section 1.4 for more detail. 
However, the relation between the duration of discharges and the severity of 
cognitive impairment, or between the laterality of discharges and the nature of 
dysfunction has not been fully examined. TCI may impair day-to-day psychosocial 
function. In children discharges are associated with faster, but less accurate reading 
(Kasteleijn-Nolst Trenite et aI., 1988) and impaired performance in IQ testing with a 
characteristic subtest profile (Siebelink et aI., 1988). In adults driving abilities were 
significantly impaired during interictal discharges in 3 out of 6 patients with epilepsy 
and frequent EEG discharges (Kasteleijn-Nolst Trenite et aI., 1987). 
It remains unclear whether suppression of interictal discharges with antiepileptic 
drugs (AEDs) can improve cognitive and psychosocial functioning. In a preliminary 
placebo controlled, add-on study with sodium valproate or clobazam in children with 
drug-resistant epilepsy, Marston et aI., (1993) found improved behaviour associated 
with reduction of interictal discharges in most patients. Chapter 6 describes the 
results of our double blind, placebo-controlled, cross-over study with lamotrigine 
add-on providing evidence that reduction of discharges improves behaviour in 
children with epilepsy. However, within the same group of patients no improvement 
of cognitive performance was seen during treatment with lamotrigine (chapter 7). 
The aim of this chapter is to examine the relationship between interictal discharges, 




Patients were recruited from paediatric outpatient clinics at three study sites: Guy's 
Hospital, King's College Hospital and The National Centre for Young People with 
Epilepsy (NCYPE, former St Piers Lingfield), UK. Patients aged 7 to 17 years were 
eligible if they had a confident diagnosis of epilepsy and were seizure free or were 
having occasional seizures but in whom the responsible clinician or parent/carers felt 
that further adjustments to AEDs was not warranted. For more details on patient 
recruitment and inclusion criteria see section 3.5. 
Patients were grouped according to the occurrence of interictal discharges and results 
of TCI testing into three groups: (1) no interictal discharges; (2) interictal discharges, 
but no TCI; (3) interictal discharges and TCI. 
8.3.2. Procedure 
This was a double blind, randomised, placebo-controlled, cross-over study with 
lamotrigine. See section 3.6 for study protocol (Figure 3.7 and Table 3.2) and dosage 
regime (Table 3.1). 
8.3.3. Neuropsychological test battery 
Patients were tested on three occasions within a 31 week period. Two were whilst on 
baseline medication (with or without placebo) and one was after adding lamotrigine 
to the AED regime. As earlier described lamotrigine did not affect cognitive 
performance (see chapter 7) and thus all three test sessions were analysed together. 
On each occasions the following investigations were performed: 
• Seizure history 
• Ambulatory EEG recording 
• Cognitive test battery 
• Tel testing 
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TCl testing was performed using the N grams test battery which has been developed 
from the computerized 'Modified Corsi' test (S.G. Coleshill, PhD 1999). The Ngrams 
measures working memory, the 'Corsi' subtest spatial memory, and 'words' subtest 
verbal memory. A Medlec® Profile EEG system by Taugagreining was used for co-
registration of EEG signal and for analysis. Sixteen chlorided silver electrodes \\'ere 
placed according to the Modified Maudsley placement at Fp2, Fp1, F4, F3, F8, F7, 
C4, C3, P4, P3, T4, T3, T6, T5, 02, 01. 
The test consists of presenting a sequential string of items on the touch-screen within 
a 3 x 4 matrix. Recall of the string (item, order of item, location and order of 
location) was indicated by the subject by touch-selecting items from a menu of 12 
possibles, then entering them into the array. Items appeared in a pseudo-randomised 
sequence. Each subtest consists of 40 trials, 4 of which are practice trials. The 
sequence length was adaptive to performance: when two consecutive sequences were 
performed correctly, the length of the sequence was increased by one (minimum 
length: 3 items, maximum: 5 items). The test was self-paced and depending on the 
memory capacity and speed of the child each test lasted between 30 and 45 min. It 
can be used as a working memory test or with real-time EEG co-registration as a TCl 
test. 
F or more detail on TCl testing see chapter 3.3. 
The following cognitive test battery was used. All tests were thought to be suitable 







Continuous performance test 
FEPSY Verbal and Non-verbal Recognition Tests 
Delayed recognition test (SMTS-16): words and faces 
FEPSY Computerised Visual Searching Task 
Binary choice reaction time 
N-Grams working memory test: words and corsi (also used for TCl testing) 
See chapter 3.1 for details about the cogniti\'e test battery. 
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8.3.4. Statistical analysis 
For Ngrams-words there are four principal fractionated working memory 
performance scores (Identity: id, Order of Identity: ida, Location: lac and Order of 
Location: loco), together with 2 derivative measures (Match score: mat and 
Compound score: camp). For Ngrams-corsi there are only two principal fractionated 
performance scores (Location: lac and Order of Location: loco), together with 1 
derivative measures (Compound score: camp). The Match score for any item in the 
string is a binary measure of the concordance between the two measures Identity and 
Location: a match score of one represents the correct item in the correct position; a 
score of zero represents a mismatch, irrespective of whether the sequence order was 
correct or incorrect. The Compound score is a general measure of performance 
including all measured variables. Each record with sufficient number of interictal 
discharges was analysed to determine whether an association exists between 
score/reaction time and occurrence of discharges during this particular triaL 
comparing trials with discharges to trials without discharges in the non-parametric 
Mann-Whitney test. A sufficient number of interictal discharges was defined as at 
least four trials with discharges during testing (excluding practice trials) or a 
maximum of 33 trials with discharges. A patient was considered to have TCI if the 
p-value was smaller than 0.05 in the compound score or the reaction time. In order to 
reduce the number of variables and therefore the risk of diagnosing TCI by chance 
impaired performance in other variables (lac or loco in Ngrams-corsi; id, lac, mat, 
ida, loco in Ngrams-words) alone was not regarded as TCl. 
See chapter 3.3 for more details on TCI analysis. 
Correlation between lateralisation and type of cognitive impairment was examined 
using the chi-square test. Cognitive performance was compared between the three 




Of the 64 children screened, 61 patients were included into the study (39 males, 22 
females; mean age: 11.5 years, range 7-17 years). One patient was excluded before 
cognitive testing was performed (parents withdrew consent). Ten patients were 
withdrawn before the second testing and another two before the third testing. Six had 
adverse events, parents of four children withdrew consent and one had protocol 
violations. Thus, a total of 158 test occasions were performed. 
The seizure frequency did not change significantly during the study (Table 5.2). 
Forty-seven patients were seizure free on baseline (770/0), 40 during the placebo 
phase (78%) and 39 during the lamotrigine phase (810/0). 
Seven patients were left handed. Six of them had symptomatic partial epilepsy and 
one had idiopathic generalised epilepsy. Another patient with symptomatic partial 
epilepsy was ambidextrous. The mean age of onset of left handed patients with 
symptomatic partial epilepsy was 4.1 years, in contrast to the whole group with a 
mean age of onset of 6.7 years. 
8.4.1. Interictal discharges 
On baseline interictal discharges were found in 42 out of 60 (70%) patients during 
ambulatory recording. In the initial ambulatory EEG recording 19 (31 0/0) children 
had no discharges and 42 (690/0) had discharges during the eyes open phase. In 
children with discharges the median number of discharges was 3.85/hr (range 0.6 to 
115.6/hr, SD 24.68) and the median duration of discharges was 4.75 sec/hr (range 1.0 
to 140.8 sec/hr, SD 33.78) (see chapter 5). These discharges were generalised in 11 
patients, focal in 17 (right sided in seven, left sided in three and bilateral in seven) 
and both focal and generalised in 14 patients (with focal discharges right sided in 
seven, left sided in three and bilateral in four). However, we found interictal 
discharges only in 33/60, 28/50 and 25/48 patients during cognitive testing on 
baseline, placebo and lamotrigine respectively. The number of discharges was 
sufficient for Tel analysis in 34-400/0 patients. This was due to too few discharges in 
7 patients and too many discharges in 2 patients on baseline, too fe\\' discharges in 8 
patients and too many discharges in 3 patients on placebo and too few discharges in 
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patients on lamotrigine. The four patients with too frequent discharges had idiopathic 
partial epilepsy. Table 8.1 summarises the occurrence of interictal discharges for all 
three test sessions. It becomes clear that lamotrigine does not suppress numbers of 
discharges in our group of patients (see chapter 5). The percentage of patients with 
sufficient numbers of discharges for TCI testing was 370/0 in our population. 
Baseline Placebo Lamotrigine All sessions 
Patient sessions 60 50 48 158 
ID in ambulatory recording 42 (70) 36 (72) 32 (67) 110(70) 
ID in TCI test 33 (54) 28 (56) 25 (52) 86 (54) 
Sufficient ID for TCI analysis 24 (40) 17 (34) 18 (38} 59 (37) 
Table 8.1: Occurrence of interictal discharges during ambulatory recording and 
cognitive testing (in %). id: interictal discharges, 
8.4.2. Tel analysis 
TCI defined as significantly poorer performance in RT and/or compound score 
during trials with discharges compared to trials without discharges was found in 21 
patients. Nine had TCI only in one test, seven in two tests, three in three tests, one in 
four, and one in five tests. Thus, 41 test sessions revealed TCl. Table 8.2 list the 
results ofNgrams Corsi and Ngrams Words on three test occasions. 
Ngrams-corsi revealed TCI on baseline in 7 out of 17 patients with sufficient 
numbers of discharges. In 2 this was due to a significant compound score and in 5 
due to a significant reaction time. In a further two patients loc was significant and in 
another loco. Interestingly all three patients had TCI at other occasions: one had a 
significant reaction time, another one had TCI in Ngrams-words on baseline and the 
last had Tel on placebo in words. On placebo TCI was due to a significant 
compound score in 4 patients and due to a significant reaction time in one patient. In 
no other patients was only loc or loco significant. On lamotrigine TCI was due to a 
significant con1pound score in 5 patients and due to a significant reaction time in 1 
patient. In no other patients was only loc or loco significant. 
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No ID Insuf. ID p<0.05 ns Too many 
BL (n 60) 
loc 4 (7) 13 (21) 
loco 3 (5) 14 (23) 
comp 2 (3) 15 (25) 
RT 5 (8) 12 (20) 
Comp/RT 32 (53) 9 (15) 7 (11) 10(17) 2 (3) 
PLC (n-49) 
loc 3 (6) 13 (26) 
loco 4 (8) 12 (24) 
comp 4 (8) 12 (24) 
RT 1(2) 14 (29)* 
Comp/RT 24 (49) 8 (16) 5 (10) 10 (20) 2 (4) 
LTG (n=48) 
loc 4 (8) 10(21) 
loco 5 (10) 9 (19) 
comp 5 (10) 9 (19) 
RT 1 (2) 13 (27) 
Comp/RT 25 (52) 8 (17) 6 (13) 8 (17) 1 (2) 
Table 8.2 (a): TCI in Ngrams Corsi test. Number of patients with significantly 
impaired performance during interictal discharges (% of patients). Only a significant 
difference in R T or Comp is considered as TCI, Impaired function in other variables 
is not regarded as TCl. ID: interictal discharges, insuf: insufficient, BL@ baseline, 
PLC: placebo, LTG: lamotrigine, loc: location, loco: order of location, comp: 
compound score, RT: reaction time, comp/RT: in reaction time or compound score. * 
one RT measurement failed. 
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NolD InsufflD TCI NoTCI Too many 
BL (n 58) 
ld 6 (10) 15 (25) 
Loc 6 (10) 15 (25) 
Mat 4 (7) 17 (28) 
ido 4 (7) 17 (28) 
Loco 5 (8) 16 (27) 
Comp 8 (13) 13 (22) 
RT 7 (12) 14 (25) 
Comp/RT 29 (50) 6 (10) 10 (17) 11 (19) 2 (3) 
PLC (n-49) 
ld 2 (4) 14 (29) 
Loc 1 (2) 15 (31) 
Mat 3 (6) 13 (27) 
ido 2 (4) 14 (29) 
Loco 2 (4) 14 (29) 
Comp 3 (6) 13 (27) 
RT 3 (6) 13 (27) 
Comp/RT 24 (49) 7 (14) 6 (12) 10 (20) 2 (4) 
LTG (n=48) 
ld 6 (13) 9 (19) 
Loc 0(0) 15 (31) 
Mat 2 (4) 13 (27) 
ido 4 (8) 11 (23) 
Loco 1 (2) 14 (29) 
Comp 6 (13) 9 (19) 
RT 5 (10) 10 (21) 
Comp/RT 24 (50) 8 (17) 7 (15) 8 (17) 1 (2) 
Table 8.2 (b): TCI in Ngrams Words test: Number of patients with significantly 
impaired perforn1ance during ID (0/0 of patients). Legend see (a). id: identity. mat: 
matching. ido: order of identity. 
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Ngrams-words revealed TCI on baseline in 10 out of21 patients with sufficient 
numbers of discharges. In 3 this was due to a significant compound score, in 2 due to 
a significant reaction time and in 5 due to both compound score and reaction time 
being significant. In a further four patients lac was significant. Again, all four 
patients had TCI on other occasions; one had a significant reaction time, another two 
had TCI in N grams-corsi on baseline and the last had TCI on lamotrigine in N grams-
corsi. On placebo TCI was due to a significant compound score in 3 patients and due 
to a significant reaction time in 3 patients. In a further patient only id was significant 
in one lac and loco, in one mat and in another only loco. All but one of these four 
patients had TCI on other occasions: two for reaction time and one for Ngrams-
words at baseline and for Ngrams-words on lamotrigine. On lamotrigine TCI was 
due to a significant compound score in 2 patients, due to a significant reaction time 
in 1 patient and in 4 due to both compound score and reaction time being significant. 
In a further patient only id was significant, and in another one id and ida. One of 
them had Tel for reaction time, the other had no Tel on any occasion. Tabe 8.3 
summarises Tel results. 
Note that included in this table are also patients without interictal discharges or 
insufficient number of discharges for statistical analysis. Numbers differ from Table 
8.1 because in Table 8.2 results are listed separately for Ngrams-corsi and words. If 
only patients with sufficient discharges are considered we found TCI in 33 to 41 % of 
patients in the Ngrams-corsi and in 38-480/0 in Ngrams-words (see Table 8.3). 
TCI@ Spatial Verbal Either 
Baseline n=24 410/0 480/0 630/0 
Placebo n=18 33% 38% 610/0 
Lamotrigine n= 18 36% 470/0 550/0 
Any phase n=30 480/0 52% 700/0 
Table 8.3: Summary of Tel results at different test seSSIOns III patients \vith 
sufficient numbers of discharges during testing. 
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Eight out of 26 patients with symptomatic partial epilepsy had sufficient interictal 
discharges at some point during the study and 6 of those had Tel. Seven out of 18 
patients with idiopathic generalised epilepsy had sufficient interictal discharges and -+ 
of those had TCI. Fifteen out of 16 patients with idiopathic partial epilepsy had 
sufficient interictal discharges and 11 of those had TCI. These included 2 patients 
with atypical partial epilepsy, 7 patients with benign epilepsy with centro-temporal 
spikes (BECT) and 2 patients with childhood epilepsy with occipital paroxysms. 
There was a tendency for patients with seizures (n=20) to be more likely to have Tel 
(9 out of 10 with sufficient discharges) than patients without seizures (n=40) (8 out 
of 20 with sufficient discharges) but this difference was not significant (i=2.857; 
df-l; p=0.091). 
Twenty patients had repeated TCI testing. Ten patients had two separate sessions 
three months apart and ten patients had 3 sessions with 3 months in between each 
session. This was distributed as follows: 
• TCI/TCI/TCI 4 patients 
• TCI/TCI 6 patients 
• no TCI/no TeI/no Tel 2 patients 
• no TCI/no TCI 2 patients 
• TCI/TCI/no TCI 2 patients 
• TCI/no TCI/no TCI 2 patients 
• TCI/no TCI 2 patients 
Thus, 14 patients had consistent results in all the sessions they did: 10 had Tel in all 
sessions, and 4 had no Tel in any session. Six patients had mixed results. but only 
two had TCI on baseline and/or placebo but not on lamotrigine. 
Table 8.4 summarises the association between lateralisation of discharges with the 
type of test in which Tel was found. Twenty one patients performed 41 positive Tel 
tests four had Tel for both Corsi and Words. Although there was a tendency for left , 
sided discharges to cause Tel in Words, this was not the case for right sided 
discharges (i=5.909; df 4: ns). 
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~ Corsi Words Both Total ID 
Right sided 5 9* 1 15 
Symmetrical 8 5 16 
Left sided 1 5 3 6 
Total 14 19 4 37 
* 5 were left handed, 
Table 8.4: Association between TCI and lateralisation of epileptiform activity 
However, of the nine positive Ngrams-words tests during right-sided discharges five 
were from left-sided patients (five positive test sessions of three patients). After 
correction for hemisphere dominance the chi-square test reaches a significant level 
(X2=9.840; df 4; p<O.05). 
Three left handed patients with right-sided discharges had TCI in the Corsi test: no 
left handed patient with left-sided discharges had TCI in the Corsi test. Thus, we 
found a significant correlation of side of discharges to the type of test (spatial or 
verbal), when correcting for dominant hemisphere in words. Table 8.4 also 
demonstrates that we found that TCI was just as common during focal interictal 
discharges as during bilateral or generalised EEG discharges. 
8.4.3. Relationship of ID, Tel and cognitive performance 
To evaluate whether interictal discharges or TCI effect overall cognitive 
performance, patients were grouped into the following groups: (1) no interictal 
discharges (n=94), (2) interictal discharges, but no TCI (n=24), (3) interictal 
discharges causing TCI (n=36). Patients with insufficient discharges for TCI analysis 
were grouped in the not discharge group. Trials with too many discharges for 
analysis were not included in the analysis, because the number of trials was too small 
(n=3) to constitute a separate group, but inclusion in any other group did not appear 
logical. Table 8.5 summarises comparison of test performance between groups for 1:; 





NolD ID, no TCI ID & TCI ANOVA 
mean SD mean SD Mean SD F Sig. 
Tracker level 6.33 l.38 6.33 0.86 5.75 1.44 2.50 ns 
Recognition v 18.97 3.65 20.18 2.46 18.10 3.84 1.86 ns 
Recognition nv 14.82 3.59 15.29 3.04 14.50 3.89 0.27 ns 
SMTS-16, faces 2.25 0.74 2.37 0.67 2.09 0.75 0.93 ns 
SMTS-16, words 2.46 0.76 2.45 0.69 2.20 0.83 1.26 ns 
CYST score 23.10 l.72 23.30 0.93 22.68 2.07 1.08 ns 
CYST, RT* 7.27 3.01 7.94 l.64 8.09 2.49 l.39 ns 
Tiger RT, left* 0.42 0.13 0.43 0.07 0.44 0.11 0.32 ns 
Tiger RT, right* 0.40 0.13 0.41 0.08 0.41 0.11 0.35 ns 
corSI comp score 0.81 0.16 0.75 0.12 0.72 0.14 4.79 0.01 
corsi RT* l.15 0.60 l.19 0.35 1.31 0.53 1.06 ns 
words comp 0.70 0.13 0.62 0.11 0.63 0.11 4.98 0.008 
words RT* 3.22 0.97 3.66 0.83 3.87 l.68 3.65 0.029 
Table 8.5: Mean values of cognitive test according to the three groups, as well as 
results of One-way ANOVA. * are variables where higher values indicate worse 
performance (reaction times). 
There was a tendency for patients with interictal discharges to have a poorer 
performance than patients without interictal discharges and for patients with TCI to 
have a poorer performance than patients without TCI (with or without interictal 
discharges). 
Performance was worst in patients with discharges for 12 out of 13 variables 
compared to patients without intericta1 discharges and in patients with TCI for 10 out 
of 13 variables compared to patients without TCI (Tab. 8.5). This difference was 
significant for 3 out of 4 working memory tasks: spatial Ngrams compound scores 
and verbal Ngrams compound scores and reaction time (p< 0.05). 
Figure 8.1 a and b show the mean compound scores and reaction times for the three 
groups in the working memory tests. Post-Hoc analysis (Scheffe) re\'ealed significant 
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Figure 8.2 (a) : Mean compound scores in Working memory test (Corsi: spatial; 
Words: verbal) according to presence or absence ofID and TCI. Higher values mean 
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Figure 8.2 (b): Mean reaction times in Working memory test (Corsi: pati al' Word 
verbal) according to presence or absence of ID and TCI. High r alu m an w r 
perfo rmanc . * p<O.05 in po t-Hoc analysis. 
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8.5. Discussion 
We found TCl in over half of the patients with sufficient numbers of interictal 
discharges for analysis in children with well-controlled or mild epilepsy. lnterictal 
discharges and TCl were associated with worse overall working memory compared 
to patients without interictal discharges. 
lnterictal discharges are common phenomena in patients with epilepsy. Around 500/0 
of patients show interictal discharges during a routine 30 min waking EEG recording, 
but 850/0 of individuals do so on some occasions (Ajmone Marsan and Zivin, 1970; 
Salinsky et aI., 1987, Sundaram et aI., 1990). lnterictal discharges are also found in 
family members of children with epilepsy (Gerken and Doose, 1973), and even in 1 -
3.5% of children without a history of clinical seizures (Eeg-Olafson et aI., 1971; 
Cavazzuti et aI., 1980). EEG discharges in general occur most readily in a relaxed, 
eyes-closed state and are suppressed by psychological testing. 
Detection of TCl demands a high initial discharge rate or a test that participants 
tolerate long enough to capture sufficient discharges and does not suppress 
discharges (Binnie, 2003). Although 70% of our patients had discharges in the 
ambulatory EEG recording, only just over a third had sufficient discharges during 
testing to perform TCI analysis. Similar findings have been described by Kooi and 
Hovey (1957), Tizard und Margerison (1963a) and Rugland (1990). Nevertheless, 
considering the discharge rate of most patients was not very high, the N grams test 
fulfils the criteria for a routine test for TCl according to Aarts et ai. (1984) not to 
suppress discharges so that testing is impossible. In some patients with idiopathic 
partial epilepsy discharge rate was even too high to allow statistical analysis, as there 
were too few discharge-free trials for comparison. 
We found TCI in 350/0 of all patients, but if only patients with sufficient discharges 
are considered the percentage (50 - 600/0 per test session) is similar to that in other 
studies (Binnie, 2003). As some patients were tested up to three times the number of 
positive tests was higher than so far described. This is most likely because we used 
both a compound score and reaction time. The 'Modified Corsi' test introduced by 
Binnie and co-workers (Aarts et aI., 1984; Binnie et aL 1987) has to be considered as 
the' gold standard' in TCl testing. They compared the number of correctly performed 
trials rather than a compound score and did not include the reaction time. Other 
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studies measured only the reaction time (Shimanzono et aI., 1953; Tizard and 
Margerison, 1963a; Davidoff and Johnson, 1964; Mirsky and Van Buren, 1965. Hutt 
and Fairweather, 1975; Pressler, 1997). Simple reaction time tests are not sensiti\e to 
TCI, particularly in focal discharges (Sellden, 1971), whereas more complex reaction 
time tasks detect TCI in similar numbers to complex memory tests (Hutt and 
Fairweather, 1975; Pressler, 1997). One could argue that by including more variables 
we only increased the statistical probability to find a positive result rather than 
increasing the sensitivity of the test. However, even if one included all sub-variables 
of the compound score only one further patient would test positive for TCI. This was 
a patient with very frequent discharges, who had been excluded from analysis 
because of too frequent discharges at 3 out of 6 test sessions. If increased probability 
was random one would expect more patients to test positive (10% per variable). 
It is known that focal discharges have a specific effect on test performance (Aarts et 
aI., 1984; Shewmon and Erwin, 1988a). See section 1.4.3.3 for more details. We 
could for the first time confirm the effect on a larger group of patients after 
correction for hemisphere dominance. It is interesting to note that most of our left 
handed patients had symptomatic partial epilepsy (six out of seven patients) with the 
presumed lesion in the left hemisphere. These children have a younger age of onset 
than the whole group. Three of the left sided patients had impaired verbal memory 
during right sided discharges. This correlates with the expected 500/0 of left handed 
subjects with right sided language dominance. Shewmon and Erwin (1988 a and b) 
showed lateralised effects of focal discharges on reaction times when the stimulus 
was presented in the visual field contralateral to the discharge or when the response 
was made with the contralateral hand. Thus, TCI is a specific impairment of 
cognitive function of the brain region involved in interictal discharges and not a 
global impairment of attention or channel capacity (Tizard und Margerison. 1963: 
Hutt et aI., 1977). Some patients will have impairment of reaction time, while others 
will have an impairment of verbal or spatial memory. Consequently, using a test \\ith 
both modules will increase the sensitivity of the test. Nevertheless. it is important to 
reduce the risk of false positive test results. and the compound score rather than t\\O 
(Ngrams-corsi) or four variables (Ngrams-words) appears a good compromise. 
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The test-retest stability ofNgrams was relatively good: 14 patients had consistent 
results on retesting, whereas 6 patients had inconsistent results. This is definitely' 
more than expected by chance. Considering the fluctuant nature of interictal 
discharges (see chapter 5), it is not surprising that TCI will not be found on every test 
occasion. Detection of TCI depends on discharge frequency. Too few or too many 
make statistical analysis impossible. More discharges increase the probability of 
disturbance. Furthermore, discharges occurring during stimulus presentation (Mirsky 
and Van Buren, 1965) or within the preceding 2 seconds (Binnie et aI., 1987 have a 
greater effect than discharges occurring during the response phase. A discharge 
during serial presentation is most likely to impair recall of the last item (Hutt and 
Gilbert, 1980). This suggests a disturbance of sensory or perceptual mechanisms or 
reduced capacity of working memory. Thus, failure to detect TCI does not indicate 
its absence: the number of discharges may be insufficient or not at the appropriate 
time of the trial. In other patients, the nature of the test may be inappropriate. 
This illustrates the predicament of TCI testing: In everyday life impairment from 
interictal discharges in children may be more common than indicated by formal 
testing. In most situations children are presented with new stimuli and often they are 
required to cope with both presentation of stimuli and respond at the same time. On 
the other hand children may be able to compensate for the impairment due to EEG 
discharges in ways poorly understood as these situations are difficult to simulate in 
the EEG lab. There is evidence that least scholastic performance is impaired in 
children with epilepsy and interictal discharges (Siebelink et aI., 1988). Chapter 6 
illustrated that suppression of EEG discharges can improve behaviour. 
We found evidence that children with well-controlled epilepsy and interictal 
discharges have the same percentage and characteristics of TCI than patients with 
on-going epilepsy. In addition we found TCI in patients with idiopathic or benign 
partial epilepsy. This is a particularly interesting group of patients with regard to Tel 
because according to the definition by the international classification of epileptic 
syndromes these syndromes are age-dependent, idiopathic, non-Iesional and not 
accompanied by neurological deficits. The most common syndrome is that of BECT. 
Theses children have frequent interictal discharges, yet seizures are infrequent and 
easily controlled, if AED treatment is required at all. This has implications for 
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treatment strategies in patients with epilepsy. Only two studies have described TCI in 
benign partial epilepsy (Binnie et aI., 1992; Pressler, 1997). See section 1.4.6. for 
more details. We were able to confirm these findings detecting TCI in 11 out of 15 
patients with idiopathic partial epilepsy, including children with BECT, childhood 
epilepsy with occipital paroxysms and atypical benign partial epilepsy. Some of the 
behavioural and cognitive problems described in these syndromes may be caused by 
TCI. Notwithstanding, prolonged nocturnal spike-wave activity is related to 
cognitive dysfunction in some patients with idiopathic partial epilepsy as has been 
described in children with Landau-Kleffner syndrome (Robinson et aL 2001) or 
ESES (Jayakar et aI., 1991). 
We were able to show a relationship between interictal discharges, TCI and overall 
cognitive performance. Although it has been suggested in the past that patients with 
frequent interictal discharges have impaired cognitive performance (KI0ve, 1956; 
Parsons and Kemp, 1960; Dodrill and Wilkus, 1976), for the first time patients with 
interictal discharges were divided into patients with and without TCI. Our study 
confirms these findings, but furthermore suggests that TCI plays a causative role in 
the cognitive impairment associated with interictal discharges, because in the same 
patients a temporal relationship was proven during the TCI test. It goes without 
saying that other factors also playa role in the neuropsychological impairment of 
people with epilepsy. 
Clearly TCI analysis differs from group analysis although both show a significant 
impairment in working memory. TCI testing is an intra-individual analysis of 
performance comparing performance with and without discharges within the same 
subtest. In contrast the group comparison is an inter-individual analysis comparing 
groups of patients according to the presence or absence of interictal discharges and 
TCI. It is reassuring that patients with TCI in a working memory test have overall 
worse performance of working memory compared to other patients. This confirms 
that Tel is a realistic impairment rather than a random statistical flaw. It also makes 
clear that a wide range of tests is necessary to be able to detect impairment in 
different individuals. Further studies are needed including a wider test battery. Only 
then would it be possible to e\'aluate a possible effect of medication on o\'erall 
cognitive performance. 
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Chapter 9: Discussion 
9.1. Summary of main findings 
The main theme of this thesis addresses the question as to whether interictal 
discharges have a direct effect on cognition and behaviour in children with epilepsy 
and whether suppression of discharges improves psychosocial function. 
The main findings of this thesis were: 
• Interictal discharges are common in children with epilepsy even if seizures 
are well controlled. Gender and type of epilepsy may influence the frequency 
of interictal discharges. 
• The spontaneous fluctuations of discharges in ambulatory recordings were 
considerable; number and duration varied more within than between subjects. 
Lamotrigine reduced the duration of discharges per hour, but not the total 
number per hour. 
• During active treatment with lamotrigine global rating of behavior 
significantly improved only in patients who showed a reduction in either 
frequency or duration of discharges, but not in patients without a change in 
discharge rate. This improvement was mainly seen in patients with partial 
epilepsy. 
• Lamotrigine had no significant effect on cognitive performance in children 
with epilepsy, specifically not on continuous performance, binary choice 
reaction time, verbal and non-verbal recognition, a computerised visual 
searching task, verbal and spatial delayed recognition and verbal and non-
verbal working memory. Results were not influenced by the reduction of 
interictal discharges during active treatment. 
• TCI was found in over 500/0 of patients with sufficient discharges for analysis. 
There was a significant correlation of side of discharges to the type of deficit 
(spatial or verbal), after correction for hemispheric dominance. Interictal 
discharges were associated with impaired memory performance, particularly 
in patients testing positi\'e for TCI. 
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9.2. Considerations 
There are other circumstances during which interictal discharges have a negative 
impact on cognition and behaviour which are distinct from Tel. The most important 
are: Nocturnal EEG discharges in children with ESES or Landau-Kleffner syndrome. 
autistic regression and non-convulsive status epilepticus. 
In the syndrome ofESES (see chapter 1.1.3.6) it is generally accepted that the severe 
cognitive deficits in the course of the syndrome are due to the frequent nocturnal 
epileptiform EEG discharges (Patry et aI., 1971; Tassinari et aI., 1985). There also is 
a relationship between the disappearance of these EEG abnormalities and 
improvement of function, although this is still under debate (Robinson et aI., 2001). 
Nonetheless there is consensus that in ESES there is no definite evidence to what 
extent the discharges itself, the disturbed sleep, or the various underlying aetiologies 
cause the cognitive deterioration. 
Landau-Kleffner syndrome (see chapter 1) is often seen as the paradigm syndrome to 
demonstrate the relationship between epileptiform EEG discharges and cognitive 
impairment. The EEG shows nocturnal epileptiform discharges, very similar to 
ESES, and sometimes centro-temporal spikes. Some argue that Landau-Kleffner 
syndrome is secondary to an active epileptic focus in the areas supporting language 
and point to the intermittent character of the language symptoms (Deonna, 1995). 
Others consider the epileptiform EEG discharges an epiphenomenon reflecting 
underlying brain pathology, rather than the direct cause of the language disorders 
(Holmes et aI., 1981). 
Autistic regression may also give some evidence on the effect of epileptiform EEG 
discharges. Some children with autism regress from a normal or mildly delayed 
baseline. Those children have a worse prognosis with respect to IQ and core features 
of autism. Tuchman and Rapin (1997) found no significant difference in the 
prevalence of interictal discharges with or without epilepsy between the group of 
children with a history of regression and those without. However, if children with 
epilepsy were excluded from the analysis, there was a significant increase in 
interictal discharges in those with a history of regression (19% vs. 10% - p<0.05). 
Tuchn1an has called this "autistic epileptiform regression" (Tuchman and Rapin. 
1997). The types of EEG abnormalities have in some cases reported to be similar to 
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those in the Landau-Kleffner syndrome and in ESES. This is probably only relevant 
to a minority of children with autism. 
Non-convulsive status epilepticus includes a heterogeneous set of states that have in 
common a change in mental state and EEG evidence of electro graphic seizures in the 
absence of clear convulsive seizures. As these states may be prolonged (at least 30 
minutes) and often evade notice because of the subtle nature of the clinical ictal 
activity, the cognitive effects of non-convulsive status epilepticus are a frequent issue 
in clinical practice. Often a definite diagnosis of non-convulsive status epilepticus 
cannot be made until EEG evidence is obtained. Two types of non-convulsive status 
epilepticus have been distinguished: (1) absence status epilepticus or generalized 
non-convulsive status epilepticus; and (2) complex partial status epilepticus. Long-
term cognitive effects were not observed by some (Scholtes et aI., 1995), whereas 
others (Treiman et aI., 1983), found memory impairments persisting over weeks. All 
studies show a favourable cognitive outcome in the long term. This conclusion is still 
under debate as animal studies (Lothman et aI., 1989) have demonstrated 
hippocampal neuronal loss in the CA-1 region after inducing a period of non-
convulsive status epilepticus in rats. As yet, this discrepancy with human data has not 
been clarified. However, in only few patients were baseline evaluations available 
(Dodrill and Wilenski 1990). In the light of this shortcoming, all claims of no 
cognitive impairment are limited to serious clinical effects, as more subtle effects 
have not been investigated. 
These phenomena are clearly different from TCl. Non-convulsive status is obviously 
a seizure even if it goes clinically undetected. In the ESES and Landau-Kleffner 
syndrome prolonged nocturnal discharges cause longer-lasting cognitive and 
behavioural disturbances. The temporal relation is different: these are not time 
locked deficits as in TCI even though treatment of discharges may result in an 
overall improvement of cognition. In addition, a child with ESES or Landau-Kleffner 
syndrome can also have TCI during daytime interictal discharges independent of the 
effect of nocturnal discharges. TCI may contribute to the cognitive problems in those 
patients but this is difficult to examine, not only because most children have too 
severe deficits to permit formal TCI testing. 
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If it can be shown that discharges are contributing to a patient's psychosocial 
difficulties, there arises the question of antiepileptic drug treatment of EEG 
phenomena. Obviously this proposition has been disputed. However, the point at 
issue is not whether to treat the EEG, but whether seizures, so subtle as to be 
recognisable only by EEG and behavioural monitoring, produce disability sufficient 
to justify treatment. This also questions the terms' subclinical discharges' and 
'interictal discharge': if they are causing cognitive changes like Tel and the 
behavioural changes as seen in this study, they are strictly speaking not subclinical. 
Equally, an event associated with disruption of neuropsychological function fulfils 
the criteria for a seizure and as such is not 'interictal'. The question is whether I 
should retain the terms 'subclinical epileptiform discharge' or 'interictal discharge' 
as they are currently used: 'a discharge during which the available methods of 
clinical observation, applied under particular circumstances, fail to show any changes 
in the patient' (Aarts et aI., 1984) or try and find a new name for this type of 
epileptiform discharge. 
A further dilemma is that discharges seen in the EEG mayor may not cause Tel or 
behavioural problems, depending in which area of the brain they occur. This thesis 
has confirmed Tel is a specific dysfunction of the brain area where the discharges 
occur (Aarts et aI., 1984) and thus, discharges may cause such a wide range of 
deficits that they are impractical to assess in every single patient. In addition, for 
many deficits, particularly behavioural problems, an appropriate test may not exist. 
Besag suggested the term 'subtle seizure' (Besag, 1994), however, the word seizure 
suggests at least some change felt by the patient if not a visible manifestation. 
Patients are in general unaware of EEG discharges and consequent Tel or 
behavioural changes. 
Although one should be open to question ones terminology and thus way of thinking, 
both terms' interictal discharges' and 'Tel' have been used in the literature for years 
and there is good general agreement among the international researchers. Moreoyer, 
animal studies have suggested that interictal discharges are indeed different from 
ictal discharges and the disruption caused has a different electrophysiological 
explanation. Lebovitz (1979) demonstrated the existence of a prolonged period of 
inhibition after a single interictal discharge. This has been confirmed in the acute 
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focal epilepsy animal model by others (for review, see de Curtis and Avanzini , 
2001). On the basis of experimental and clinical observations, it has been 
hypothesized that the interictal discharge-state represents a protective brain 
mechanism to prevent the occurrence of an ictal discharge( de Curtis and A vanzini. 
2001; Librizzi and de Curtis, 2003). Just after an interictal discharge, indeed, 
hippocampal after-discharges are not effective in generating a subsequent interictal 
discharge but induce small amplitude potentials subthreshold for the generation of a 
discharge (Librizzi and de Curtis, 2003). Halgren and colleagues (Halgren et aI., 
1978 a and b; Halgren and Wilson, 1985) studied the effect of electrical stimulation 
on behavioural performance during intracranial monitoring in patients with drug-
resistant epilepsy. They found evidence that the after-discharges are responsible for 
disruption of memory function in patients with hippocampal sclerosis. However, 
such studies are difficult to interpret, since after-discharges may propagate to remote 
brain regions. These studies suggest interictal discharge-induced synaptic inhibitory 
after-potentials rather than excessive synchronous electrical discharges of seizure 
activity may be involved in the disruption of cognitive performance during TCl. 
Semantic arguments and electrophysiological considerations apart, the case for 
possible treatment depends on showing that cognitive disturbances accompanying 
EEG discharges significantly affect the patient's psychosocial functioning in daily 
life. This study provides evidence to settle the controversy as to whether interictal 







~ cognitive impairment 
Figure 9.1: Interaction between interictal discharges, brain pathology and cognitive 
impairment. 
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Our results have far reaching implications for the treatment of children with epilepsy. 
Do we under-treat patients with epilepsy by aiming only to suppress clinical 
seizures? It appears that clinical seizures are only one aspect of neuronal dysfunction 
in epilepsy. Our study suggests that at least in children with epilepsy and additional 
behavioural disturbances, treatment of interictal discharges, if present, with 
appropriate antiepileptic drugs should be considered. Further studies, with larger 
numbers of patients and long-term follow-up are needed to assess the benefit of 
treating the EEG in patients with interictal discharges. 
9.3. Limitations of the study 
The following points have to be considered: 
• The patients had a wide range of syndromes, age of onset and different 
antiepileptic drugs. However, the hypothesis of the study was that 
interictal discharges are causing Tel and behavioural problems. Thus, 
regardless of the cause (syndrome), suppression of discharges would 
improve behaviour and/or cognition. 
• Not all patients were completely seizure free. Although the study would 
have been easier to interpret if all patients were seizure free, this would 
have made recruitment even more difficult. The rationale behind the 
inclusion criteria used was, that (1) it is unlikely that few very brief 
seizures have a relevant impact on behavior and that (2) during a 3-month 
period (equals one phase) no significant change in seizure frequency 
would be seen even if some children were not completely seizure free. 
Patients with so few seizures as to be ordinarily regarded as not requiring 
a change in medication are no less members of the group of potential 
candidates for AED treatment to improve behavior than are those \\'ho ar\.? 
seizure-free. In the event, the factor . seizure free' did not influence 
outcome (see chapter 6, 7 and 8). 
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• The study was very demanding for children and parents. During the 7-
month period they were required to attend at least 5 hospital visits, 4 of 
which would last 3-4 hours. Furthermore, they had 3 24-hour ambulatory 
recordings. They had to take medication in addition to their normal 
antiepileptic drugs although seizures were well-controlled. This resulted 
in poor compliance in some patients (chapter 5) and withdrawal of 
consent in 5 patients (nearly 10%). 
• Bias in patient selection. All children participating in this study had in 
addition to epilepsy some degree of behavioural problems or cognitive 
impairment. Nevertheless, this was not reflected by the baseline 
behavioral scores. Our results are only applicable for patients with some 
concern about learning or behavior, which may seem self-evident as one 
can hardly normalize normal behavior. It would be both unusual and 
unethical to include in a therapeutic trial subjects not showing the 
condition that it was proposed to treat. The presence or suspicion of 
behavioral problems as evidenced by parental complaints was therefore a 
proper and essential admission criterion. I feel it is appropriate that the 
population should be 'biased' towards that group of patients to whom the 
investigation relates. 
• Choice of behavioral measure. Although the Conner Rating scale has 
widely been used to evaluate behavior in children with epilepsy, more 
recently other tests are used, in particular the Achenbach Child Behavior 
Checklist. It remains open whether the latter test would have been the 
better choice. 
• Clinical significance of the improvement in behavioral score. It remains 
unclear what a relatively small improvement in global score means. The 
Connor Rating scale and other behavioral scales as the Achenbach Child 
Behavior Checklist have been used in clinical research as a quantitative 
measure by comparing the t-score before and after intervention rather 
than using it as a qualitative tool by looking for normal and abnormal 
scores (Aman et aL 1992; Marston et aL 1993; Weglage et al., 1997). 
This may provide a statistically significant result which mayor may not 
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be clinically relevant, but this is an inherent problem with all research 
using behavioral scales in children with mild problems. Since these are 
the majority of patients seen in epilepsy clinics I feel it is important to 
study this patient group. 
9.4. Further studies 
In view of the limitations of the study a further study with more patients, a more 
effective AED, but fewer investigations would test the results. In particular, the use 
of the Achenbach Child Behavior Checklist appears advisable. The results of this 
study make clear that lamotrigine is not very effective in suppressing interictal 
discharges in the majority of patients. An alternative should be sought. As discussed 
in section 1.2 few AED are effective in suppressing interictal discharges whilst at the 
same time having no or few adverse effects on cognition. There is good evidence 
emerging that levetiracetam has very few cognitive or behavioural side effects, while 
having good efficacy both in partial and generalised epilepsy (Neyens et al., 1995; 
Ben-Menachem and Falter, 2000; Cramer et aI., 2000). Preliminary studies suggest 
that it is also effective in suppressing interictal discharges (Gallagher et aI., 2004). 
In addition to patients with epilepsy there are in particular two groups of patients of 
great interest: 
1. Children with EEG discharges but without clinically evident epilepsy. As 
discussed in section 1.3 up to 3.50/0 of school children have interictal discharges. 
most of whom will have either centro-temporal spikes or generalized 3 per sec 
spike-and-wave discharges. It has been suggested that these children have an 
increased risk of behavioral and cognitive problems (Cavazzuti, 1980). but it 
remains unclear whether suppression of discharges influences psychosocial 
problems. Until further information is available, treatment of this group of 
children will continue to a clinical and ethical problem. 
, Children with autistic spectrum disorder with or without epilepsy. Tuchman and 
Rapin (1997) ha\'e suggested an association bet\\'een seizures and regression in 
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autistic children. Improvement in behaviour and language in the children after 
initiation of antiepileptic drug therapy has been seen as evidence that at least 
important aspects of the behavioural disorders are caused by the epilepsy and 
may thus be related to the occurrence of epileptiform EEG discharges. Most of 
this evidence is based on case studies and is not convincing (Nass et aI., 1998) 
and there is inadequate evidence on which to base specific recommendations 
(Tuchman, 2000). In fact, a recent study on the effects of lamotrigine on autistic 
behaviour did not show a significant difference to placebo in a group of 28 
autistic children aged 3 to 11 years (Belsito et aI., 2001). However, no EEG 
monitoring was performed and consequently data were not separately analysed 
for patients with and without interictal discharges. Autistic children have not 
been investigated for Tel and the exact effect of discharges in the autistic 
spectrum disorder is unclear. Further studies should include this group of 
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